Difference between revisions of "LncRNAWiki:Featured"
| Line 12,032: | Line 12,032: | ||
|oral squamous cell cancer;osteosarcoma;prostate cancer;ovarian cancer;non-small cell lung cancer;acute myocardial infarction;pancreaticobiliary maljunction;pancreatic cancer;melanoma;tongue squamous cell cancer;hepatocelluar cancer;bladder cancer;acute myeloid leukemia;esophageal squamous cell cancer;esophageal cancer;liver cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;urinary bladder;gastric cancer;endometrial cancer;breast cancer;hepatocellular cancer;squamous cell cancer;lung cancer;renal cell cancer | |oral squamous cell cancer;osteosarcoma;prostate cancer;ovarian cancer;non-small cell lung cancer;acute myocardial infarction;pancreaticobiliary maljunction;pancreatic cancer;melanoma;tongue squamous cell cancer;hepatocelluar cancer;bladder cancer;acute myeloid leukemia;esophageal squamous cell cancer;esophageal cancer;liver cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;urinary bladder;gastric cancer;endometrial cancer;breast cancer;hepatocellular cancer;squamous cell cancer;lung cancer;renal cell cancer | ||
|Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Endocrine System Diseases;Digestive System Diseases | |Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Endocrine System Diseases;Digestive System Diseases | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|- | |- | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289475 HSALNT0289475] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0289475 HSALNT0289475] | ||
Revision as of 05:07, 13 September 2019
| LncBook ID | Symbol | Synonyms | Functional Mechanism | Biological Process | Disease | Mesh Ontology |
|---|---|---|---|---|---|---|
| HSALNT0289501 | HPVC1 | PE5L,HPV18E5L | NA | pathogenic process | NA | NA |
| HSALNT0289605 | NONHSAT104559 | lnc-C9orf53-2:1 | NA | NA | NA | NA |
| HSALNT0199632 | N4BP2L2-IT2 | CG030 | NA | NA | NA | NA |
| HSALNT0171094 | LINC01150 | 2G7,TCONS_00019134 | NA | pathogenic process | Wilms' tumor | Neoplasms |
| HSALNT0289115 | LINC01587 | C4orf6,aC1 | NA | pathogenic process | neuroblastoma | Neoplasms |
| HSALNT0290105 | NONHSAT115106 | NONHSAT115106 | NA | NA | NA | NA |
| HSALNT0289234 | RNF217-AS1 | STL | NA | pathogenic process | acute lymphoblastic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0280481 | INE2 | NCRNA00011 | NA | NA | NA | NA |
| HSALNT0289485 | INE1 | NCRNA00010 | NA | NA | NA | NA |
| HSALNT0289511 | LINC01565 | C3orf27,GR6 | NA | pathogenic process | leukemia | Neoplasms |
| HSALNT0289068 | LINC00869 | KIAA0493 | NA | NA | NA | NA |
| HSALNT0289430 | ERC2-IT1 | C1orf1,C3orf51,Po42 | NA | pathogenic process | NA | NA |
| HSALNT0290394 | Lnc-PDIA4-1:1 | lnc-PDIA4-1:1 | NA | NA | NA | NA |
| HSALNT0289195 | NOP14-AS1 | C4orf10,RES4-24 | NA | NA | NA | NA |
| HSALNT0290309 | NONHSAT022116 | NONHSAT022116,AF080092,TSU | NA | developmental process | NA | NA |
| HSALNT0289243 | SMAD5-AS1 | SMAD5O,DAMS | NA | pathogenic process | malignant hematopoietic | Cell Physiological Phenomena |
| HSALNT0289025 | LINC00244 | C7orf4,NCRNA00244 | NA | pathogenic process | preaxial polydactyly | NA |
| HSALNT0289017 | KIF25-AS1 | C6orf54,NCRNA00300,HGC6.1.1 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289332 | LINC01558 | C6orf123,LINC01557,HGC6.2,dJ431P23.4 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289438 | AFDN-AS1 | C6orf124,MLLT4-AS1,HGC6.4,dJ431P23.3 | NA | pathogenic process | NA | NA |
| HSALNT0289232 | RFPL3S | RFPL3-AS1,RFPL3-A, NCRNA00005 | NA | pathogenic process | opitz syndrome | NA |
| HSALNT0289393 | RFPL1S | RFPL1-AS1,RFPL1-A, NCRNA00006 | NA | pathogenic process | NA | NA |
| HSALNT0289500 | HCG4B | HCG4P6,HCGIV-6,HCGIV.5,HCGIV-06,bCX67J3.3,Em:AB023056.16,bPG309N1.1,bQB90C11.3 | NA | NA | NA | NA |
| HSALNT0289894 | LINC00294 | NA | NA | NA | NA | NA |
| HSALNT0289345 | LINC00893 | NA | NA | pathogenic process | hunter syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| HSALNT0290133 | PCBP3-OT1 | PCBP3-OT1,FLJ44028 | NA | NA | NA | NA |
| HSALNT0289488 | ENST00000418282.1 | NCRNA00187 | NA | pathogenic process | blepharophimosis syndrome | Eye Diseases |
| HSALNT0289712 | COPG2IT1 | CIT1,NCRNA00170,COPG2AS | NA | NA | NA | NA |
| HSALNT0265040 | LINC00652 | HSPC072 | NA | developmental process | NA | NA |
| HSALNT0289282 | WASIR2 | NCRNA00286A | NA | NA | NA | NA |
| HSALNT0246856 | LINC00470 | C18orf2 | NA | pathogenic process | age-related macular degeneration | Eye Diseases |
| HSALNT0289507 | LINC00588 | C8orf71,DKFZP434F122 | NA | NA | NA | NA |
| HSALNT0276604 | TTC28-AS1 | TTC28AS,TTC28-AS,KIAA1648 | NA | NA | NA | NA |
| HSALNT0237577 | CDRT7 | NCRNA00025,LINC00025 | NA | NA | NA | NA |
| HSALNT0288912 | CDRT8 | NA | NA | NA | NA | NA |
| HSALNT0275048 | CECR3 | NA | NA | pathogenic process | cat eye syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| HSALNT0288915 | CECR9 | NA | NA | pathogenic process | cat eye syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| HSALNT0288998 | HDHD5-AS1 | CECR4,CECR5-AS1,NCRNA00017 | NA | pathogenic process | cat eye syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| HSALNT0288914 | CECR5-AS1 | NCRNA00017 | NA | pathogenic process | cat eye syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| HSALNT0288919 | CLRN1-AS1 | CLRN1O,UCRP | NA | pathogenic process | usher syndrome type 3 | NA |
| HSALNT0289271 | TMEM9B-AS1 | C11orf18 | NA | NA | NA | NA |
| HSALNT0289324 | LINC01547 | C21orf69,C21orf67 | NA | pathogenic process | Down syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0270409 | LINC00029 | C20orf51,NCRNA00029,bA305P22.4 | NA | NA | NA | NA |
| HSALNT0289336 | LINC00529 | C8orf8 | NA | pathogenic process | keratolytic winter erythema | NA |
| HSALNT0288978 | FLVCR1-AS1 | FLVCR1-DT,LQK1 | NA | NA | NA | NA |
| HSALNT0238050 | SMCR2 | NA | NA | pathogenic process | Smith-Magenis syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0289401 | SMCR5 | NCRNA00034 | NA | pathogenic process | Smith-Magenis syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0290246 | SMCR6 | NA | NA | pathogenic process | Smith-Magenis syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0274626 | LINC00205 | C21orf86,NCRNA00205, | NA | pathogenic process | NA | NA |
| HSALNT0271512 | C21orf91-OT1 | NCRNA00285,D21S2089E | NA | NA | NA | NA |
| HSALNT0272596 | LINC00307 | NCRNA00307,D21S2091E | NA | NA | NA | NA |
| HSALNT0274502 | TSPEAR-AS2 | C21orf90 | NA | NA | NA | NA |
| HSALNT0274807 | MCM3AP-AS1 | C21orf85,MCM3APAS,MCM3AP-AS,FLJ10508,NCRNA00031 | NA | NA | NA | NA |
| HSALNT0288888 | B3GALT5-AS1 | C21orf88 | NA | NA | NA | NA |
| HSALNT0288898 | BRWD1-AS2 | C21orf87,NCRNA00257,BRWD1-IT2 | NA | NA | NA | NA |
| HSALNT0289031 | LINC00315 | C21orf93,NCRNA00315 | NA | NA | NA | NA |
| HSALNT0289033 | LINC00334 | C21orf89,NCRNA00334 | NA | NA | NA | NA |
| HSALNT0289322 | LINC00314 | C21orf94,NCRNA00314 | NA | NA | NA | NA |
| HSALNT0271821 | LINC00308 | C21orf74,NCRNA00308,PRED16 | NA | pathogenic process | NA | NA |
| HSALNT0289023 | LINC00189 | C21orf109,NCRNA00189 | NA | pathogenic process | NA | NA |
| HSALNT0289375 | NCRUPAR | ncR-uPAR,ncRuPAR,NCRNA00193 | transcriptional regulation | developmental process | NA | NA |
| HSALNT0273467 | DSCR10 | NA | NA | NA | NA | NA |
| HSALNT0289480 | DSCR9 | NCRNA00038 | NA | NA | NA | NA |
| HSALNT0290051 | MDS2 | NA | NA | pathogenic process | myelodysplastic syndrome | Hemic and Lymphatic Diseases |
| HSALNT0127810 | ST7-AS2 | ST7OT2,ST7AS2 | NA | pathogenic process | autism | Mental Disorders |
| HSALNT0127813 | ST7-OT3 | ST7OT3,NCRNA00026 | NA | pathogenic process | autism | Mental Disorders |
| HSALNT0290258 | ST7-OT4 | NA | NA | pathogenic process | autism | Mental Disorders |
| HSALNT0290257 | NONHSAT122926 | NONHSAT122926 | NA | NA | NA | NA |
| HSALNT0289372 | MIR600HG | C9orf45,NCRNA00287,GL012,FLJ22161 | NA | NA | NA | NA |
| HSALNT0013239 | ATP1A1-AS1 | C1orf203,ATP1A1OS,MGC16179 | NA | NA | NA | NA |
| HSALNT0048563 | SPATA3-AS1 | NA | NA | NA | NA | NA |
| HSALNT0050859 | LINC00852 | C3orf42,GHRLOS2,NAG73,GHRL-AS2 | NA | NA | NA | NA |
| HSALNT0069395 | LINC01096 | NA | NA | NA | NA | NA |
| HSALNT0072367 | LINC02260 | NA | NA | NA | NA | NA |
| HSALNT0077259 | LINC01091 | NA | NA | NA | NA | NA |
| HSALNT0096480 | SAP30L-AS1 | FLJ38109,GALNT10-AS1 | NA | NA | NA | NA |
| HSALNT0098558 | PRR7-AS1 | NA | NA | NA | NA | NA |
| HSALNT0099356 | LINC01622 | TCONS_00011202 | NA | NA | NA | NA |
| HSALNT0113415 | LINC01312 | MGC34034 | NA | NA | NA | NA |
| HSALNT0134652 | EXTL3-AS1 | C8orf50 | NA | NA | NA | NA |
| HSALNT0138253 | C8orf34-AS1 | NA | NA | NA | NA | NA |
| HSALNT0154876 | PSMD5-AS1 | NA | NA | NA | NA | NA |
| HSALNT0163228 | LINC01553 | C10orf40,AC023904.2 | NA | NA | NA | NA |
| HSALNT0175689 | LINC00301 | C11orf64,NCRNA00301,MGC39681 | NA | NA | NA | NA |
| HSALNT0247235 | DLGAP1-AS3 | NA | NA | NA | NA | NA |
| HSALNT0254200 | CIRBP-AS1 | C19orf23,MGC39338 | NA | NA | NA | NA |
| HSALNT0257335 | LINC01785 | NA | NA | NA | NA | NA |
| HSALNT0261582 | LINC01869 | MGC45922 | NA | NA | NA | NA |
| HSALNT0269743 | LINC01711 | MGC4294 | NA | NA | NA | NA |
| HSALNT0288468 | FAM41AY1 | FAM41AY | NA | NA | NA | NA |
| HSALNT0288899 | C5orf66-AS2 | NA | NA | NA | NA | NA |
| HSALNT0288922 | CSTF3-AS1 | CSTF3-DT | NA | NA | NA | NA |
| HSALNT0288923 | CYP1B1-AS1 | C2orf58,MGC34824 | NA | NA | NA | NA |
| HSALNT0288957 | ENTPD3-AS1 | FLJ36665 | NA | NA | NA | NA |
| HSALNT0288970 | FAM27E3 | MGC42630 | NA | NA | NA | NA |
| HSALNT0288972 | FAM41C | NA | NA | NA | NA | NA |
| HSALNT0288977 | FLG-AS1 | NA | NA | NA | NA | NA |
| HSALNT0288983 | GABPB1-IT1 | FLJ10038 | NA | NA | NA | NA |
| HSALNT0289010 | ILF3-AS1 | ILF3-DT | NA | NA | NA | NA |
| HSALNT0289034 | LINC00347 | NA | NA | NA | NA | NA |
| HSALNT0289039 | LINC00466 | NA | NA | NA | NA | NA |
| HSALNT0289040 | LINC00471 | C2orf52,MGC43122 | NA | NA | NA | NA |
| HSALNT0289044 | LINC00526 | C18orf18,MGC17515,HsT959 | NA | NA | NA | NA |
| HSALNT0289048 | LINC00593 | C15orf50,MGC42951 | NA | NA | NA | NA |
| HSALNT0289050 | LINC00608 | NA | NA | NA | NA | NA |
| HSALNT0289054 | LINC00638 | MGC23270 | NA | NA | NA | NA |
| HSALNT0289056 | LINC00661 | NA | NA | NA | NA | NA |
| HSALNT0289057 | LINC00662 | NA | NA | NA | NA | NA |
| HSALNT0289062 | LINC00692 | NA | NA | NA | NA | NA |
| HSALNT0289064 | LINC00705 | NA | NA | NA | NA | NA |
| HSALNT0289067 | LINC00868 | C17orf52 | NA | NA | NA | NA |
| HSALNT0130693 | LINC00996 | NA | NA | NA | NA | NA |
| HSALNT0289101 | LINC01252 | NA | NA | NA | NA | NA |
| HSALNT0289131 | LINC02135 | NA | NA | NA | NA | NA |
| HSALNT0289193 | NIFK-AS1 | NA | NA | NA | NA | NA |
| HSALNT0289244 | SMG7-AS1 | DKFZP564C196 | NA | NA | NA | NA |
| HSALNT0235326 | SNAI3-AS1 | MGC23284 | NA | NA | NA | NA |
| HSALNT0215205 | SNHG10 | C14orf62,FLJ40557,NCRNA00063,LINC00063 | NA | NA | NA | NA |
| HSALNT0289290 | ZNF205-AS1 | MGC3771 | NA | NA | NA | NA |
| HSALNT0289294 | LINC00260 | C1orf217,NCRNA00260,MGC5457 | NA | NA | NA | NA |
| HSALNT0289295 | LINC00337 | C1orf211,NCRNA00337,MGC40168 | NA | NA | NA | NA |
| HSALNT0289298 | WAC-AS1 | NA | NA | NA | NA | NA |
| HSALNT0289299 | LINC00839 | NA | NA | NA | NA | NA |
| HSALNT0289303 | LINC00612 | C12orf33,MGC40170,FLJ41814 | NA | NA | NA | NA |
| HSALNT0289312 | LINC00663 | MGC39821 | NA | NA | NA | NA |
| HSALNT0289320 | LINC00494 | NA | NA | NA | NA | NA |
| HSALNT0289330 | LINC01019 | NA | NA | NA | NA | NA |
| HSALNT0289333 | LINC00265 | NCRNA00265,NCRNA00265-1 | NA | NA | NA | NA |
| HSALNT0289334 | LINC00689 | NA | NA | NA | NA | NA |
| HSALNT0289337 | LINC01591 | NA | NA | NA | NA | NA |
| HSALNT0289340 | LINC01501 | NA | NA | NA | NA | NA |
| HSALNT0289346 | LINC01560 | CXorf24 | NA | NA | NA | NA |
| HSALNT0289352 | LINC01959 | NA | NA | NA | NA | NA |
| HSALNT0289353 | LINC02175 | NA | NA | NA | NA | NA |
| HSALNT0289354 | LINC02209 | FAM183CP | NA | NA | NA | NA |
| HSALNT0289359 | LINGO1-AS1 | NA | NA | NA | NA | NA |
| HSALNT0289362 | MAFG-AS1 | MAFG-DT | NA | NA | NA | NA |
| HSALNT0289373 | MORF4L2-AS1 | NA | NA | NA | NA | NA |
| HSALNT0289381 | NPHP3-AS1 | NCRNA00119 | NA | NA | NA | NA |
| HSALNT0289385 | PAXIP1-AS1 | NA | NA | NA | NA | NA |
| HSALNT0289413 | TOLLIP-AS1 | NA | NA | NA | NA | NA |
| HSALNT0289416 | LINC00311 | TMEM148,NCRNA00311,MGC22001 | NA | NA | NA | NA |
| HSALNT0289422 | ZNF252P-AS1 | C8orf77 | NA | NA | NA | NA |
| HSALNT0289423 | ZNF436-AS1 | C1orf213,FLJ90508 | NA | NA | NA | NA |
| HSALNT0289429 | BFSP2-AS1 | MGC2848 | NA | NA | NA | NA |
| HSALNT0289432 | CTBP1-DT | C4orf42,CTBP1-AS1,CTBP1-DT,MGC21675 | NA | NA | NA | NA |
| HSALNT0289436 | EXOC3-AS1 | C5orf55 | NA | NA | NA | NA |
| HSALNT0289441 | HCG27 | bPG299F13.9,bCX101P6.9,bQB115I13.2,FLJ40123 | NA | NA | NA | NA |
| HSALNT0289450 | BAALC-AS2 | C8orf56,BAALCOS,MGC39526 | NA | NA | NA | NA |
| HSALNT0289453 | FAM87A | NA | NA | NA | NA | NA |
| HSALNT0289459 | JMJD1C-AS1 | NA | NA | NA | NA | NA |
| HSALNT0289465 | ATP2B1-AS1 | LINC00936 | NA | NA | NA | NA |
| HSALNT0289466 | CEP83-AS1 | CEP83-DT | NA | NA | NA | NA |
| HSALNT0289470 | HEXA-AS1 | C15orf34,FLJ13315 | NA | NA | NA | NA |
| HSALNT0289487 | BIN3-IT1 | FLJ14107 | NA | NA | NA | NA |
| HSALNT0289490 | CSNK1G2-AS1 | C19orf34,MGC39696 | NA | NA | NA | NA |
| HSALNT0289508 | LINC00634 | NA | NA | NA | NA | NA |
| HSALNT0289510 | LINC00685 | CXYorf10,NCRNA00107,PPP2R3B-AS1,OTTHUMT00000055574 | NA | NA | NA | NA |
| HSALNT0289515 | SHANK2-AS3 | C11orf76 | NA | NA | NA | NA |
| HSALNT0290073 | NCBP2-AS2 | NA | NA | NA | NA | NA |
| HSALNT0289502 | NONHSAT095745 | NCRNA00099,UM9-5 | NA | NA | NA | NA |
| HSALNT0289856 | GTSCR1 | NA | NA | pathogenic process | Gilles de la Tourette syndrome | Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0289325 | LINC00272 | C1orf120,NCRNA00272,RP1-223H12.3 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0288512 | TTTY9B | NCRNA00132 | NA | NA | NA | NA |
| HSALNT0290155 | Prion-associated RNAs | NA | NA | pathogenic process | prion disease | Nervous System Diseases |
| HSALNT0289444 | BLACE | NA | NA | pathogenic process | acute B lymphoblastic leukemias | Hemic and Lymphatic Diseases |
| HSALNT0060411 | H1FX-AS1 | C3orf47,FLJ34151 | NA | NA | NA | NA |
| HSALNT0186668 | LINC00477 | C12orf67,FLJ32894,FAM191B | NA | NA | NA | NA |
| HSALNT0275096 | LINC00528 | C22orf37,FLJ40542 | NA | NA | NA | NA |
| HSALNT0287824 | ASMTL-AS1 | CXYorf2,NCRNA00105,ASMTLAS,ASMTL-AS,FLJ13330 | NA | NA | NA | NA |
| HSALNT0288887 | ANP32A-IT1 | C15orf28,NCRNA00321,FLJ11722,HsT18971 | NA | NA | NA | NA |
| HSALNT0289396 | RUSC1-AS1 | C1orf104,FLJ35976 | NA | NA | NA | NA |
| HSALNT0084628 | LINC01194 | CT49,TAG | NA | pathogenic process | melanoma | Neoplasms |
| HSALNT0289468 | NONHSAT040032 | C14orf134,NCRNA00041,DIO3-AS1,NONHSAT040032,NONHSAT040039,BC111049 | NA | NA | NA | NA |
| HSALNT0121060 | NPSR1-AS1 | AAA1,IMAGE:4827585 | NA | NA | NA | NA |
| HSALNT0074370 | LINC00575 | C4orf11 | NA | pathogenic process | NA | NA |
| HSALNT0137345 | LINC01602 | T1560 | NA | pathogenic process | NA | NA |
| HSALNT0289433 | FAM13A-AS1 | FAM13A1OS,FAM13AOS,NCRNA00039 | NA | NA | NA | NA |
| HSALNT0289186 | MIRLET7DHG | NA | NA | NA | NA | NA |
| HSALNT0155254 | MIR181A2HG | NA | NA | NA | NA | NA |
| HSALNT0289283 | WDFY3-AS2 | C4orf12,NCRNA00247,FBI4 | NA | NA | NA | NA |
| HSALNT0154555 | PAPPA-AS1 | PAPPAS,PAPPA-AS,DIPAS,TAF4B,TAF2C2,TAFII105,NCRNA00156 | NA | NA | NA | NA |
| HSALNT0136307 | LINC00293 | BEYLA | NA | developmental process | NA | NA |
| HSALNT0030983 | SIX3-AS1 | SIX3OS | NA | developmental process | NA | NA |
| HSALNT0211503 | Lnc-C14orf101-5:1 | OTX2OS1 | NA | developmental process | NA | NA |
| HSALNT0063422 | LINC01192 | CT64 | NA | NA | NA | NA |
| HSALNT0217123 | LINC01193 | CT60,LOC348120 | NA | NA | NA | NA |
| HSALNT0289664 | C1QTNF9B-AS1 | PCOTH | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289623 | ATP6V1G2-DDX39B | NA | NA | pathogenic process | dilated cardiomyopathy | Cardiovascular Diseases |
| HSALNT0289498 | FAM226B | CXorf50B,NCRNA00246B,LINC00246B | NA | NA | NA | NA |
| HSALNT0289321 | LINC00163 | C21orf134,NCRNA00163,NLC1-A,NLC1A | NA | pathogenic process | narcolepsy | Mental Disorders;Nervous System Diseases |
| HSALNT0289505 | LINC00165 | C21orf135,NCRNA00165,NLC1-B | NA | NA | NA | NA |
| HSALNT0290297 | NONHSAT035776 | ENSG00000251002 | NA | NA | NA | NA |
| HSALNT0274212 | LINC00322 | C21orf136,NCRNA00322,FLJ16545 | NA | NA | NA | NA |
| HSALNT0289741 | NONHSAT102417 | DHFR minor transcript 5'-UTR,ENSG00000228716,NONHSAT102417 | transcriptional regulation | NA | NA | NA |
| HSALNT0289527 | NONHSAT128494 | ncRNA 21A,NONHSAT128494 | NA | NA | NA | NA |
| HSALNT0289409 | TLX1NB | TD1,TDI,APT-B7 | NA | pathogenic process | leukemogenesis | Hemic and Lymphatic Diseases |
| HSALNT0289662 | C15orf2 | NA | NA | pathogenic process | Angelman syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0290097 | NPAP1 | NA | NA | pathogenic process | Angelman syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0217406 | NONHSAT040875 | NCRNA00199 | NA | pathogenic process | Prader-Willi syndrome | Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0289227 | NONHSAT040920 | NCRNA00198 | NA | pathogenic process | Prader-Willi syndrome | Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0262816 | MIMT1 | MIM1,NCRNA00067,LINC00067 | NA | NA | NA | NA |
| HSALNT0289180 | MIR34AHG | NA | NA | NA | NA | NA |
| HSALNT0289357 | LINC02570 | XXbac-BPG27H4.8 | NA | pathogenic process | MHC-associated diseases | Immune System Diseases |
| HSALNT0290177 | RNY1 | NA | NA | pathogenic process | cervix cancer;prostate cancer;colorectal cancer;bladder cancer;kidney cancer;lung cancer | Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
| HSALNT0289378 | NKX2-2-AS1 | NKX2-2AS | transcriptional regulation | pathogenic process | NA | NA |
| HSALNT0290151 | NONHSAT023851 | FJ515872.1,NONHSAT023851 | transcriptional regulation | NA | NA | NA |
| HSALNT0289607 | Anti-NOS2A | NA | NA | pathogenic process | meningioma;glioblastoma | Neoplasms;Nervous System Diseases |
| HSALNT0289687 | CDKN1A-AS1 | p21NAT | transcriptional regulation | NA | NA | NA |
| HSALNT0116668 | RPS6KA2-AS1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289384 | PAPPA-AS2 | AGU1 | NA | NA | NA | NA |
| HSALNT0262802 | ZIM2-AS1 | ZIM2as | NA | NA | NA | NA |
| HSALNT0289824 | Lnc-DLX5-3:1 | Evf-2,Dlx6as1,Dlx6os1,ENSG00000231764, ENST00000430027.2,lnc-DLX5-3:1 | transcriptional regulation | NA | NA | NA |
| HSALNT0289481 | ADORA2A-AS1 | C22orf45,FLJ34651 | NA | NA | NA | NA |
| HSALNT0290146 | POU5F1P4 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290033 | LSINCT1 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290034 | LSINCT10 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290035 | LSINCT11 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290036 | LSINCT12 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290037 | LSINCT2 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290038 | LSINCT3 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290039 | LSINCT4 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290041 | LSINCT6 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290042 | LSINCT7 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290043 | LSINCT8 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290044 | LSINCT9 | NA | NA | pathogenic process | lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289676 | NONHSAT016928 | FLJ31066,NONHSAT016928,lnc-FANK1-3:1 | transcriptional regulation | NA | NA | NA |
| HSALNT0290032 | LRRC3DN | C21orf30,DKFZP434C128 | transcriptional regulation | NA | NA | NA |
| HSALNT0266984 | SNHG11 | C20orf198,LINC00101,NCRNA00101 | NA | pathogenic process | obesity | Nutritional and Metabolic Diseases |
| HSALNT0289880 | NONHSAT113225 | NONHSAT113225,ENSG00000220635 | ceRNA | NA | NA | NA |
| HSALNT0006368 | ENST00000444042.2 | ncRNA-a3 | transcriptional regulation | NA | NA | NA |
| HSALNT0027470 | ENST00000417473.2 | ncRNA-a5 | transcriptional regulation | NA | NA | NA |
| HSALNT0289066 | ENST00000429328.2 | PDZK1IP1-AS1,ncRNA-a4 | transcriptional regulation | NA | NA | NA |
| HSALNT0289936 | NONHSAT059436 | ROR,lincRNA-ST8SIA3,ENSG00000258609,NONHSAT059436 | NA | NA | NA | NA |
| HSALNT0289705 | CHL1-AS2 | NA | NA | pathogenic process | adolescent idiopathic scoliosis | Musculoskeletal Diseases |
| HSALNT0076084 | SEC24B-AS1 | 1/2-SBSRNA4 | siRNA | NA | NA | NA |
| HSALNT0290137 | PDZRN3-AS1 | NA | NA | pathogenic process | type 2 diabetes | Nutritional and Metabolic Diseases;Endocrine System Diseases |
| HSALNT0290237 | SCAANT1 | ATXN7-AS1 | transcriptional regulation | pathogenic process | spinocerebellar ataxia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0289594 | AK123790 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289911 | LINC01451 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290401 | ZNF350-AS1 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289845 | GADD45G | NA | NA | pathogenic process | pituitary adenoma | Endocrine System Diseases;Neoplasms;Nervous System Diseases |
| HSALNT0289410 | Lnc-RASA1-3:23 | AK082072,linc-POLR3G-8,ENSG00000247828 | NA | NA | NA | NA |
| HSALNT0289736 | DAPK1 | NA | NA | pathogenic process | Pancreatic ductal adenocarcinoma | Neoplasms |
| HSALNT0290048 | MAP3K14 | MAP3K14 | NA | pathogenic process | Pancreatic ductal adenocarcinoma | Neoplasms |
| HSALNT0290150 | PPP3CB | NA | NA | pathogenic process | Pancreatic ductal adenocarcinoma | Neoplasms |
| HSALNT0151531 | DAPK1-IT1 | NA | NA | pathogenic process | NA | NA |
| HSALNT0288990 | GDNF-AS1 | GDNFOS | transcriptional regulation | pathogenic process | Alzheimer's disease | Mental Disorders;Nervous System Diseases |
| HSALNT0029702 | BIRC6-AS2 | megamind | NA | developmental process | NA | NA |
| HSALNT0029692 | BIRC6-AS1 | NA | NA | NA | NA | NA |
| HSALNT0289310 | LINC00854 | NA | NA | NA | NA | NA |
| HSALNT0290332 | Uc.73 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289841 | FR0257520 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290104 | NRG1 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289689 | CDKN2B-AS11 | NA | NA | pathogenic process;developmental process | stroke | Cardiovascular Diseases;Nervous System Diseases |
| HSALNT0289690 | CDKN2B-AS12 | NA | NA | pathogenic process | glioma | Neoplasms |
| HSALNT0289691 | CDKN2B-AS13 | NA | NA | pathogenic process | plexiform neurofibroma | Neoplasms;Nervous System Diseases |
| HSALNT0289697 | CDKN2B-AS7 | NA | NA | pathogenic process | acute lymphoblastic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0289826 | FADS1 | NA | NA | pathogenic process | lipid metabolism disorder | Nutritional and Metabolic Diseases |
| HSALNT0289698 | CDKN2B-AS8 | NA | NA | pathogenic process | melanoma | Neoplasms |
| HSALNT0289696 | CDKN2B-AS6 | NA | NA | pathogenic process | neuroblastoma | Neoplasms |
| HSALNT0289699 | CDKN2B-AS9 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289688 | CDKN2B-AS10 | NA | NA | pathogenic process | stroke | Cardiovascular Diseases;Nervous System Diseases |
| HSALNT0288950 | ENST00000456816 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290021 | LOC389332 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290306 | TMEM72 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289641 | BC029135 | NA | NA | pathogenic process | renal clear cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290374 | X91348 | NA | NA | pathogenic process | renal clear cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289694 | CDKN2B-AS4 | NA | NA | pathogenic process | cancer | Neoplasms |
| HSALNT0289692 | CDKN2B-AS2 | NA | NA | pathogenic process | coronary heart disease | Cardiovascular Diseases |
| HSALNT0289693 | CDKN2B-AS3 | NA | NA | pathogenic process | intracranial aneurysm | Cardiovascular Diseases;Nervous System Diseases |
| HSALNT0289695 | CDKN2B-AS5 | NA | NA | pathogenic process | type 2 diabetes | Nutritional and Metabolic Diseases;Endocrine System Diseases |
| HSALNT0290319 | T-UCRs | NA | NA | pathogenic process | neuroblastoma | Neoplasms |
| HSALNT0289530 | 51A | NA | splicing regulation | pathogenic process | Alzheimer's disease | Mental Disorders;Nervous System Diseases |
| HSALNT0290163 | RAB4B-EGLN2 | NA | NA | pathogenic process | cancer | Neoplasms |
| HSALNT0290167 | RERT | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0265263 | LINC00237 | NCRNA00237 | NA | pathogenic process | macrocephaly;obesity | Musculoskeletal Diseases;Pathological Conditions, Signs and Symptoms;Nutritional and Metabolic Diseases;Physiological Phenomena |
| HSALNT0267186 | LINC01370 | HI-LNC25,HILNC25 | NA | pathogenic process | type 2 diabetes | Nutritional and Metabolic Diseases;Endocrine System Diseases |
| HSALNT0289114 | LINC01574 | HI-LNC12,TCONS_00009551 | NA | pathogenic process | type 2 diabetes | Nutritional and Metabolic Diseases;Endocrine System Diseases |
| HSALNT0290159 | PTHLH | NA | NA | pathogenic process | brachydactyly | Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| HSALNT0189394 | NONHSAT028496 | CISTR-ACT,CISTRACT,re52431 | transcriptional regulation | pathogenic process | brachydactyly | Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| HSALNT0289862 | HELLPAR | LINC-HELLP | NA | pathogenic process | HELLP syndrome | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289904 | LINC01125 | NA | NA | pathogenic process | uremia | Male Urogenital Diseases |
| HSALNT0289544 | AC002511.1 | LINC01531 | NA | pathogenic process | enterovirus 71 infection | Virus Diseases |
| HSALNT0289609 | AP000688.29 | AP000688.2 | NA | pathogenic process | enterovirus 71 infection | Virus Diseases |
| HSALNT0289832 | FFAR2 | NA | NA | pathogenic process | enterovirus 71 infection | Virus Diseases |
| HSALNT0290222 | RP4-620F22.3 | AC099063.2 | NA | pathogenic process | enterovirus 71 infection | Virus Diseases |
| HSALNT0290227 | RP5-843L14.1 | LINC01716 | NA | pathogenic process | enterovirus 71 infection | Virus Diseases |
| HSALNT0287285 | MAGEA8-AS1 | RP5-869M20.2 | NA | NA | NA | NA |
| HSALNT0289019 | LHX5-AS1 | locus4010 | NA | NA | NA | NA |
| HSALNT0288902 | CAPN10-AS1 | CAPN10-DT,locus959 | NA | NA | NA | NA |
| HSALNT0289404 | STAM-AS1 | locus3182 | NA | NA | NA | NA |
| HSALNT0148276 | PTENP1-AS | PTENpg1-asRNA | transcriptional regulation | NA | NA | NA |
| HSALNT0289562 | AF116616 | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
| HSALNT0289589 | AK094838 | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
| HSALNT0289620 | ASLNC00339 | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
| HSALNT0289629 | BC002350 | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
| HSALNT0289651 | BC091525 | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
| HSALNT0289652 | BE503655 | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
| HSALNT0289753 | ENO1 | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
| HSALNT0289835 | FKBP10 | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
| HSALNT0290064 | MYHAS | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
| HSALNT0289985 | LncRNA-LALR1 | NA | transcriptional regulation | pathogenic process | liver cancer | Neoplasms;Digestive System Diseases |
| HSALNT0091577 | NR2F1-AS1 | FLJ42709 | NA | NA | NA | NA |
| HSALNT0289709 | CK19 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289943 | Llme23 | NA | NA | pathogenic process | melanoma | Neoplasms |
| HSALNT0289553 | AC096655.1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289178 | ENST00000602507.1 | Lnc-Ang362 | NA | pathogenic process | Ang II-associated cardiovascular disease | Cardiovascular Diseases |
| HSALNT0289261 | STX18-AS1 | LOC100507266 | NA | pathogenic process | atrial septal defect | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289849 | GHSR | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289210 | ENST00000452148.2 | PCAN-R2 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289702 | CES1P1 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289892 | LINC00210 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290006 | LOC100506974 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290219 | RP3-508I15.14 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290243 | SLC6A6 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290342 | Uc003bgl.1 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289075 | LINC00970 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0211868 | SALRNA1 | SAL-RNA1,XLOC_023166 | NA | developmental process | NA | NA |
| HSALNT0222267 | SALRNA3 | SAL-RNA3,XLOC_025918 | NA | developmental process | NA | NA |
| HSALNT0222274 | SALRNA2 | SAL-RNA2,XLOC_025931 | NA | developmental process | NA | NA |
| HSALNT0289428 | NONHSAT076558 | GPR1-AS1,GPR1AS | transcriptional regulation | NA | NA | NA |
| HSALNT0226207 | LINC00235 | NA | NA | pathogenic process | anorexia nervosa | Mental Disorders |
| HSALNT0289526 | 1B FGF-antisense transcripts | NA | NA | pathogenic process | endometriosis | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0290171 | RNA polymerase III-dependent lncRNAs | NA | NA | pathogenic process | diffuse cerebral hypomyelination | NA |
| HSALNT0290168 | REST/CoREST-regulated lncRNAs | NA | NA | pathogenic process | Huntington disease | Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0289606 | Alu lncRNAs | NA | NA | pathogenic process | macular degeneration | Eye Diseases |
| HSALNT0290358 | UCH1LAS | NA | NA | pathogenic process | Parkinson's disease | Nervous System Diseases |
| HSALNT0290244 | SLC7A2-IT1A/B | NA | NA | pathogenic process | progressive encephalopathy with severe infantile anorexia | Nervous System Diseases |
| HSALNT0289877 | Kcna2-AS | NA | NA | pathogenic process | neuropathic pain | Nervous System Diseases |
| HSALNT0289191 | NCOA7-AS1 | NA | NA | pathogenic process | NA | NA |
| HSALNT0290020 | LOC389023 | NA | transcriptional regulation | pathogenic process | psychiatric disease | Nervous System Diseases |
| HSALNT0175124 | PTPRJ-AS1 | NA | transcriptional regulation | NA | NA | NA |
| HSALNT0289654 | BM742401 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289331 | LINC00951 | lincRNA-uc003opf.1,FLJ41649 | NA | pathogenic process | esophageal squamous cell cancer | Neoplasms |
| HSALNT0290130 | PAWR | NA | NA | pathogenic process | acute lymphoblastic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0290264 | T-ALL-R-LncR1 | NA | NA | pathogenic process | acute lymphoblastic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0289599 | AK130977 | NA | NA | pathogenic process | malignant pleural mesothelioma | Neoplasms |
| HSALNT0289625 | AX746718 | NA | NA | pathogenic process | malignant pleural mesothelioma | Neoplasms |
| HSALNT0289738 | DDR2 | NA | NA | pathogenic process | malignant pleural mesothelioma | Neoplasms |
| HSALNT0290003 | LOC100131831 | NA | NA | pathogenic process | malignant pleural mesothelioma | Neoplasms |
| HSALNT0290144 | POT1-AS1 | NA | NA | pathogenic process | malignant pleural mesothelioma | Neoplasms |
| HSALNT0290253 | SNORA17B | NA | NA | pathogenic process | malignant pleural mesothelioma | Neoplasms |
| HSALNT0207421 | GAS6-AS1 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289838 | FMR5 | NA | NA | pathogenic process | fragile X syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0208907 | FOXG1-AS1 | FOXG1-AS | NA | pathogenic process | autism spectrum disorder | Mental Disorders |
| HSALNT0290263 | SYNGAP1-AS1 | SYNGAP1-AS | NA | pathogenic process | autism spectrum disorder | Mental Disorders |
| HSALNT0290176 | RNase MRP | NA | NA | pathogenic process | cartilage hair hypoplaisia | Cardiovascular Diseases |
| HSALNT0289469 | GABPB1-AS1 | NA | NA | pathogenic process | NA | NA |
| HSALNT0289009 | IDI2-AS1 | C10orf110,IDI2-A,HT009,Em:AC022536.4 | NA | NA | NA | NA |
| HSALNT0289093 | LINC01184 | FLJ33630 | NA | NA | NA | NA |
| HSALNT0290108 | OGT | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290077 | NcNRFR | NA | transcriptional regulation | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290337 | Uc001lsz | NA | NA | pathogenic process | gastric cancer;prostate cancer;liver cancer;lung cancer | Respiratory Tract Diseases;Male Urogenital Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289087 | LINC01090 | NA | NA | pathogenic process | post-traumatic stress disorder | Mental Disorders |
| HSALNT0289981 | LncRNA-DQ786227 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289876 | JADRR | LINC00915,lncRNA-JADE | transcriptional regulation | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290254 | SOX2OT-S1 | NA | NA | pathogenic process | esophageal squamous cell cancer | Neoplasms |
| HSALNT0289870 | HOXA13 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0078946 | SMAD1-AS1 | ENST00000513542 | NA | pathogenic process | ventricular septal defects | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0087329 | FGF10-AS1 | RP11-473L15.2 | transcriptional regulation | pathogenic process | ventricular septal defects | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0290318 | TUC339 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289819 | Lnc-CHRAC1-2:1 | LINC01130,TCONS_00014875,ERIC | transcriptional regulation | pathogenic process | retinoblastoma | Neoplasms |
| HSALNT0289615 | ARA | NA | NA | pathogenic process | cancer | Neoplasms |
| HSALNT0289822 | ESCCAL-5 | NA | NA | pathogenic process | esophageal squamous cell cancer | Neoplasms |
| HSALNT0290074 | NcC11orf49 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290076 | NcHDAC5 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290078 | NcRAB31 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290080 | NcSRPK1 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0018253 | ENST00000442621.1 | LINC01131,OVAL | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289884 | LALR | NA | transcriptional regulation | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289701 | CEACAMP8 | CEACAMP8 | NA | pathogenic process | pre-eclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0290018 | LOC284100 | NA | NA | pathogenic process | pre-eclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0290023 | LOC391533 | NA | NA | pathogenic process | pre-eclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0189558 | LINC01154 | NA | NA | NA | NA | NA |
| HSALNT0196616 | Lnc-DHX37-1:1 | BRI3BP-AS1,BRI3BPAS1,Linc1992,TCONS_00020260 | transcriptional regulation | pathogenic process | Kawasaki disease | Cardiovascular Diseases |
| HSALNT0289235 | RNF219-AS1 | NA | NA | pathogenic process | blood pressure | Cardiovascular Diseases |
| HSALNT0289561 | AF086415 | NA | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0289583 | AK056098 | NA | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0289590 | AK095147 | NA | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0289600 | AK294004 | NA | transcriptional regulation | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0289612 | AP5M1 | NA | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0290110 | ORAOV1 | NA | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0290210 | RP1-179N16.3 | Z95152.1 | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0037026 | LINC01159 | linc-Brn1b | NA | developmental process | NA | NA |
| HSALNT0289014 | ENST00000604849.1 | KDM5C adjacent non-coding transcript | NA | developmental process | NA | NA |
| HSALNT0289905 | LINC01157 | TCONS_00010378,linc-Enc1 | NA | developmental process | NA | NA |
| HSALNT0289460 | ENST00000444200.1 | NA | transcriptional regulation | NA | NA | NA |
| HSALNT0290400 | ZNF300P1 | ZNF300P1 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289750 | EEF1A1P9 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
| HSALNT0289796 | ENST00000318333 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
| HSALNT0289797 | ENST00000374520 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
| HSALNT0289800 | ENST00000422362 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
| HSALNT0289808 | ENST00000455912 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
| HSALNT0289809 | ENST00000456007 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
| HSALNT0289810 | ENST00000456185 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
| HSALNT0289817 | EPOR | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
| HSALNT0289913 | LINC01550 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
| HSALNT0290142 | PMS2P5 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
| HSALNT0290269 | TCF7 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
| HSALNT0290345 | Uc003jfz.2 | NA | NA | pathogenic process | gastric cardia adenocarcinoma | Neoplasms |
| HSALNT0289095 | ENST00000412690.1 | VIN,lnc-ACTR3 | transcriptional regulation | pathogenic process | influenza A virus | Virus Diseases |
| HSALNT0288976 | ENST00000427391.1 | LINC01200 | transcriptional regulation | NA | NA | NA |
| HSALNT0289097 | LINC01202 | NA | NA | NA | NA | NA |
| HSALNT0290271 | TCONS_00014512 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
| HSALNT0290272 | TCONS_00014978 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
| HSALNT0290274 | TCONS_00024647 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
| HSALNT0290279 | TCONS_00090092_MEG3 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
| HSALNT0290280 | TCONS_l2_00000179 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
| HSALNT0290283 | TCONS_l2_00004424 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
| HSALNT0290284 | TCONS_l2_00006843 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
| HSALNT0290289 | TCONS_l2_00014091 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
| HSALNT0290291 | TCONS_l2_00018070 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
| HSALNT0290292 | TCONS_l2_00020565 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
| HSALNT0290293 | TCONS_l2_00021262 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
| HSALNT0290296 | TCONS_l2_00030560 | NA | NA | pathogenic process | hepatoblastoma | Neoplasms |
| HSALNT0289927 | LincRNA1611 | NA | NA | pathogenic process | Pancreatic ductal adenocarcinoma | Neoplasms |
| HSALNT0290149 | Ppp3ca | NA | NA | pathogenic process | Pancreatic ductal adenocarcinoma | Neoplasms |
| HSALNT0290265 | TC0100223 | NA | NA | pathogenic process | epithelial ovarian cancer | Neoplasms |
| HSALNT0290267 | TC0101686 | NA | NA | pathogenic process | epithelial ovarian cancer | Neoplasms |
| HSALNT0290268 | TC1500845 | NA | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289318 | LAMP5-AS1 | NA | NA | pathogenic process | acute lymphoblastic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0234022 | LINC01228 | lincRNA-DYNLRB2-2 | NA | pathogenic process | NA | NA |
| HSALNT0162654 | SGMS1-AS1 | NA | NA | pathogenic process | NA | NA |
| HSALNT0289206 | PCAT19 | LOC100505495,LINC01190 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289521 | ABHD15-AS1 | linc-TP53I13,lnc-TP53I13 | NA | pathogenic process | cardiometabolic disease | Cardiovascular Diseases |
| HSALNT0289100 | LINC01230 | linc-DMRT2,lnc-DRMT2,TCONS_00015639 | NA | pathogenic process | cardiometabolic disease | Cardiovascular Diseases |
| HSALNT0249183 | PCAT18 | LINC01092 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290029 | LOC728606 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0288956 | ENST00000547963.1 | NA | NA | pathogenic process | esophageal squamous cell cancer | Neoplasms |
| HSALNT0289802 | ENST00000435885 | NA | NA | pathogenic process | oesophageal squamous cell cancer | Neoplasms |
| HSALNT0205898 | LINC01232 | FLJ41590,TCONS_00021520 | NA | pathogenic process | NA | NA |
| HSALNT0257311 | LINC01233 | XLOC_013014 | NA | pathogenic process | NA | NA |
| HSALNT0183247 | ENST00000526269.2 | FLI1-AS1 | NA | pathogenic process | vascular SMC phenotype | Cardiovascular Diseases |
| HSALNT0289296 | LINC00467 | C1orf97,MGC14801 | NA | pathogenic process | neuroblastoma | Neoplasms |
| HSALNT0143586 | CASC21 | LINC01244,CARLo-2 | NA | pathogenic process | NA | NA |
| HSALNT0288906 | CASC19 | LINC01245,CARLo-6 | NA | pathogenic process | NA | NA |
| HSALNT0289754 | ENSG00000135253.9 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289755 | ENSG00000147753.5 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289756 | ENSG00000196096 | AC079610.1 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289757 | ENSG00000197251.3 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289758 | ENSG00000203325 | AL445248.1 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289759 | ENSG00000206129 | AC006305.1 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289760 | ENSG00000215231.3 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289761 | ENSG00000215374.4 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289762 | ENSG00000215808.2 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289763 | ENSG00000226496.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289764 | ENSG00000229563.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289765 | ENSG00000230133.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289766 | ENSG00000230544.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289767 | ENSG00000231133.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289768 | ENSG00000231185 | AC010317.1 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289769 | ENSG00000232021.2 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289770 | ENSG00000232046.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289771 | ENSG00000232956.3 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289772 | ENSG00000233154.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289773 | ENSG00000233251 | AC007743.1 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289774 | ENSG00000235285.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289775 | ENSG00000237036.3 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289776 | ENSG00000237548.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289777 | ENSG00000240453.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289778 | ENSG00000241269.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289779 | ENSG00000245910.3 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289780 | ENSG00000248176 | AC109349.1 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289781 | ENSG00000249364 | AC112206.2 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289782 | ENSG00000249772 | AC026427.1 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289783 | ENSG00000250195 | AC109927.1 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289784 | ENSG00000250608 | AC010210.1 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289785 | ENSG00000254154 | AL359075.2 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289786 | ENSG00000255471 | AP001528.2 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289787 | ENSG00000256218 | AC007848.2 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289788 | ENSG00000259150.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289789 | ENSG00000259334.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289790 | ENSG00000259484.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289791 | ENSG00000259758.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289793 | ENSG00000263753.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289794 | ENSG00000264772 | AC016876.2 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289795 | ENSG00000266952.1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289828 | FAM66B | FAM66E | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289895 | LINC00336 | C6orf227,NCRNA00336 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289899 | LINC00929 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289906 | LINC01204 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289912 | LINC01538 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289915 | LINC01721 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289916 | LINC01762 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289917 | LINC01798 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0290247 | SMIM2-IT1 | C13orf44-IT1 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0290316 | TTTY7 | CLONE795723,LINC00129,NCRNA00129A,TTTY7B,TTY7,TTTY7 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0290175 | RNA-a | NA | transcriptional regulation | pathogenic process | Opitz-Kaveggia syndrome | NA |
| HSALNT0289525 | 116HG | NA | transcriptional regulation | pathogenic process | Prader-Willi syndrome | Nervous System Diseases |
| HSALNT0290320 | U1 spliceosomal lncRNA | NA | NA | pathogenic process | Parkinson's disease | Nervous System Diseases |
| HSALNT0289102 | LINC01262 | TCONS_l2_00021807,RP11-462G22.1 | ceRNA | pathogenic process | Parkinson's disease | Nervous System Diseases |
| HSALNT0289681 | CCAT1-L | NA | transcriptional regulation | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290062 | MT-LIPCAR | uc022bqs.1,LIPCAR | NA | pathogenic process | heart disease | Cardiovascular Diseases |
| HSALNT0289941 | LIPCAR | NA | NA | pathogenic process | heart failure | Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases |
| HSALNT0200965 | TUSC8 | LINC01071,XLOC_010588 | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0161787 | LINC01264 | RP11-124O11.2 | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289733 | D4Z4 | NA | NA | pathogenic process;developmental process | facioscapulohumeral muscular dystrophy | Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0289678 | CARL | NA | ceRNA | pathogenic process | myocardial infarction | Cardiovascular Diseases |
| HSALNT0289923 | Linc-CBR1-2 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0243354 | Lnc-HEATR6-1:4 | WAP four-disulfide core domain 21,pseudogene | transcriptional regulation | pathogenic process | DC dysfunction | NA |
| HSALNT0290232 | RUNX1 | NA | NA | pathogenic process | acute myeloid leukemia | Neoplasms |
| HSALNT0290234 | RUNXOR | NA | NA | pathogenic process | hematopoietic malignancies | Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0289979 | LncRNA-CIR | NA | NA | pathogenic process | osteoarthritis | Musculoskeletal Diseases |
| HSALNT0290368 | VIM2P | NA | NA | pathogenic process | osteoarthritis | Musculoskeletal Diseases |
| HSALNT0289879 | KRAS1P | NA | NA | pathogenic process | cancer | Neoplasms |
| HSALNT0290054 | MINA | NA | NA | pathogenic process | esophageal squamous cell cancer;gastric cancer;lung cancer;hepatocelluar cancer | Respiratory Tract Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289270 | TMEM92-AS1 | RP11-893F2.9,lncRNA-508851,TCONS_00025237 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0288900 | ENST00000604200.1 | LINC00468 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289593 | AK123657 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289659 | BX648207 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289660 | BX649059 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289846 | GAS2L3 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289633 | BC011663 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289867 | HIV1230 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290045 | M14574 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290245 | SLCO5A1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290326 | Uc.341 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290344 | Uc003iqu | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290346 | Uc003tfx | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289950 | Lnc-AL355149.1-1 | NA | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0290001 | Lnc-ZNF674-1 | NA | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0286909 | LINC00632 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289105 | LINC01317 | NA | NA | NA | NA | NA |
| HSALNT0234804 | LINC01081 | TCONS_00024764 | transcriptional regulation | pathogenic process | alveolar capillary dysplasia | Respiratory Tract Diseases |
| HSALNT0289840 | FOSB | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289587 | AK093543 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289732 | D16366 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289814 | ENST00000501583 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289907 | LINC01374 | TCONS_00018278 | NA | pathogenic process | NA | NA |
| HSALNT0231106 | CASC22 | LINC01373,TCONS_00024290,LincRNA-ENST00000515084 | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0058246 | LINC00882 | NA | ceRNA | pathogenic process | airway diseases | Respiratory Tract Diseases |
| HSALNT0018288 | KIAA1614-AS1 | RP11-46A10.4 | ceRNA | pathogenic process | airway smooth muscle (ASM) disease | Respiratory Tract Diseases |
| HSALNT0142310 | LINC00536 | NA | NA | pathogenic process | trichorhinophalangeal syndrome | NA |
| HSALNT0034200 | LBX2-AS1 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0149799 | ENST00000414223 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290012 | LOC105374631 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290305 | TMEM179 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290315 | TSPAN8 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290334 | Uc001aka.2 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290339 | Uc001vjj.1 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290343 | Uc003erl.1 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290354 | Uc009wkz.1 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0027893 | ENST00000433810.1 | MYCNUN,lncUSMycN | NA | pathogenic process | neuroblastoma | Neoplasms |
| HSALNT0273205 | LINC01436 | AP000688.8 | NA | pathogenic process | Down syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0266116 | MIR663AHG | RP3-410C9.1 | NA | pathogenic process | turner syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Endocrine System Diseases |
| HSALNT0289108 | LINC01435 | RP11-215N21.1,TCONS_00018040 | NA | pathogenic process | NA | NA |
| HSALNT0289674 | CADM3-AS1 | NA | NA | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289882 | KRT19P3 | NA | NA | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290310 | TNXA | NA | NA | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0008750 | ZRANB2-AS2 | NA | NA | NA | NA | NA |
| HSALNT0289745 | DMTF1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290059 | MRUL | NA | transcriptional regulation | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0185163 | FAM66C | NA | NA | NA | NA | NA |
| HSALNT0289476 | ENST00000357401.3 | NA | NA | NA | NA | NA |
| HSALNT0289535 | AA174084 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0266298 | ABALON | INXS | splicing regulation | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290370 | VTRNA2-1 | CBL-3,CBL3,MIR886,MIRN886,VTRNA2,hsa-mir-886,hvg-5,nc886,svtRNA2-1a | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289619 | ASK00420 | NA | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289749 | EBIC | NA | transcriptional regulation | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290299 | TI09485 | NA | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290300 | TI10124 | NA | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290301 | TI13831 | NA | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290302 | TI18318 | NA | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290303 | TI21327 | NA | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290304 | TI22687 | NA | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290307 | TMPOP2 | NA | transcriptional regulation | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289570 | AK021444 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289601 | AK307796 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289801 | ENST00000425785 | SEC63P1 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289871 | HOXB-AS3 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290367 | URHC | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289085 | LINC01080 | TCONS_00021856 | NA | pathogenic process | Alzheimer's disease | Mental Disorders;Nervous System Diseases |
| HSALNT0289751 | EFNA3 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289798 | ENST00000395084 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289829 | FAM83A-AS1 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290164 | RAD1 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289585 | AK056988 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289638 | BC017743 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290156 | PRR26 | C10orf108 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290349 | Uc003yqb.1 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289675 | CAI2 | NA | NA | pathogenic process | neuroblastoma | Neoplasms |
| HSALNT0290313 | TSLC1-AS1 | NA | NA | pathogenic process | glioma | Neoplasms |
| HSALNT0013359 | LINC01525 | lnc-MAN1A2-1 | NA | pathogenic process | squamous cell cancer | Neoplasms |
| HSALNT0109106 | LINC01526 | Lnc-FAM46A-1 | NA | pathogenic process | squamous cell cancer | Neoplasms |
| HSALNT0162774 | LINC01468 | lnc-MBL2-4 | NA | pathogenic process | squamous cell cancer | Neoplasms |
| HSALNT0289110 | LINC01503 | lnc-PPP2R4-5 | NA | pathogenic process | tongue squamous cell cancer | Neoplasms |
| HSALNT0289968 | Lnc-MBL2-4:3 | NA | NA | pathogenic process | tongue squamous cell cancer | Neoplasms |
| HSALNT0289993 | Lnc-STXBP5-1 | NA | NA | pathogenic process | tongue squamous cell cancer | Neoplasms |
| HSALNT0289563 | AF118081 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289597 | AK124939 | NA | NA | pathogenic process | pulmonary adenocarcinoma | Neoplasms |
| HSALNT0290153 | PRAS | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290249 | SNAR-A1 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289929 | LincRNA-BC2 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289930 | LincRNA-BC4 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289931 | LincRNA-BC5 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289932 | LincRNA-BC8 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0083190 | LINC01511 | RP11-325I22.2 | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290026 | LOC440905 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289552 | AC079776.2 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289720 | CTA-363E6.2 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289901 | LINC00987 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290185 | RP11-1C1.7 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290197 | RP11-445K13.2 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290199 | RP11-473M20.11 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290213 | RP11-893F2.6 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290217 | RP13-514E23.1 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290218 | RP1-90D4.3 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290220 | RP4-575N6.5 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290226 | RP5-826L7.1 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290378 | XLOC_003286 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290379 | XLOC_003405 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290389 | XLOC_012255 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290056 | MIR21 | NA | NA | pathogenic process | laryngeal squamous cell cancer | Neoplasms |
| HSALNT0289621 | ASncmtRNAs | NA | transcriptional regulation | pathogenic process | cancer | Neoplasms |
| HSALNT0289316 | LINC01614 | LCAL4,TCONS_00003105 | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289982 | LncRNA-FER1L4 | NA | ceRNA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290016 | LOC283177 | NA | NA | pathogenic process | diffuse large B-cell lymphoma | Hemic and Lymphatic Diseases |
| HSALNT0289003 | HORMAD2-AS1 | MTMR3-AS1,NONHSAG033653 | NA | pathogenic process | type 1 diabetes;bowel disease | Nutritional and Metabolic Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0290372 | WNT4 | NA | NA | pathogenic process | endometriosis | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289540 | AB074278 | NA | NA | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290166 | RCCRT1 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289043 | LINC00491 | BC008363 | NA | pathogenic process | pancreatic ductal adenocarcinoma | Neoplasms |
| HSALNT0289858 | H1.3 | NA | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289896 | LINC00582 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289301 | LINC01537 | RP11-169D4.1-001 | NA | pathogenic process | laryngeal squamous cell cancer | Neoplasms |
| HSALNT0289551 | AC026166.2 | MTCO1P5 | NA | pathogenic process | laryngeal squamous cell cancer | Neoplasms |
| HSALNT0290184 | RP11-169D4.1-001 | NA | NA | pathogenic process | laryngeal squamous cell cancer | Neoplasms |
| HSALNT0289545 | AC006050.3 | NA | NA | pathogenic process | lung squamous cell cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289556 | AC138128.1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289818 | ERCC1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290061 | MT1DP | MT1DP | NA | pathogenic process | liver cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289578 | AK023096 | NA | NA | pathogenic process | Wilmsâ tumor;uterine leiomyomas | Neoplasms |
| HSALNT0289112 | LINC01562 | RP11-296A18.3 | transcriptional regulation | pathogenic process | intervertebral disc degeneration | Musculoskeletal Diseases |
| HSALNT0289567 | AK000974 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289579 | AK024118 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289645 | BC040204 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290321 | U79277 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289869 | HOST2 | NA | ceRNA | pathogenic process | epithelial ovarian cancer | Neoplasms |
| HSALNT0289368 | MGAT3-AS1 | TapSAKI | NA | pathogenic process | acute kidney injury | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289624 | ATXN7L3B | NA | NA | pathogenic process | spinocerebellar ataxia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0289990 | Lnc-SCA7 | NA | ceRNA | pathogenic process | spinocerebellar ataxia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0290004 | LOC100287482 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290383 | XLOC_007697 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290384 | XLOC_008559 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290385 | XLOC_009911 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289813 | ENST00000480739 | RPL13AP23 | NA | pathogenic process | Pancreatic ductal adenocarcinoma | Neoplasms |
| HSALNT0290111 | OS9 | NA | NA | pathogenic process | Pancreatic ductal adenocarcinoma | Neoplasms |
| HSALNT0290324 | Uc.283-plus | NA | NA | pathogenic process | glioma | Neoplasms |
| HSALNT0289117 | LINC01611 | RP1-90L14.1,TCONS_l2_00025430 | NA | pathogenic process | diabetic retinopathy | Endocrine System Diseases;Male Urogenital Diseases;Cardiovascular Diseases |
| HSALNT0289529 | 2900055J20Rik | 2900055J20Rik | NA | pathogenic process | left ventricular hypertrophy | Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases |
| HSALNT0289792 | ENSG00000261777 | AC012184.3 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289618 | Asb3 | NA | NA | pathogenic process | cardiovascular and renal disease | Cardiovascular Diseases |
| HSALNT0289703 | Chac2 | NA | NA | pathogenic process | cardiovascular and renal disease | Cardiovascular Diseases |
| HSALNT0290139 | Pex11b | NA | NA | pathogenic process | cardiovascular and renal disease | Cardiovascular Diseases |
| HSALNT0290255 | Sp5 | NA | NA | pathogenic process | cardiovascular and renal disease | Cardiovascular Diseases |
| HSALNT0211639 | PSMA3-AS1 | FLJ31306 | NA | pathogenic process | NA | NA |
| HSALNT0289319 | LINC00493 | LOC388789 | NA | pathogenic process | NA | NA |
| HSALNT0288903 | CARD8-AS1 | LOC100505812 | transcriptional regulation | pathogenic process | leukemia and neuroblastoma | Neoplasms |
| HSALNT0064729 | KCNMB2-AS1 | RP11-385J1.2 | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289548 | AC013264.2 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289857 | GUCY1B2 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290190 | RP11-385J1.2 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290216 | RP1-317E23.3 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290317 | TUBA4B | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290375 | XLOC_000371 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290397 | Z82214.3 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289735 | DALIR | DALI | transcriptional regulation | NA | NA | NA |
| HSALNT0290376 | XLOC_000620 | NA | NA | pathogenic process | H. pylori-related diseases | Bacterial Infections and Mycoses |
| HSALNT0290380 | XLOC_004122 | NA | NA | pathogenic process | H. pylori-related diseases | Bacterial Infections and Mycoses |
| HSALNT0290381 | XLOC_004562 | NA | NA | pathogenic process | H. pylori-related diseases | Bacterial Infections and Mycoses |
| HSALNT0290382 | XLOC_005912 | NA | NA | pathogenic process | H. pylori-related diseases | Bacterial Infections and Mycoses |
| HSALNT0290391 | XLOC_014388 | NA | NA | pathogenic process | H. pylori-related diseases | Bacterial Infections and Mycoses |
| HSALNT0290028 | LOC652276 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290162 | R05532 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0098175 | LINC01411 | RP11-267A15.1 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290025 | LOC401317 | NA | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0289726 | CTD-2574D22.4 | AC120114.2 | NA | pathogenic process | osteoarthritis | Musculoskeletal Diseases |
| HSALNT0290141 | PMS2L2 | NA | NA | pathogenic process | osteoarthritis | Musculoskeletal Diseases |
| HSALNT0289974 | LncRNA-422 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289520 | AATBC | NA | NA | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289311 | LINC00974 | NA | ceRNA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0089943 | ZBED3-AS1 | NA | NA | developmental process | NA | NA |
| HSALNT0289116 | LINC01589 | CTA-941F9.9,TCONS_00029353 | NA | pathogenic process | NA | NA |
| HSALNT0289910 | LINC01426 | NA | NA | pathogenic process | esophageal squamous cell cancer | Neoplasms |
| HSALNT0290341 | Uc002yug.2 | NA | splicing regulation | pathogenic process | esophageal squamous cell cancer | Neoplasms |
| HSALNT0290250 | SNCG | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289996 | Lnc-uc003wbd | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289559 | AF085935 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290347 | Uc003wbd | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290098 | NR_001284 | TNXA | NA | pathogenic process | chronic thromboembolic pulmonary hypertension | Cardiovascular Diseases |
| HSALNT0290327 | Uc.343 | NA | NA | pathogenic process | osteoarthritis | Musculoskeletal Diseases |
| HSALNT0289196 | NRAV | DYNLL1-AS1 | transcriptional regulation | pathogenic process | influenza A virus | Virus Diseases |
| HSALNT0290140 | PLEC | NA | NA | pathogenic process | chronic obstructive pulmonary disease | Respiratory Tract Diseases |
| HSALNT0290172 | RNA44121 | NA | NA | pathogenic process | chronic obstructive pulmonary disease | Respiratory Tract Diseases |
| HSALNT0290173 | RNA50010 | NA | NA | pathogenic process | chronic obstructive pulmonary disease | Respiratory Tract Diseases |
| HSALNT0290174 | RNA58351 | NA | NA | pathogenic process | chronic obstructive pulmonary disease | Respiratory Tract Diseases |
| HSALNT0289714 | CR613944 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289933 | LincRNA-CALCA | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290200 | RP11-501G6.1 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290208 | RP11-672F9.1 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290405 | C14orf132 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289937 | LincRNA-TSPAN8 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290225 | RP5-1014O16.1 | AC244098.1 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290275 | TCONS_00026102 | NA | NA | pathogenic process | atrial fibrillation | Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases |
| HSALNT0290277 | TCONS_00032546 | NA | NA | pathogenic process | atrial fibrillation | Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases |
| HSALNT0289037 | LINC00441 | RB1-DT,ncRNA-RB1 | NA | pathogenic process | NA | NA |
| HSALNT0289661 | C1401f132 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289141 | LINC02365 | LVCAT8 | NA | pathogenic process | NA | NA |
| HSALNT0288885 | ADGRD1-AS1 | LACAT8 | NA | NA | NA | NA |
| HSALNT0289142 | LINC02475 | LVCAT1 | NA | NA | NA | NA |
| HSALNT0289542 | Abhd11os | NA | NA | pathogenic process | neurodegenerative diseases | Nervous System Diseases |
| HSALNT0288895 | BISPR | NA | NA | pathogenic process | virus infection | Virus Diseases |
| HSALNT0233975 | MAFTRR | linc-MAF-4 | transcriptional regulation | NA | NA | NA |
| HSALNT0290058 | MRAK052686 | NA | NA | pathogenic process | nonalcoholic fatty liver disease | Digestive System Diseases |
| HSALNT0290221 | RP4-583P15.10 | AL121845.1 | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0211341 | KTN1-AS1 | C14orf33,MYCLo-3 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0266752 | DLGAP4-AS1 | CCAT7 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289682 | CCAT3 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289684 | CCAT8 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289898 | LINC00659 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289627 | BALR-2 | NA | NA | pathogenic process | B cell acute lymphoblastic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0289948 | Lnc-ACACA-1 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289953 | Lnc-BMP2-2 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289955 | Lnc-CPN2-1 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289958 | Lnc-FOXG1-2 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289960 | Lnc-FZD1-2 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289962 | Lnc-ITPR2-3 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289965 | Lnc-LCP2-2 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289988 | Lnc-RP3-368B9 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289991 | Lnc-SLC30A4-1 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289992 | Lnc-SPAM1-6 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289995 | Lnc-TTC34-3 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0222064 | DRAIC | NA | NA | pathogenic process | prostate cancer;glioma;cancer;bladder cancer;renal clear cell cancer;skin melanoma;hepatocellular cancer;lung adenocarcinoma;stomach adenocarcinoma | Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
| HSALNT0290390 | XLOC_014172 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290014 | LOC149086 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290183 | RP11-160H22.5 | AL121983.2 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289945 | LNC00964-3 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289616 | Arid2-IR | NA | NA | pathogenic process | renal inflammation | NA |
| HSALNT0289716 | CR619813 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289739 | DDX6P1 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289938 | LincRNA-ZNF532 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0290011 | LOC105372753 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0290013 | LOC105377769 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0290205 | RP11-58D2.1 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0288946 | ENST00000434223 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0288947 | ENST00000442037 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0288953 | ENST00000540136 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290103 | NR_038125 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290136 | PDLIM3 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290335 | Uc001gch.1 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290336 | Uc001gzl.3 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290351 | Uc004bbl.1 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290369 | VNN2 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289577 | AK022798 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289663 | C1orf74 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289602 | AKR7L | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289711 | COL3A1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289878 | KCNE2 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289636 | BC015134 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289713 | CR594506 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289928 | LincRNA-BBOX1-2 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0271719 | LINC00320 | PRED14,FLJ37539 | NA | pathogenic process;developmental process | cortical white matter | Nervous System Diseases |
| HSALNT0289823 | EVADR | NA | NA | pathogenic process | pancreatic cancer;lung cancer;colorectal cancer;rectal cancer | Respiratory Tract Diseases;Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289952 | Lnc-bc060912 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289613 | APF | NA | ceRNA | pathogenic process | myocardial infarction | Cardiovascular Diseases |
| HSALNT0289617 | AS Uchl1 | NA | NA | pathogenic process | Parkinson's disease | Nervous System Diseases |
| HSALNT0289104 | LINC01296 | FLJ39632 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290403 | ZXF2 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290113 | P14695 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290114 | P16984 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290115 | P19780 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290116 | P23099 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290117 | P24363 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290118 | P28210 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290120 | P33863 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290121 | P4091 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290122 | P6391 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290123 | P6488 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290124 | P700 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290125 | P8611 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290126 | P8725 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290127 | P8860 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290128 | P9745 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289269 | TH2LCRR | TH2-LCR | transcriptional regulation | pathogenic process | allergic asthma | Respiratory Tract Diseases;Immune System Diseases |
| HSALNT0289964 | Lnc-LCE5A-1 | NA | NA | pathogenic process | laryngeal cancer;head and neck squamous cell cancer | Respiratory Tract Diseases;Otorhinolaryngologic Diseases;Neoplasms |
| HSALNT0055198 | FAM3D-AS1 | lnc-KCTD6-3 | NA | pathogenic process | tongue cancer;pharyngeal cancer;head and neck squamous cell cancer;laryngeal cancer | Respiratory Tract Diseases;Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0289843 | FRLnc1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0242005 | ENST00000575202 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0288952 | ENST00000539009 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0288954 | ENST00000544591 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289752 | EHHADH-AS1 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289812 | ENST00000468960 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290276 | TCONS_00026506 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0189952 | LRP1-AS | NA | transcriptional regulation | pathogenic process | Alzheimer's disease | Mental Disorders;Nervous System Diseases |
| HSALNT0032045 | LINC01122 | FLJ30838,AC007092.1 | NA | NA | NA | NA |
| HSALNT0289565 | AI364715 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289921 | LINC0949 | NA | NA | pathogenic process | systemic lupus erythematosus | Immune System Diseases;Skin and Connective Tissue Diseases |
| HSALNT0289680 | CCAL | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289079 | LINC00993 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289811 | ENST00000460164 | NA | NA | pathogenic process | triple-negative breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290282 | TCONS_l2_00003938 | NA | NA | pathogenic process | triple-negative breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289888 | LGALS3 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0289963 | Lnc-KCMF1-2:1 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0289967 | Lnc-LLPH-2:1 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0289971 | Lnc-PLA2R1-1:1 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0289972 | Lnc-PSD4-1:14 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0290066 | N335550 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0290070 | N340790 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0290072 | N386477 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0290286 | TCONS_l2_00010365 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0289118 | LINC01612 | RP11-789C1.1,TCONS_00008319 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289610 | AP001439.2 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289671 | CACNAICAS3 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289853 | GS1-5L10.1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290065 | MYLK-AS1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290157 | PRSS21 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290202 | RP11-528G1.2 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290207 | RP11-643M14.1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290209 | RP11-789C1.1 | LINC01612 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290314 | TSNAX-DISC1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290386 | XLOC_010235 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289558 | AF075041 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289564 | AF339813 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289575 | AK022029 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289576 | AK022159 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289604 | AL389956 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289640 | BC023629 | NA | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0290096 | NONHSAT125629 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290393 | XR_250621.1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0288951 | ENST00000503938 | NA | NA | pathogenic process | triple-negative breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290085 | NONHSAT012762 | NA | NA | pathogenic process | triple-negative breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289151 | LMCD1-AS1 | NA | NA | pathogenic process | acute kidney injury | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289926 | Linc-PXN-1 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290281 | TCONS_l2_00001418 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290285 | TCONS_l2_00008237 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290287 | TCONS_l2_00011130 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290288 | TCONS_l2_00013175 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290294 | TCONS_l2_00022611 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290295 | TCONS_l2_00022670 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290352 | Uc004bdv.3 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290363 | ULK4P2 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289942 | LK4P2 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289538 | AB019562 | NA | NA | pathogenic process | hypopharyngeal squamous cell cancer | Neoplasms |
| HSALNT0091661 | ENST00000503710 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289806 | ENST00000445734 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289807 | ENST00000448093 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289815 | ENST00000502941 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290340 | Uc002nbr.3 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290356 | Uc021re1.1 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289549 | AC016745.3 | AC016745.1 | NA | pathogenic process | glioma | Neoplasms |
| HSALNT0290180 | RP11-128A17.1 | AC078909.1 | NA | pathogenic process | glioma | Neoplasms |
| HSALNT0290377 | XLOC_001711 | NA | NA | pathogenic process | glioma | Neoplasms |
| HSALNT0289975 | LncRNA-AK058003 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289061 | LINC00682 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289305 | LINC01559 | FLJ33810 | NA | pathogenic process | Huntington disease | Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0289854 | GSTT1-AS1 | NA | transcriptional regulation | pathogenic process | mycobacterium tuberculosis infection | Bacterial Infections and Mycoses |
| HSALNT0289978 | LncRNA-CD244 | NA | transcriptional regulation | pathogenic process | tuberculosis infection | Bacterial Infections and Mycoses |
| HSALNT0289237 | SAMD12-AS1 | NA | NA | pathogenic process | neuroblastoma | Neoplasms |
| HSALNT0290179 | RP11-119F7.4 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290278 | TCONS_00068220 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0285573 | DANT1 | NA | transcriptional regulation | NA | NA | NA |
| HSALNT0288926 | DANT2 | NA | transcriptional regulation | NA | NA | NA |
| HSALNT0290399 | ZMAT1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289554 | AC100865.1 | NA | NA | pathogenic process | coronary artery disease | Cardiovascular Diseases |
| HSALNT0289228 | RAD51-AS1 | TODRA | transcriptional regulation | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289743 | DKFZP434K028 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289630 | BC002811 | NA | NA | pathogenic process | astrocytoma | Neoplasms |
| HSALNT0290387 | XLOC_010967 | NA | NA | pathogenic process | astrocytoma | Neoplasms |
| HSALNT0288955 | ENST00000545440 | NA | NA | pathogenic process | pediatric acute myeloid leukemia | Hemic and Lymphatic Diseases |
| HSALNT0288981 | FRGCA | LncRNA-AP001631.9 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289976 | LncRNA-AP001631.9 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289686 | CD99P1 | NA | ceRNA | pathogenic process | idiopathic pulmonary fibrosis | Respiratory Tract Diseases |
| HSALNT0289119 | LINC01613 | n341773 | NA | pathogenic process | idiopathic pulmonary fibrosis | Respiratory Tract Diseases |
| HSALNT0289844 | FTH1P3 | FTH1P3 | NA | pathogenic process | oral squamous cell cancer | Neoplasms |
| HSALNT0289855 | GTF2IRD2P1 | GTF2IRD2P1 | NA | pathogenic process | oral squamous cell cancer | Neoplasms |
| HSALNT0290135 | PDIA3F | NA | NA | pathogenic process | oral squamous cell cancer | Neoplasms |
| HSALNT0289329 | LINC00994 | NA | NA | pathogenic process | inflammatory bowel disease | Digestive System Diseases |
| HSALNT0289208 | PCAT5 | LINC01452,TPCAT-10-36067 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0114870 | LUADT1 | NA | transcriptional regulation | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289154 | LOXL1-AS1 | NA | NA | pathogenic process | exfoliation syndrome | Eye Diseases |
| HSALNT0289734 | DACOR1 | TCONS_00023265 | transcriptional regulation | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289060 | LINC00675 | NA | NA | pathogenic process | Pancreatic ductal adenocarcinoma | Neoplasms |
| HSALNT0288889 | B4GALT1-AS1 | NA | transcriptional regulation | pathogenic process | NA | NA |
| HSALNT0289348 | LINC01616 | n341006 | NA | pathogenic process | Alzheimer's disease | Mental Disorders;Nervous System Diseases |
| HSALNT0290068 | N336934 | NA | NA | pathogenic process | Alzheimer's disease | Mental Disorders;Nervous System Diseases |
| HSALNT0290240 | SIRT1-AS | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290198 | RP11-457M11.2 | NA | ceRNA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0150768 | LINC01507 | XLOC_000303 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289903 | LINC01057 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289914 | LINC01617 | C8orf23,NCRNA00249,XLOC_006844 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290015 | LOC152578 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0072252 | LINC01618 | LOC152578 | NA | pathogenic process | NA | NA |
| HSALNT0156870 | NALT1 | MIR4674HG,LINC01573,TCONS_l2_00029132 | transcriptional regulation | pathogenic process | acute lymphoblastic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0289083 | MALINC1 | LINC01024,MA-linc1 | NA | pathogenic process | human breast and lung cancer | Neoplasms |
| HSALNT0289902 | LINC01024 | MA-linc1 | NA | pathogenic process | osteosarcoma;lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289120 | LINC01627 | RP11-397D12.4 | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289121 | LINC01628 | AC007403.1 | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289820 | ERICH1-AS1 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290193 | RP11-397D12.4 | LINC01627 | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289122 | LINC01629 | linc-KIAA1737-2 | transcriptional regulation | pathogenic process | hypoxic and inflammatory renal epithelial injury | NA |
| HSALNT0290161 | PTPRG-AS1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289980 | LncRNA-DLEU1 | NA | ceRNA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289983 | LncRNA-Hh | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0288986 | GAS1RR | LncRNA-Hh | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0288908 | CCDC18-AS1 | ENST00000440778.1 | NA | pathogenic process | adolescent idiopathic scoliosis | Musculoskeletal Diseases |
| HSALNT0289055 | LINC00649 | TCONS_00028768 | NA | pathogenic process | adolescent idiopathic scoliosis | Musculoskeletal Diseases |
| HSALNT0289219 | PRKCQ-AS1 | ENST00000414894.1 | NA | pathogenic process | adolescent idiopathic scoliosis | Musculoskeletal Diseases |
| HSALNT0290203 | RP11-567G11.1 | LINC02041 | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289805 | ENST00000438550 | RPS24P1 | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0290083 | NONHSAG011351 | NA | NA | pathogenic process | type 1 diabetes | Nutritional and Metabolic Diseases;Endocrine System Diseases |
| HSALNT0290049 | MCHR2-AS1 | NA | NA | pathogenic process | psychiatric disease | Nervous System Diseases |
| HSALNT0289799 | ENST00000414355 | NA | NA | pathogenic process | cadmium toxicology | Disorders of Environmental Origin |
| HSALNT0290241 | SKP2 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289837 | FLJ90757 | NA | ceRNA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290017 | LOC283663 | NA | ceRNA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290019 | LOC338651 | NA | ceRNA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290132 | PCATs | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0086786 | EGFLAM-AS1 | lncRNA-LOWEG | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290031 | LOWEG | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289635 | BC014579 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289721 | CTB-167B5.2 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289863 | HELLS | NA | NA | pathogenic process | leukemia | Neoplasms |
| HSALNT0290195 | RP11-401P9.4 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290252 | SNHG19 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289557 | AF070632 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289569 | AK021443 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289728 | CTD-3080P12.3 | NA | ceRNA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289987 | LncRNA-n336928 | NA | NA | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289723 | CTC-523E23.5 | AC008555.2 | NA | pathogenic process | intervertebral disc degeneration | Musculoskeletal Diseases |
| HSALNT0289724 | CTD-2246P4.1 | NA | NA | pathogenic process | intervertebral disc degeneration | Musculoskeletal Diseases |
| HSALNT0290055 | MIR132 | MIRN132,miRNA132,mir-132 | NA | pathogenic process | intervertebral disc degeneration | Musculoskeletal Diseases |
| HSALNT0290189 | RP11-363G2.4 | NA | NA | pathogenic process | intervertebral disc degeneration | Musculoskeletal Diseases |
| HSALNT0290191 | RP11-38F22.1 | LINC02424 | NA | pathogenic process | intervertebral disc degeneration | Musculoskeletal Diseases |
| HSALNT0290223 | RP4-639J15.1 | AC006967.2 | NA | pathogenic process | intervertebral disc degeneration | Musculoskeletal Diseases |
| HSALNT0290233 | RUNX1-IT1 | C21orf96 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0288943 | ENST00000415964 | NA | NA | pathogenic process | pediatric acute myeloid leukemia | Hemic and Lymphatic Diseases |
| HSALNT0290009 | LOC101927497 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289956 | Lnc-CYP4A22-2/3 | NA | NA | pathogenic process | clear cell renal cell cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289999 | Lnc-ZNF180-2 | NA | NA | pathogenic process | renal clear cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290086 | NONHSAT037832 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0289658 | BX647187 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289584 | AK056155 | NA | NA | pathogenic process | Loeys-Dietz syndrome | Musculoskeletal Diseases |
| HSALNT0290057 | MR1 | NA | NA | pathogenic process | Loeys-Dietz syndrome | Musculoskeletal Diseases |
| HSALNT0289543 | AC002454.1 | AC002454.1 | NA | pathogenic process | endometriosis | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289909 | LINC01420 | NA | NA | pathogenic process | systemic lupus erythematosus | Immune System Diseases;Skin and Connective Tissue Diseases |
| HSALNT0289531 | 53BP1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290101 | NR_024118 | NA | NA | pathogenic process | rheumatoid arthritis | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases |
| HSALNT0290239 | SGO1-AS1 | SGOL1-AS1 | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289293 | ZNF667-AS1 | MORT | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289984 | LncRNA-HIF2PUT | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0288945 | ENST00000433673 | AC068282.1 | NA | pathogenic process | polycystic ovary syndrome | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0288948 | ENST00000454271 | AL021940.1 | NA | pathogenic process | polycystic ovary syndrome | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289495 | ENST00000432431 | AC023128.1 | NA | pathogenic process | polycystic ovary syndrome | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289918 | LINC01828 | NA | NA | pathogenic process | polycystic ovary syndrome | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0290388 | XLOC_011402 | NA | NA | pathogenic process | polycystic ovary syndrome | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289873 | ICAM-1 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289666 | C5-OT1 | C5T1lncRNA | NA | pathogenic process | rheumatoid arthritis | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases |
| HSALNT0289626 | AX800134 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290338 | Uc001ncr | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290330 | Uc.48+ | NA | NA | pathogenic process | diabetic neuropathic pain | Male Urogenital Diseases |
| HSALNT0289098 | LINC01207 | NA | transcriptional regulation | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289628 | BALR-6 | NA | transcriptional regulation | pathogenic process | B-lymphoblastic leukemia | Hemic and Lymphatic Diseases |
| HSALNT0290022 | LOC389641 | NA | NA | pathogenic process | Pancreatic ductal adenocarcinoma | Neoplasms |
| HSALNT0289725 | CTD-2541M15 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289940 | LINK-A | NA | NA | pathogenic process | triple-negative breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290107 | NUTF2P3 | NUTF2P3 | NA | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0290095 | NONHSAT123350 | NA | NA | pathogenic process | renal clear cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290362 | UHRF1 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290366 | UPAT | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289307 | LINC00324 | FLJ34790,MGC104931 | NA | pathogenic process | NA | NA |
| HSALNT0289969 | Lnc-MX1-1 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290024 | LOC400891 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289883 | LA16c-313D11.11 | NA | ceRNA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290192 | RP11-395G23.3 | AC027031.2 | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289581 | AK027294 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290371 | WISP1 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0206117 | FGF14-AS2 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290131 | PCAT2 | CARLo-4,PCA2,TCONS_00015167 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289528 | 2700086A05Rik | 2700086A05Rik | NA | pathogenic process | idiopathic pulmonary fibrosis | Respiratory Tract Diseases |
| HSALNT0290251 | SNED1 | NA | NA | pathogenic process | Idiopathic pulmonary fibrosis | Respiratory Tract Diseases |
| HSALNT0290333 | Uc.77 | NA | NA | pathogenic process | idiopathic pulmonary fibrosis | Respiratory Tract Diseases |
| HSALNT0289816 | ENST00000537266 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0289860 | HAGLROS | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0289881 | KRT18P55 | KRT18P55 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0229266 | IL21R-AS1 | NA | NA | pathogenic process | coronary artery disease | Cardiovascular Diseases |
| HSALNT0290112 | OTTHUMT00000387022 | NA | NA | pathogenic process | coronary artery disease | Cardiovascular Diseases |
| HSALNT0000551 | PRKCZ-AS1 | RP11-181G12.2 | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0030981 | LINC01833 | RP11-89,K21.1 | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290214 | RP11-89K21 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0165271 | LINC00857 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290109 | OR3A4 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290046 | MAGI1-IT1 | NA | ceRNA | pathogenic process | cardiac hypertrophy | Cardiovascular Diseases |
| HSALNT0290242 | SLC26A4-AS1 | NA | ceRNA | pathogenic process | cardiac hypertrophy | Cardiovascular Diseases |
| HSALNT0289302 | KRT7-AS | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0218672 | LINC01852 | ENST00000434223 | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290178 | RP11-1008C21.2 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289592 | AK123072 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289573 | AK021954 | NA | NA | pathogenic process | atherosclerosis | Cardiovascular Diseases |
| HSALNT0288916 | CERNA1 | LOC100129973 | ceRNA | pathogenic process | cardiovascular disease | Cardiovascular Diseases |
| HSALNT0018525 | LAMC1-AS1 | lnc-LAMC2-1:1 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290087 | NONHSAT040387 | NA | NA | pathogenic process | atrial fibrillation | Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases |
| HSALNT0290092 | NONHSAT098586 | NA | NA | pathogenic process | atrial fibrillation | Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases |
| HSALNT0289213 | PCSK6-AS1 | NA | NA | NA | NA | NA |
| HSALNT0289637 | BC016831 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289874 | IGKV | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290196 | RP11-434D9.1 | AC112206.2 | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289885 | LCAL6 | NA | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289650 | BC088254 | NA | NA | pathogenic process | myocardial hypertrophy | Cardiovascular Diseases |
| HSALNT0289596 | AK124454 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289731 | CYP4B1-PS1 | NA | NA | pathogenic process | diabetic nephropathy | Endocrine System Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289106 | LINC01405 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290259 | ST8SIA6-AS1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289278 | TRIM52-AS1 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289634 | BC012900 | NA | NA | pathogenic process | ulcerative colitis | Digestive System Diseases |
| HSALNT0274011 | UMODL1-AS1 | FLJ33471 | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289454 | ARRDC1-AS1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289456 | FAM74A3 | OTTHUMG00000067149 | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289834 | FH | NA | NA | pathogenic process | Fumarase deficiency | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289961 | Lnc-HOXC4-3:1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289994 | Lnc-TEAD4-1:1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290270 | TCONS_00003876 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290235 | SARCC | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290360 | Ucoo2kmd.1 | NA | ceRNA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289015 | KAZN-AS1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289722 | CTB-89H12.4 | AC021078.1 | ceRNA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289496 | EPB41L4A-AS2 | FLJ11235 | NA | pathogenic process | lung cancer;breast cancer;kidney cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289146 | LINC02567 | ENST00000427806 | NA | pathogenic process | attention deficit hyperactivity disorder | Mental Disorders |
| HSALNT0289833 | FGFR3-AS1 | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
| HSALNT0289707 | CILinc01 | NA | NA | pathogenic process | osteoarthritis | Musculoskeletal Diseases |
| HSALNT0289708 | CILinc02 | NA | NA | pathogenic process | osteoarthritis | Musculoskeletal Diseases |
| HSALNT0286597 | LINC00629 | LINC00629AB,LINC00629C,LINC00629D,LINC00629 | NA | pathogenic process | choriocarcinoma | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289665 | C2dat1 | NA | NA | pathogenic process | ischemic brain injury | Cardiovascular Diseases |
| HSALNT0289217 | POU6F2-AS2 | FLJ12971 | protein localization | pathogenic process | oesophageal squamous cell cancer | Neoplasms |
| HSALNT0289946 | Lnc13 | NA | NA | pathogenic process | celiac disease | Nutritional and Metabolic Diseases;Digestive System Diseases |
| HSALNT0289729 | CTD903 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290093 | NONHSAT104436 | NA | NA | pathogenic process | esophageal squamous cell cancer | Neoplasms |
| HSALNT0289550 | AC024560.2 | AC024560.1 | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289483 | ENST00000436681 | AP000552.1 | NA | pathogenic process | congenital heart defect | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289536 | AA584040 | NA | NA | pathogenic process | congenital heart defect | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289537 | AA709223 | NA | NA | pathogenic process | congenital heart defect | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289657 | BX478947 | NA | NA | pathogenic process | congenital heart defect | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0247515 | LINC00668 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289719 | CRNDE-h | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0142879 | SMILR | NA | NA | pathogenic process | vascular pathologies | Cardiovascular Diseases |
| HSALNT0290396 | Z38 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0197213 | LINC00507 | NA | NA | developmental process | NA | NA |
| HSALNT0289086 | LINC01082 | TCONSNA00024492 | NA | pathogenic process | alveolar capillary dysplasia with misalignment of pulmonary veins | Cardiovascular Diseases |
| HSALNT0289094 | LINC01185 | FLJ16341 | NA | pathogenic process | NA | NA |
| HSALNT0290160 | PTPRD-AS1 | NA | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290186 | RP11-254I22.1 | MIR583HG | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290204 | RP11-57P19.1 | AC009432.1 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290211 | RP11-80H5.7 | AL157400.4 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290215 | RP1-223E5.4 | AL441883.1 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290224 | RP4-799P18.3 | AL122008.4 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289126 | LINC01844 | LOC101926975 | NA | pathogenic process | hirschsprung disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases |
| HSALNT0289947 | Lnc34a | NA | transcriptional regulation | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289150 | LINP1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289951 | LncARSR | NA | ceRNA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289392 | RBM15-AS1 | AS-RBM15 | translational control | pathogenic process | acute megakaryocytic leukemia | Neoplasms |
| HSALNT0290089 | NONHSAT073641 | NA | NA | pathogenic process | vascular diseases | Cardiovascular Diseases |
| HSALNT0290027 | LOC572558 | NA | NA | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289582 | AK033210 | NA | NA | pathogenic process;developmental process | bronchopulmonary dysplasia | Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| HSALNT0289848 | GClnc1 | NA | transcriptional regulation | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289572 | AK021630 | NA | NA | pathogenic process | Parkinson's disease | Nervous System Diseases |
| HSALNT0289603 | AL049437 | NA | NA | pathogenic process | Parkinson's disease | Nervous System Diseases |
| HSALNT0290007 | LOC100507661 | NA | NA | pathogenic process | thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0289084 | LINC01029 | NA | NA | pathogenic process | cognitive functions and neuronal plasticity | Nervous System Diseases |
| HSALNT0290169 | RMEL3 | NA | NA | pathogenic process | melanoma | Neoplasms |
| HSALNT0289959 | Lnc-FRG2C-3 | NA | NA | pathogenic process | ankylosing spondylitis | Musculoskeletal Diseases |
| HSALNT0289966 | Lnc-LIN54-1 | NA | NA | pathogenic process | ankylosing spondylitis | Musculoskeletal Diseases |
| HSALNT0289997 | Lnc-USP50-2 | NA | NA | pathogenic process | ankylosing spondylitis | Musculoskeletal Diseases |
| HSALNT0290000 | Lnc-ZNF354A-1 | NA | NA | pathogenic process | ankylosing spondylitis | Musculoskeletal Diseases |
| HSALNT0288949 | ENST00000455309 | NA | NA | pathogenic process | primary Sjögren's syndrome | Immune System Diseases |
| HSALNT0289920 | LINC02384 | NA | NA | pathogenic process | primary Sjögren's syndrome | Immune System Diseases |
| HSALNT0289998 | Lnc-UTS2D-1:1 | NA | NA | pathogenic process | primary Sjögren's syndrome | Immune System Diseases |
| HSALNT0290067 | N336161 | NA | NA | pathogenic process | primary Sjögren's syndrome | Immune System Diseases |
| HSALNT0290069 | N340599 | NA | NA | pathogenic process | primary Sjögren's syndrome | Immune System Diseases |
| HSALNT0290099 | NR_002712 | NA | NA | pathogenic process | primary Sjögren's syndrome | Immune System Diseases |
| HSALNT0290290 | TCONS_l2_00014794 | NA | NA | pathogenic process | primary Sjögren's syndrome | Immune System Diseases |
| HSALNT0290170 | RMRP | CHH,NME1R,RRP2,RMRP | ceRNA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289900 | LINC00961 | NA | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289077 | LINC00977 | NA | NA | pathogenic process | primary spontaneous pneumothorax | Respiratory Tract Diseases |
| HSALNT0289560 | AF085995 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289566 | AK000053 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289571 | AK021595 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289574 | AK022024 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289595 | AK124307 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289639 | BC020384 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289642 | BC030759 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289715 | CR615992 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289954 | Lnc-CC3 | NA | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289614 | APOC1P1-3 | NA | transcriptional regulation | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290365 | UNMIBC | NA | transcriptional regulation | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290323 | Uc.167 | NA | NA | pathogenic process | ventricular septal defects | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0290212 | RP11-838N2.4 | GAPLINC | ceRNA | pathogenic process | glioblastoma | Neoplasms |
| HSALNT0289109 | LINC01478 | NA | NA | pathogenic process | blood pressure | Cardiovascular Diseases |
| HSALNT0289313 | LINC00342 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289677 | CAR10 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289365 | MAPT-AS1 | NA | transcriptional regulation | pathogenic process | Parkinson's disease | Nervous System Diseases |
| HSALNT0289679 | CAT104 | NA | ceRNA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290260 | STXBP5-AS1 | NA | ceRNA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289861 | HAR1 | NA | NA | pathogenic process | Huntington disease | Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0290359 | UCHL1-AS1 | NA | translational control | pathogenic process | Parkinson's disease | Nervous System Diseases |
| HSALNT0290238 | SCAANT1-AS | NA | NA | pathogenic process | spinocerebellar ataxia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0289648 | BC041488 | NA | transcriptional regulation | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290188 | RP11-359E19.2 | AC022733.1 | transcriptional regulation | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289851 | GIHCG | NA | transcriptional regulation | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289649 | BC087858 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290353 | Uc004cov.4 | NA | NA | pathogenic process | hypertrophic cardiomyopathy | Cardiovascular Diseases |
| HSALNT0290357 | Uc022bqu.1 | NA | NA | pathogenic process | hypertrophic cardiomyopathy | Cardiovascular Diseases |
| HSALNT0127837 | CFTR-AS1 | BGas | transcriptional regulation | pathogenic process | cystic fibrosis | Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases |
| HSALNT0046367 | MYOSLID | NA | NA | pathogenic process | vascular smooth muscle cell (VSMC) contractile phenotype | Cardiovascular Diseases |
| HSALNT0290331 | Uc.63 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290106 | Numb | NA | NA | pathogenic process | uveal melanoma | Neoplasms |
| HSALNT0289847 | GCASPC | TCONS_00011605,RP1-56L9.7-001,lnc-SOD2-1 | NA | pathogenic process | gallbladder cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289568 | AK001094 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289588 | AK093735 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289631 | BC003519 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290100 | NR_003573 | ANXA2P2 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290119 | P2RX7-V3 | NA | NA | pathogenic process | uveal melanoma | Neoplasms |
| HSALNT0290308 | TMSB4 | NA | ceRNA | pathogenic process | osteoarthritis | Musculoskeletal Diseases |
| HSALNT0288928 | DDX11-AS1 | CONCR | NA | pathogenic process | NA | NA |
| HSALNT0290052 | MELOE | NA | NA | pathogenic process | melanoma | Neoplasms |
| HSALNT0290231 | RSU1P2 | RSU1P2 | ceRNA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290165 | RBMY2FP | RBMY2FP | NA | NA | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290071 | N375709 | NA | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0289748 | DUXAP8 | DUXAP8 | NA | NA | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290030 | LOC729966 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0290143 | POIR | NA | ceRNA | pathogenic process | periodontitis | Stomatognathic Diseases |
| HSALNT0067481 | MELTF-AS1 | MFI2-AS1,AC068302.3 | NA | pathogenic process | osteosarcoma | Neoplasms |
| HSALNT0290053 | MFI2 | NA | NA | pathogenic process | osteosarcoma | Neoplasms |
| HSALNT0289922 | Linc-223 | NA | ceRNA | pathogenic process | acute myeloid leukemia | Neoplasms |
| HSALNT0014603 | LINC01138 | LINC00875,FLJ39739 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290262 | SUZ12P1 | SUZ12P1 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0290005 | LOC100505976 | NA | NA | pathogenic process | laryngeal squamous cell cancer | Neoplasms |
| HSALNT0290392 | XLOC_l2_010636 | NA | NA | pathogenic process | laryngeal squamous cell cancer | Neoplasms |
| HSALNT0090295 | RASGRF2-AS1 | CTC-459I6.1 | NA | pathogenic process | sepsis-induced endothelial dysfunction | Bacterial Infections and Mycoses |
| HSALNT0289852 | GPC3-AS1 | NA | transcriptional regulation | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0189472 | HOXC-AS1 | NA | transcriptional regulation | pathogenic process | atherosclerosis | Cardiovascular Diseases |
| HSALNT0289157 | LUARIS | lncRNA#32 | transcriptional regulation | NA | NA | NA |
| HSALNT0289371 | MIR3936HG | LOC553103,SLC22A5-AS1 | NA | pathogenic process | gastric cancer;nasopharyngeal cancer | Otorhinolaryngologic Diseases;Stomatognathic Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0290148 | Ppp1r1b | NA | transcriptional regulation | pathogenic process | congenital heart defect | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289038 | LINC00460 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290194 | RP1-13P20.6 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290364 | Unigene56159 | NA | ceRNA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290355 | Uc009yby.1 | NA | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289406 | TFAP2A-AS2 | HIPSTR | NA | developmental process | NA | NA |
| HSALNT0289704 | Chaer | NA | transcriptional regulation | pathogenic process | cardiac hypertrophy | Cardiovascular Diseases |
| HSALNT0211378 | LINC00520 | C14orf34 | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0087374 | MRPS30-DT | BRCAT54 | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289388 | PPP1R12A-AS1 | R12A-AS1 | translational control | NA | NA | NA |
| HSALNT0289013 | ITFG2-AS1 | NA | NA | NA | NA | NA |
| HSALNT0290088 | NONHSAT041499 | NA | NA | pathogenic process | schizophrenia | Mental Disorders |
| HSALNT0290091 | NONHSAT089447 | NA | NA | pathogenic process | schizophrenia | Mental Disorders |
| HSALNT0289970 | Lnc-NKX2-3-1 | NA | transcriptional regulation | pathogenic process | acute lymphoblastic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0289989 | Lnc-RTN4R-1 | NA | transcriptional regulation | pathogenic process | acute lymphoblastic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0289821 | ERL | NA | NA | pathogenic process | Marek's disease | Immune System Diseases;Hemic and Lymphatic Diseases;Virus Diseases |
| HSALNT0192459 | LINC02258 | RP11-248E9.5 | NA | pathogenic process | pneumonia | Respiratory Tract Diseases |
| HSALNT0241871 | SKAP1-AS1 | RP11-456D7.1 | NA | pathogenic process | pneumonia | Respiratory Tract Diseases |
| HSALNT0289439 | DINOL | DINO | NA | NA | NA | NA |
| HSALNT0288901 | CAMTA1-DT | lncCAMTA1 | transcriptional regulation | pathogenic process | liver cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290328 | Uc.345 | NA | transcriptional regulation | pathogenic process | pancreatic cancer | Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0290060 | MSNP1AS | NA | translational control | pathogenic process | autism spectrum disorder | Mental Disorders |
| HSALNT0289376 | NEXN-AS1 | C1orf118,FLJ90637 | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0183194 | LINC02098 | RP11-702B10.1 | NA | pathogenic process | esophageal cancer | Neoplasms |
| HSALNT0198055 | PSPC1-AS2 | RP11-523H24.3 | NA | pathogenic process | esophageal cancer | Neoplasms |
| HSALNT0289155 | LRRC75A-AS1 | C17orf45,NCRNA00188,C17orf76-AS1,FAM211A-AS1,MGC40157 | NA | pathogenic process | rheumatoid arthritis | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases |
| HSALNT0289220 | PRKG1-AS1 | RP11-573I11.2 | NA | pathogenic process | rheumatoid arthritis | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases |
| HSALNT0289262 | SVIL-AS1 | RP11-534G20.3 | NA | pathogenic process | rheumatoid arthritis | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases |
| HSALNT0289281 | VPS33B-DT | NA | NA | pathogenic process | rheumatoid arthritis | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases |
| HSALNT0289804 | ENST00000438399 | NA | NA | pathogenic process | rheumatoid arthritis | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases |
| HSALNT0290228 | RPKG1-AS1 | NA | NA | pathogenic process | rheumatoid arthritis | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases |
| HSALNT0290350 | Uc004afb.1 | NA | NA | pathogenic process | rheumatoid arthritis | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases |
| HSALNT0289398 | SLC5A4-AS1 | RP1-90G24.10 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289411 | TNFRSF10A-AS1 | RP11-1149O23.2 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289727 | CTD-2616J11.14 | AC008750.7 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290182 | RP11-150O12.3 | AC124067.4 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289730 | CXCL1P1 | CXCL1P1 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289803 | ENST00000438347 | CCND3P1 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289897 | LINC00601 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289503 | KIAA0087 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289827 | FAM212B-AS1 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290010 | LOC102723552 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290181 | RP11-140I24 | LINC01568 | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290201 | RP11-501O2 | LINC02046 | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290206 | RP11-600K151 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290084 | NONHSAG051968 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0290090 | NONHSAT076747 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0290094 | NONHSAT122730 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0138768 | MIR2052HG | NA | transcriptional regulation | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289096 | LINC01198 | NA | NA | pathogenic process | glioma | Neoplasms |
| HSALNT0289274 | TPT1-AS1 | NA | NA | pathogenic process | glioma | Neoplasms |
| HSALNT0289924 | Linc-cdh4-2 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0144641 | LINC02055 | RP1130-1 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289737 | DBCCR1 | NA | transcriptional regulation | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289547 | AC012065.7 | NA | NA | pathogenic process | chronic lymphocytic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0289229 | RAMP2-AS1 | NA | NA | pathogenic process | glioblastoma | Neoplasms |
| HSALNT0289591 | AK098081 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289644 | BC037331 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289646 | BC040303 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289717 | CR749831 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289250 | SNHG18 | NA | NA | pathogenic process | glioma | Neoplasms |
| HSALNT0106140 | FOXP4-AS1 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0026202 | RNASEH1-AS1 | LOC100506054 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0288993 | GSEC | ST3GAL4-AS1,DCPS-AS1,FLJ39051 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0060264 | DNAJB8-AS1 | NA | NA | NA | NA | NA |
| HSALNT0248137 | CHMP1B-AS1 | NA | NA | NA | NA | NA |
| HSALNT0021970 | TGFB2-AS1 | NR_046268 | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0078323 | SLC7A11-AS1 | NA | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0134663 | INTS9-AS1 | ENST00000520055 | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0231572 | MMP2-AS1 | NA | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0267869 | SLC12A5-AS1 | RP11-465L10.10 | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0288921 | CSMD2-AS1 | ENST00000434181 | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0288997 | HDAC2-AS2 | ENST00000421891 | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289012 | INO80-AS1 | NA | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289140 | LINC02247 | NA | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289161 | MAGI2-AS3 | NA | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289188 | MNX1-AS2 | NA | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289245 | SMIM10L2B-AS1 | NA | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289407 | TGFB3-AS1 | NA | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289457 | HSD17B3-AS1 | NA | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289919 | LINC02246 | NA | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289288 | ZNF710-AS1 | ENST00000558334 | NA | pathogenic process | early-onset preeclampsia | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289266 | TDRKH-AS1 | RP11-98D18.9 | NA | pathogenic process | NA | NA |
| HSALNT0289128 | LINC01952 | AC004854.4 | NA | pathogenic process | recurrent miscarriage | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0290075 | NCF4-AS1 | CTA-833B7.2 | NA | pathogenic process | recurrent miscarriage | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289360 | LNCSRLR | lncRNA-SRLR | transcriptional regulation | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0288918 | CFLAR-AS1 | ALS2CR10 | NA | pathogenic process | esophageal squamous cell cancer | Neoplasms |
| HSALNT0289710 | COL1A2-AS1 | TCONS_00013888,lncRNA8975-1 | transcriptional regulation | pathogenic process | hypertrophic scar | Skin and Connective Tissue Diseases |
| HSALNT0075075 | LNCPRESS2 | lncPRESS2 | transcriptional regulation | NA | NA | NA |
| HSALNT0011289 | LINC01930 | EU358092 | NA | pathogenic process | schizophrenia | Mental Disorders |
| HSALNT0097120 | HMMR-AS1 | NA | NA | pathogenic process | basal-like breast cancer | Neoplasms |
| HSALNT0184498 | CCND2-AS1 | CCND2-AS2 | NA | pathogenic process | glioma | Neoplasms |
| HSALNT0289045 | LINC00578 | NA | NA | pathogenic process | major depression disorder | Behavior and Behavior Mechanisms |
| HSALNT0288884 | ADAMTS9-AS1 | NA | NA | pathogenic process | epithelial ovarian cancer | Neoplasms |
| HSALNT0080041 | FAM198B-AS1 | NA | NA | pathogenic process | NA | NA |
| HSALNT0103007 | LINC00240 | C6orf41,NCRNA00240,bA373D17.1 | ceRNA | pathogenic process | esophageal squamous cell cancer | Neoplasms |
| HSALNT0289071 | LINC00909 | NA | NA | NA | NA | NA |
| HSALNT0289509 | LINC00680 | NA | NA | NA | NA | NA |
| HSALNT0129070 | LINC00513 | AC016831.7 | NA | NA | NA | NA |
| HSALNT0289129 | LINC02001 | RP11-1094M14.11 | NA | NA | NA | NA |
| HSALNT0289215 | POC1B-AS1 | RP11-734K2.4 | NA | NA | NA | NA |
| HSALNT0289241 | SLC12A9-AS1 | RP11-126L15.4 | NA | NA | NA | NA |
| HSALNT0289275 | TRAM2-AS1 | NA | NA | NA | NA | NA |
| HSALNT0002243 | ENST00000457898.1 | ENSG00000226029 | ceRNA | pathogenic process | oesophageal cancer | Neoplasms |
| HSALNT0288941 | ELF3-AS1 | ENST00000415582 | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0289134 | LINC02158 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289350 | LINC01671 | BC041455 | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289124 | LINC01684 | lnc-JAM2-6 | NA | pathogenic process | nonalcoholic fatty liver disease | Digestive System Diseases |
| HSALNT0289036 | LINC00365 | NA | NA | pathogenic process | esophageal cancer | Neoplasms |
| HSALNT0289111 | LINC01554 | C5orf27,FLJ38821,FIS | NA | pathogenic process | esophageal cancer | Neoplasms |
| HSALNT0289132 | LINC02154 | GS1-600G8.5 | NA | pathogenic process | esophageal cancer | Neoplasms |
| HSALNT0137721 | LINC02155 | RP11-705O24.1 | NA | pathogenic process | esophageal cancer | Neoplasms |
| HSALNT0225363 | LINC02157 | RP11-327J17.1 | NA | pathogenic process | esophageal cancer | Neoplasms |
| HSALNT0289133 | LINC02156 | RP1-90J4.1 | NA | pathogenic process | esophageal cancer | Neoplasms |
| HSALNT0133924 | LINC02153 | NA | NA | pathogenic process | major depression disorder | Behavior and Behavior Mechanisms |
| HSALNT0181656 | LINC02151 | TCONS_00019174 | NA | pathogenic process | major depression disorder | Behavior and Behavior Mechanisms |
| HSALNT0227367 | LINC02152 | NA | NA | pathogenic process | major depression disorder | Behavior and Behavior Mechanisms |
| HSALNT0029246 | BRE-AS1 | NA | NA | NA | NA | NA |
| HSALNT0289251 | SNHG26 | AC005682.5 | NA | pathogenic process | bladder urothelial cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0252719 | LIVAR | lnc18q22.2 | NA | pathogenic process | nonalcoholic steatohepatiti | Digestive System Diseases |
| HSALNT0289074 | LINC00969 | ENST00000453324 | NA | pathogenic process | lung squamous cell cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289138 | LINC02243 | ENST00000441841 | NA | pathogenic process | lung squamous cell cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289399 | SLC9A3-AS1 | UC011CLY.2 | NA | pathogenic process | lung squamous cell cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0288934 | DM1-AS | NA | NA | pathogenic process | myotonic dystrophy type 1 | Musculoskeletal Diseases;Nervous System Diseases |
| HSALNT0009014 | LINC02238 | RP4-788P17.1 | NA | pathogenic process | B cell lymphoma | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0289163 | MEF2C-AS2 | CTC-467M3.1 | NA | pathogenic process | diffuse large B-cell lymphoma | Hemic and Lymphatic Diseases |
| HSALNT0289181 | MIR4422HG | RP11-101C11.1 | NA | pathogenic process | diffuse large B-cell lymphoma | Hemic and Lymphatic Diseases |
| HSALNT0289403 | SPON1-AS1 | RP11-21,L19.1 | NA | pathogenic process | diffuse large B-cell lymphoma | Hemic and Lymphatic Diseases |
| HSALNT0289461 | CD44-AS1 | RP1-68D18.4 | NA | pathogenic process | diffuse large B-cell lymphoma | Hemic and Lymphatic Diseases |
| HSALNT0262277 | LILRB1-AS1 | AC009892.10 | NA | pathogenic process | NA | NA |
| HSALNT0282241 | LINC01186 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289168 | MHENCR | NA | ceRNA | pathogenic process | melanoma | Neoplasms |
| HSALNT0072994 | LINC02232 | RP11-707A18.1 | NA | pathogenic process | NA | NA |
| HSALNT0080161 | LINC02233 | RP11-6C14.1 | NA | pathogenic process | NA | NA |
| HSALNT0084027 | LINC02236 | RP11-332J15.1 | NA | pathogenic process | NA | NA |
| HSALNT0091870 | LINC02234 | RP11-455B3.1 | NA | pathogenic process | NA | NA |
| HSALNT0139521 | LINC02235 | RP11-354A14.1 | NA | pathogenic process | NA | NA |
| HSALNT0142040 | LINC02237 | RP11-1101K5.1 | NA | pathogenic process | NA | NA |
| HSALNT0289135 | LINC02179 | RP11-189E14.4 | NA | pathogenic process | NA | NA |
| HSALNT0289351 | LINC01689 | AP000469.2 | NA | pathogenic process | NA | NA |
| HSALNT0289137 | LINC02231 | RP11-766N7.4 | NA | pathogenic process | Esophageal squamous cell cancer | Neoplasms |
| HSALNT0220239 | MIR4713HG | RP11-108K3.1 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0288967 | FAM160A1-DT | RP11-610P16.1 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289239 | SATB2-AS1 | NA | translational control | pathogenic process | osteosarcoma | Neoplasms |
| HSALNT0289512 | LINC01826 | lnc-MKI67IP-3 | ceRNA | pathogenic process | atherosclerosis | Cardiovascular Diseases |
| HSALNT0289024 | LINC00226 | C14orf97,NCRNA00226 | NA | pathogenic process | pancreatic ductaladenocarcinoma | Neoplasms |
| HSALNT0082192 | F11-AS1 | NA | NA | NA | NA | NA |
| HSALNT0219108 | SPINT1-AS1 | RP11-532F12.5 | NA | pathogenic process | melanoma | Neoplasms |
| HSALNT0289177 | MIR200CHG | U47924.27 | NA | pathogenic process | melanoma | Neoplasms |
| HSALNT0289328 | LINC00888 | NA | NA | pathogenic process | melanoma | Neoplasms |
| HSALNT0289309 | LINC00672 | NA | transcriptional regulation | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289198 | P4HA3-AS1 | NA | NA | pathogenic process | parkinson's disease | Nervous System Diseases |
| HSALNT0197312 | TMEM132D-AS1 | LOC283352 | NA | pathogenic process | human dermal fibroblasts | Cell Physiological Phenomena |
| HSALNT0289472 | ATP2C2-AS1 | RP11-517C16.2-001 | NA | NA | NA | NA |
| HSALNT0233849 | WWOX-AS1 | RP11-190D6.2 | NA | pathogenic process | epithelial ovarian cancer | Neoplasms |
| HSALNT0128829 | FLNC-AS1 | NA | NA | pathogenic process | cervical squamous cancer | Neoplasms |
| HSALNT0289889 | LIF-AS1 | Lnc-LIF-AS | NA | pathogenic process | cervical squamous cancer | Neoplasms |
| HSALNT0011283 | DPYD-AS2 | NA | NA | pathogenic process | cervical squamous cancer | Neoplasms |
| HSALNT0289836 | FLICR | NA | transcriptional regulation | pathogenic process | autoimmune diabete | Immune System Diseases |
| HSALNT0289356 | LINC02402 | ENST00000550337.1 | NA | pathogenic process | diabetes | Endocrine System Diseases |
| HSALNT0137118 | CERNA3 | CTA | ceRNA | pathogenic process | osteosarcoma | Neoplasms |
| HSALNT0090838 | LINC02488 | CTD-2316B1 | NA | pathogenic process | NA | NA |
| HSALNT0174947 | LINC02489 | CTD-2589M5 | NA | pathogenic process | NA | NA |
| HSALNT0220441 | LINC02490 | RP11-209E8 | NA | pathogenic process | NA | NA |
| HSALNT0289260 | STK32A-AS1 | CTC-255N20 | NA | pathogenic process | NA | NA |
| HSALNT0289143 | LINC02487 | NA | NA | pathogenic process | squamous cell cancer | Neoplasms |
| HSALNT0095585 | SPRY4-AS1 | THCAT68 | NA | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0288927 | DDN-AS1 | CAT1507 | NA | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0012862 | SLC16A1-AS1 | NA | NA | pathogenic process | acute myocardial infarction | Cardiovascular Diseases |
| HSALNT0289412 | TNFRSF14-AS1 | ENST00000416860.2 | NA | pathogenic process | acute myocardial infarction | Cardiovascular Diseases |
| HSALNT0259139 | LINC00665 | NA | NA | NA | NA | NA |
| HSALNT0040268 | DARS-AS1 | NA | NA | pathogenic process | renal disease | NA |
| HSALNT0288913 | CEBPA-AS1 | CEBPA-DT | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289011 | INHBA-AS1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0288988 | GASAL1 | GASL1 | NA | pathogenic process | liver cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289127 | LINC01857 | AC079767.4 | NA | pathogenic process | tuberculosis | Bacterial Infections and Mycoses |
| HSALNT0289091 | LINC01140 | FLJ41676 | NA | NA | NA | NA |
| HSALNT0281957 | PINCR | NA | transcriptional regulation | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289344 | LINC00890 | NA | NA | pathogenic process | leiomyoma | Neoplasms |
| HSALNT0019828 | LINC00862 | C1orf98,SMIM16 | NA | pathogenic process | cystic fibrosis | Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases |
| HSALNT0073790 | LINC02562 | RP11-44F21.5 | NA | pathogenic process | cystic fibrosis | Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases |
| HSALNT0263101 | LINC02560 | CTD-2619J13.13 | NA | pathogenic process | cystic fibrosis | Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases |
| HSALNT0289144 | LINC02551 | RP11-890B15.2 | NA | pathogenic process | cystic fibrosis | Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases |
| HSALNT0289458 | DDIT4-AS1 | RP11-442H21.2 | NA | pathogenic process | cystic Fibrosis | Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases |
| HSALNT0288992 | GPRC5D-AS1 | RP11-392P7.6 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289386 | PCBP1-AS1 | NA | NA | pathogenic process | NA | NA |
| HSALNT0289405 | STARD4-AS1 | NA | NA | pathogenic process | NA | NA |
| HSALNT0201547 | LINC00462 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0207103 | SOX1-OT | LINC00403 | NA | pathogenic process | NA | NA |
| HSALNT0002131 | SLC25A34-AS1 | RP11-169K16.4 | NA | NA | NA | NA |
| HSALNT0289218 | PPP1R26-AS1 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289047 | LINC00589 | C8orf75,TSLNC8 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289516 | TPM1-AS | TPM1-AS1 | splicing regulation | pathogenic process | esophageal cancer | Neoplasms |
| HSALNT0289314 | LINC01101 | FLJ14816 | NA | pathogenic process | HPV-induced cervical neoplasia | Neoplasms |
| HSALNT0289147 | LINC02572 | AC079776.2 | NA | pathogenic process | epithelial ovarian cancer | Neoplasms |
| HSALNT0096804 | LINC02202 | NA | NA | NA | NA | NA |
| HSALNT0289076 | LINC00973 | CTD-2021J15.2 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0288625 | TTTY10 | NCRNA00133 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289323 | LINC00319 | C21orf125,NCRNA00319,PRED49,FLJ38036 | ceRNA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0015533 | IL6R-AS1 | RP11-350G8.5 | NA | NA | NA | NA |
| HSALNT0090330 | CKMT2-AS1 | NA | NA | NA | NA | NA |
| HSALNT0012995 | HIPK1-AS1 | NA | NA | NA | NA | NA |
| HSALNT0289216 | POLH-AS1 | RP3-337H4.8 | NA | NA | NA | NA |
| HSALNT0289276 | TRDN-AS1 | HRAT13 | NA | NA | NA | NA |
| HSALNT0289159 | LY6E-DT | LOC100133669 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0288991 | GLIS3-AS1 | C9orf70,MGC16153 | NA | NA | NA | NA |
| HSALNT0288896 | BNC2-AS1 | RP11-62F24.2 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289292 | ZNF503-AS1 | NA | NA | pathogenic process | age-related macular degeneration | Eye Diseases |
| HSALNT0159506 | VIM-AS1 | NA | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0288882 | ACBD3-AS1 | RP11-275I14.4 | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289156 | LRRC8C-DT | FLJ27354 | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289447 | ELN-AS1 | CTB-51J22.1 | NA | pathogenic process | endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0076712 | LINC02264 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0093666 | LINC02201 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0271685 | LINC02573 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289125 | LINC01816 | LOC100133985 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289355 | LINC02381 | LOC400043 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289366 | MBNL1-AS1 | LOC401093 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289513 | MIR4697HG | LINC00947,LOC283174 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289073 | LINC00968 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0114453 | NMBR-AS1 | RP11-137J7.2 | NA | pathogenic process | non-melanoma skin cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289300 | LINC01518 | NA | NA | pathogenic process | non-melanoma skin cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0003783 | LINC02574 | RP11-288L9.1 | transcriptional regulation | pathogenic process | UVB-irradiated KC & non-melanoma skin cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0030828 | LINC02580 | AC093609.1 | NA | pathogenic process | UVB-irradiated KC & non-melanoma skin cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0127022 | LINC02577 | NA | NA | pathogenic process | UVB-irradiated KC & non-melanoma skin cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0154722 | LINC02578 | RP11-127L21.1 | NA | pathogenic process | UVB-irradiated KC & non-melanoma skin cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0288962 | FAM111A-DT | NA | NA | pathogenic process | UVB-irradiated KC & non-melanoma skin cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289148 | LINC02575 | AP001065.15 | transcriptional regulation | pathogenic process | UVB-irradiated KC & non-melanoma skin cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0177212 | RPS6KB2-AS1 | AP003419.16 | NA | pathogenic process | agingâassociated idiopathic pulmonary fibrosis | Physiological Phenomena |
| HSALNT0289072 | LINC00941 | lncRNA-MUF | ceRNA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289338 | LINC00094 | FLJ35348,bA374P20.3 | NA | pathogenic process | lung squamous cell cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0114192 | FILNC1 | NA | translational control | pathogenic process | renal tumor | Neoplasms |
| HSALNT0289199 | PARAL1 | NA | ceRNA | pathogenic process | obesity | Pathological Conditions, Signs and Symptoms;Nutritional and Metabolic Diseases;Physiological Phenomena |
| HSALNT0056667 | LINC02027 | LOC728290 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289069 | LINC00880 | NA | NA | NA | NA | NA |
| HSALNT0252974 | LINC02582 | CTD-2354A18.1 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289035 | LINC00364 | LncRNA00364 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0060981 | NCK1-DT | NCK1-AS1,SLC35G2-AS1 | ceRNA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0288890 | BAALC-AS1 | lncFZD6,FZD6-DT | transcriptional regulation | pathogenic process | liver cancer | Neoplasms;Digestive System Diseases |
| HSALNT0046602 | CPS1-IT1 | CPS1-IT,CPS1IT,CPS1IT1,PRO0132 | NA | pathogenic process | hepatocellular cancer;lung cancer;intrahepatic cholangiocarcinoma | Respiratory Tract Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289445 | DLX6-AS1 | DLX6-A, DLX6A, Evf-2,NCRNA00212,NCRNA00212,FLJ34048 | transcriptional regulation | pathogenic process | split hand/split foot malformation disorder;lung adenocarcinoma | Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms |
| HSALNT0289891 | LINC00114 | NA | NA | NA | NA | NA |
| HSALNT0289415 | TSIX | LINC00013,NCRNA00013,XIST-A, XIST-AS1,XISTAS | transcriptional regulation | pathogenic process | systemic sclerosis | Skin and Connective Tissue Diseases |
| HSALNT0217334 | MKRN3-AS1 | ZNF127A, MKRN3A, MKRN3-A,FNZ127,NCRNA00009,ZNF127-AS | NA | pathogenic process | Prader-Willi syndrome | Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0290256 | Lnc-SRA1-1:1 | lnc-SRA1-1:1,SRA1,ENSG00000213523 | transcriptional regulation | pathogenic process | nonalcoholic fatty liver disease;polycystic ovary syndrome;ovarian cancer;dilated cardiomyopathy;cardiomyopathy;breast cancer;laryngeal squamous cell cancer;uterus cancer | Skin and Connective Tissue Diseases;Neoplasms;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0289442 | HCP5 | 6S2650E,D6S2650E,P5-1 | NA | pathogenic process | AIDS | Immune System Diseases;Virus Diseases |
| HSALNT0289284 | Lnc-EIF3M-1:1 | WIT1,WIT-1,WT1A, WT1-AS1 | transcriptional regulation | pathogenic process | gastric cancer;primary myelofibrosis;hepatocellular cancer;Wilms' tumor;acute myeloid leukemia | Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases |
| HSALNT0289421 | NONHSAT017524 | KCNQ1-AS2,KCNQ10T1,Kncq1,KvDMR1,KvLQT1-A, LIT1,NCRNA00012 | transcriptional regulation | pathogenic process | prostate cancer;colorectal cancer;hepatocelluar cancer;acute myocardial infarction;kidney cancer;Beckwith-Wiedemann syndrome;breast cancer | Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Digestive System Diseases |
| HSALNT0263784 | PCNA-AS1 | PCNAA, PCNA-AS | transcriptional regulation | pathogenic process | gastric cancer;hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289524 | HCG9 | PERB11,HCGIX,HCGIX4,HCGIX-4 | NA | NA | NA | NA |
| HSALNT0289264 | TCL6 | TCL6e1,TNG2,TNG1 | NA | pathogenic process;developmental process | renal cell cancer;leukemia | Male Urogenital Diseases;Neoplasms |
| HSALNT0289203 | ENST00000412654.1 | DD3,NCRNA00019,PCAT3 | transcriptional regulation;ceRNA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289462 | NONHSAT017465 | ASM,ASM1,BW, D11S813E,LINC00008,NCRNA00008,WT2 | transcriptional regulation;ceRNA | developmental process;pathogenic process | prostate cancer;glioma;cancer;breast cancer;ovarian cancer;Marek's disease;gestational trophoblastic diseases;glioblastoma;non-small cell lung cancer;hyperhomocysteinemia;congenital heart defect;congenital hyperinsulinism;pancreatic cancer;Beckwith-Wiedemann syndrome;endometriosis;trophoblastic tumor;adrenocortical cancer;coronary artery disease;Wiedemann-Beckwith syndrome;bladder cancer;melanoma;myeloproliferative polycythaemia vera;hepatocelluar cancer;meningioma;breast adenocarcinoma;neuroblastoma;embryonal cancer;osteosarcoma;esophageal cancer;kidney cancer;malignant digestive cancer;chronic myeloid leukemia;mullerian aplasia;malignant hematopoiesis;gastric cardia adenocarcinoma;cervical cancer;gallbladder cancer;pheochromocytoma;germ cell tumor;colorectal cancer;hydatidiform mole;Pancreatic ductal adenocarcinoma;pre-eclampsia;atherosclerosis;esophageal squamous cell cancer;calcific aortic valve disease;gastric cancer;osteoarthritis;choriocarcinoma;chronic myeloproliferative disorders;neural tube defects;skin cancer;ulcerative colitis;type 2 diabetes;thyroid cancer;pneumoconiosis;infertility;liver cancer;heart failure;medulloblastoma;laryngeal squamous cell cancer;Silver-Russell syndrome;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;growth restriction;Prader-Willi syndrome;diabetic cardiomyopathy;obesity;lung cancer;Parkinson's disease;renal cell cancer;Wilms' tumor | Nutritional and Metabolic Diseases;Cell Physiological Phenomena;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Physiological Phenomena;Neoplasms;Male Urogenital Diseases;Endocrine System Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Immune System Diseases;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Nervous System Diseases;Digestive System Diseases;Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Respiratory Tract Diseases;Occupational Diseases;Otorhinolaryngologic Diseases;Stomatognathic Diseases |
| HSALNT0288932 | NONHSAT033797 | BCM, BCMS1,DLB1,LEU1,LEU2,LINC00021,NCRNA00021,XTP6 | transcriptional regulation;ceRNA | pathogenic process | lymphocytic leukemia;B-cell chronic lymphocytic leukemia;myeloma;multiple myeloma;hematopoietic and solid tumors;chronic lymphocytic leukemia;inherited bone marrow failure disorder;lymphoma;breast cancer;head and neck squamous cell cancer | Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Immune System Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases |
| HSALNT0289493 | DBH-AS1 | NCRNA00118,BPR | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0088415 | ENST00000506884.1 | DKFZP586D0823,NCRNA00206 | NA | pathogenic process | prostate cancer;glioblastoma | Male Urogenital Diseases;Neoplasms |
| HSALNT0289463 | IGF2-AS | IGF2A,PEG8,IGF2-AS1 | transcriptional regulation | pathogenic process | liver cancer;type 1 diabetes;prostate cancer;Wilms' tumor;hepatocelluar cancer | Neoplasms;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0269786 | Lnc-CTSZ-5:1 | GNASA, GNAS-A,SANG,NESP-A, NESPA, GNAS1A, NCRNA00075 | transcriptional regulation | pathogenic process | non-small cell lung cancer;pseudohypoparathyroidism type Ib | Musculoskeletal Diseases;Respiratory Tract Diseases;Neoplasms |
| HSALNT0289252 | NONHSAT054526 | C6orf160,MGC16362,bA33E24.2,U50HG,NCRNA00044,LINC00044 | NA | pathogenic process | gastric cancer;lymphoma;melanoma | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases |
| HSALNT0023827 | NONHSAT010191 | DISC1-AS1,DISC1O, NCRNA00015 | transcriptional regulation | pathogenic process | bipolar disorder;affective disorder;major depressive affective disorder;schizophrenia;autism spectrum disorder;depression | Bacterial Infections and Mycoses;Mental Disorders;Behavior and Behavior Mechanisms |
| HSALNT0203415 | NONHSAT034251 | SCA8,KLHL1A,NCRNA00003 | transcriptional regulation | pathogenic process | spinocerebellar ataxia;spinocerebellar ataxia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0290312 | TRAF3IP2-AS1 | C6UA, C6orf3,NCRNA00248,TRAF3IP2-AS2 | transcriptional regulation | pathogenic process | schizophrenia;cocaine abuse | Chemically-Induced Disorders;Mental Disorders |
| HSALNT0289008 | HYMAI | NCRNA00020 | NA | pathogenic process | transient neonatal diabetes | Nutritional and Metabolic Diseases |
| HSALNT0288968 | FAM201A | C9orf122 | NA | pathogenic process | leukemia | Neoplasms |
| HSALNT0288969 | FAM222A-AS1 | NA | NA | pathogenic process | NA | NA |
| HSALNT0289484 | FAM226A | CXorf50,NCRNA00246,NCRNA00246A,LINC00246A,MGC34827 | NA | pathogenic process | NA | NA |
| HSALNT0289497 | FAM215A | C17orf88,APR-2,LINC00530 | NA | pathogenic process | ovarian cancer;leukemia | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289230 | NONHSAT089783 | LUST | transcriptional regulation | pathogenic process | tumor | Neoplasms |
| HSALNT0002923 | LINC00339 | NCRNA00339,HSPC157 | NA | pathogenic process;developmental process | Pancreatic ductal adenocarcinoma | Neoplasms |
| HSALNT0144027 | ASAP1-IT1 | ASAP1-IT,ASAP1IT,ASAP1IT1,DDEF1IT1,HSPC054,NCRNA00050 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289212 | NONHSAT076153 | NCRNA00071,LINC00071,PCAT9 | transcriptional regulation;ceRNA | pathogenic process | osteoarthritis;prostate cancer;glioma | Musculoskeletal Diseases;Male Urogenital Diseases;Neoplasms |
| HSALNT0289016 | KCNQ1DN | BWRT,HSA404617 | NA | pathogenic process | aging;Wilms' tumor | Physiological Phenomena;Neoplasms |
| HSALNT0288933 | NONHSAT033821 | DLB2,BCMSUN,RFP2O,LEU2,TRIM13O, NCRNA00022,LINC00022,MIR15AHG | transcriptional regulation | pathogenic process | lymphocytic leukemia;B-cell chronic lymphocytic leukemia;myeloma;multiple myeloma;chronic lymphocytic leukemia;non-small cell lung cancer | Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases |
| HSALNT0217624 | PWAR4 | PAR4,PAR-4 | NA | pathogenic process | Prader-Willi syndrome and Angelman syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0289165 | ENST00000553584.1 | SNHG23,SNHG24,NCRNA00024,Irm,Rian,Bsr,LINC00024,AL132709.8,lnc-MGC | NA | pathogenic process | Prader-Willi syndrome and Angelman syndrome;temple syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0289482 | CECR7 | SAHL1 | NA | pathogenic process | hepatocellular cancer;cat eye syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases |
| HSALNT0074223 | ENST00000504263.1 | GDEP,PCAN1,PCA4 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0061175 | PISRT1 | NCRNA00195 | transcriptional regulation | developmental process;pathogenic process | blepharophimosis syndrome | Eye Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| HSALNT0190912 | ENST00000538665.1 | Tmevpg1,LincR-Ifng-3'A, NEST | transcriptional regulation | pathogenic process | Hashimoto's thyroiditis;primary immune thrombocytopenia;multiple sclerosis;Sjögren syndrome | Immune System Diseases ;Immune System Diseases;Endocrine System Diseases;Nervous System Diseases |
| HSALNT0038178 | FAM138B | F379 | NA | NA | NA | NA |
| HSALNT0145703 | FAM138C | F379 | NA | NA | NA | NA |
| HSALNT0288963 | FAM138A | F379 | NA | NA | NA | NA |
| HSALNT0183947 | FAM138D | F379 | NA | NA | NA | NA |
| HSALNT0226092 | FAM138E | F379 | NA | NA | NA | NA |
| HSALNT0253925 | FAM138F | F379 | NA | NA | NA | NA |
| HSALNT0289326 | NONHSAT087716 | LOH3CR2A,NCRNA00312,NAG7,NAG-7,ERR10,ERR-10,LMCD1DN | transcriptional regulation | pathogenic process | nasopharyngeal cancer;bladder cancer;non-small cell lung cancer | Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Stomatognathic Diseases |
| HSALNT0288886 | ENST00000609176.1 | AIR,NCRNA00088,IGF2RA, IGF2R-AS1 | transcriptional regulation | pathogenic process | NA | NA |
| HSALNT0254857 | MIR7-3HG | C19orf30,NCRNA00306,LINC00306,PGSF1,PGSF1a,PGSF1b,Huh7,uc002mbe.2 | NA | pathogenic process | liver cancer;hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0185751 | LOH12CR2 | LOH2CR12 | NA | pathogenic process | pre-B acute lymphoblastic leukaemia | Hemic and Lymphatic Diseases |
| HSALNT0289479 | DSCR8 | C21orf65,MTAG2,CT25.1a,CT25.1b,MMA-1a,MMA-1b | NA | pathogenic process | Down syndrome;melanoma | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Nervous System Diseases |
| HSALNT0289030 | LINC00313 | C21orf84,NCRNA00313, | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289029 | LINC00310 | C21orf82,NCRNA00310 | NA | pathogenic process | NA | NA |
| HSALNT0272435 | LINC00161 | C21orf100,NCRNA00161 | ceRNA | pathogenic process | osteosarcoma | Neoplasms |
| HSALNT0289184 | ENST00000602580.1 | C21orf35,FLJ38295,C21orf34,LINC00478,MONC | NA | pathogenic process | myeloid leukemia | Hemic and Lymphatic Diseases |
| HSALNT0289005 | HOXA11-AS | HOXA11A,HOXA11-AS1,HOXA11, HOXA-AS5,NCRNA00076 | ceRNA | pathogenic process | uterine cervix cancer;ovarian cancer;glioma;cervical cancer;gastric cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
| HSALNT0193654 | RMST | NCRM, NCRNA00054,LINC00054 | transcriptional regulation | developmental process;pathogenic process | breast cancer;rhabdomyosarcoma | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290079 | NONHSAT102247 | NCRUPAR,ENSG00000225407 | transcriptional regulation | developmental process;pathogenic process | gastric cancer;colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289167 | MESTIT1 | MEST-AS1,MEST-IT,MEST-IT1,NCRNA00040,PEG1-AS | NA | pathogenic process | Silver-Russell syndrome | Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| HSALNT0273791 | DSCAM-AS1 | M41 | NA | pathogenic process | adolescent idiopathic scoliosis;breast cancer | Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289391 | PWARSN | PAR-SN,PARSN | NA | pathogenic process | NA | NA |
| HSALNT0127791 | ST7-AS1 | ST7OT1,ST7AS1 | NA | pathogenic process | glioma;autism | Mental Disorders;Neoplasms |
| HSALNT0206298 | DAOA-AS1 | DAOAA, DAOA-A,G30 | NA | pathogenic process | panic disorder;schizophrenia;bipolar disorder | Mental Disorders |
| HSALNT0167060 | OLMALINC | C10orf75,NCRNA00263,LINC00263,bA34D15.5,FLJ12974,HI-LNC80 | NA | pathogenic process | type 2 diabetes | Nutritional and Metabolic Diseases;Endocrine System Diseases |
| HSALNT0026878 | LINC00299 | C2orf46,NCRNA00299,FLJ45673 | NA | pathogenic process;developmental process | intellectual and developmental disability;neurodevelopmental disabilities | Mental Disorders;Nervous System Diseases |
| HSALNT0289081 | LINC01020 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0101186 | LINC00518 | C6orf218,MGC40222 | NA | pathogenic process | NA | NA |
| HSALNT0083960 | LINC01018 | SRHC | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289361 | LPP-AS2 | MYCLo-5,MYCLo-6 | NA | NA | NA | NA |
| HSALNT0143233 | LINC00964 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289364 | MAPKAPK5-AS1 | C12orf47,FLJ39616 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289053 | LINC00635 | NA | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289327 | LINC00636 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0262657 | ZNF582-AS1 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289020 | LINC00115 | NCRNA00115,FLJ22639 | ceRNA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289254 | SNHG7 | MGC16037,NCRNA00061 | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289162 | MAP3K20-AS1 | MLK7-AS1 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0145357 | RHPN1-AS1 | C8orf51,MGC3113 | NA | NA | NA | NA |
| HSALNT0289343 | NONHSAT137541 | DXS399E,NCRNA00001,DXS1089,swd66,LINC00001 | transcriptional regulation;ceRNA | pathogenic process | non-small cell lung cancer;B-cell acute lymphoblastic leukemia;bladder cancer;testicular germ cell tumor;colorectal cancer;cancer;ovarian cancer;female cancers;renal collecting duct cancer;membranous nephropathy;Trisomy 21;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;Klinefelter's syndrome;glioblastoma;breast cancer;cystic fibrosis | Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Nervous System Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0289389 | PRNT | M8 | NA | pathogenic process | NA | NA |
| HSALNT0288942 | Lnc-PDZD8-3:1 | NCRNA00045,EMX2-AS1 | transcriptional regulation | pathogenic process | NA | NA |
| HSALNT0200443 | LINC00598 | TTL | NA | pathogenic process | NA | NA |
| HSALNT0289517 | TTTY17A | NCRNA00140 | NA | NA | NA | NA |
| HSALNT0027901 | MYCNOS | NCYM,N-CYM,MYCN-AS1 | transcriptional regulation | pathogenic process | neuroblastoma | Neoplasms |
| HSALNT0047175 | DIRC3 | FLJ14199 | NA | pathogenic process | familial renal cell cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289363 | ENST00000534336.1 | PRO1073,MALAT-1,NCRNA00047,HCN,NEAT2,LINC00047,mascRNA | splicing regulation;;translational control;transcriptional regulation;protein localization;ceRNA | pathogenic process | prostate cancer;glioma;cancer;breast cancer;ovarian cancer;amyotrophic lateral sclerosis;proliferative vitreoretinopathy;glioblastoma;endometrial stromal sarcoma;oral squamous cell cancer;acute myocardial infarction;hemangioma;pancreatic cancer;endometrioid endometrial cancer;melanoma;tongue squamous cell cancer;HIV;hepatocelluar cancer;bladder cancer;neuroblastoma;lung cancer;nasopharyngeal cancer;osteosarcoma;esophageal cancer;kidney cancer;hepatic steatosis;urothelial cancer;diabetes;triple-negative breast cancer;liver fibrosis;cervical cancer;uterus cancer;gallbladder cancer;decreased myogenesis;esophageal squamous cell cancer;fibrosarcoma;colorectal cancer;Pancreatic ductal adenocarcinoma;pre-eclampsia;retinal neurodegeneration;small cell lung cancer;multiple myeloma;gastric cancer;lung adenocarcinoma;uveal melanoma;epithelial ovarian cancer;TDP-43-associated pathological states;thyroid cancer;congenital microtia;liver cancer;renal clear cell cancer;laryngeal squamous cell cancer;pituitary adenoma;hepatocellular cancer;non-small cell lung cancer;pulmonary arterial hypertension;diabetic cardiomyopathy;vulvar squamous cell cancer;hyperglycaemia;papillary thyroid cancer;Parkinson's disease;renal cell cancer;lung cancer brain metastasis | Eye Diseases;Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Cell Physiological Phenomena;Immune System Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Stomatognathic Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases |
| HSALNT0289744 | DLG2-AS1 | DLG2A, DLG2-A,PSZA11q14,SZ-1 | NA | pathogenic process | schizophrenia;myotonic dystrophy type 1;heart failure | Pathological Conditions, Signs and Symptoms;Musculoskeletal Diseases;Mental Disorders;Cardiovascular Diseases;Nervous System Diseases |
| HSALNT0289164 | NONHSAT039745 | FP504,GTL2,LINC00023,NCRNA00023,PRO0518,PRO2160,onco-lncRNA-83,prebp1 | translational control;transcriptional regulation;ceRNA | pathogenic process | oral squamous cell cancer;phaeochromocytoma;prostate cancer;testicular germ cell tumor;glioma;cancer;osteosarcoma;non-functioning pituitary adenoma;heroin abuse;stroke;non-small cell lung cancer;thrombocytopenic purpura;acute myeloid leukemia;pancreatic cancer;bladder cancer;tongue squamous cell cancer;hepatocelluar cancer;meningioma;drug abuse;liver fibrosis;pancreatic neuroendocrine tumor;esophageal squamous cell cancer;myelodysplastic syndrome;retinoblastoma;chronic myeloid leukemia;type 1 diabetes;breast cancer;cervical cancer;kidney cancer;gallbladder cancer;cholestatic liver injury;colorectal cancer;neuroblastoma;multiple myeloma;gastric cancer;osteoarthritis;lung adenocarcinoma;endometrial cancer;Huntington disease;diabetes;type 2 diabetes;lung cancer;epithelial ovarian cancer;primary myelofibrosis;metabolic syndrome;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;vulvar squamous cell cancer;papillary thyroid cancer;renal cell cancer;Wilms' tumor | Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Immune System Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Chemically-Induced Disorders;Musculoskeletal Diseases;Mental Disorders;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases |
| HSALNT0290298 | TERC | DKCA1,PFBMFT2,SCARNA19,TR,TRC3,hTR | NA | pathogenic process | prostate cancer;dyskeratosis congenita;lung squamous cell cancer | Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases |
| HSALNT0288907 | CASC2 | NA | ceRNA | pathogenic process | colorectal cancer;gastric cancer;endometrial cancer;lung cancer;renal cell cancer;glioma | Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
| HSALNT0205332 | MIR17HG | C13orf25,MIRHG1,FLJ14178,MIRH1,MIHG1,NCRNA00048,miR-17-92,LINC00048 | NA | pathogenic process | diffuse large B-cell lymphoma;syndromic developmental defect;cancer | Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0288716 | TTTY6 | TTY6,TTTY6A,LINC00127 | NA | NA | NA | NA |
| HSALNT0288731 | TTTY4 | TTY4,TTTY4A,LINC00123 | NA | NA | NA | NA |
| HSALNT0288815 | TTTY3 | TTY3,TTTY3A,LINC00121 | NA | NA | NA | NA |
| HSALNT0288703 | TTTY5 | TTY5,LINC00126 | NA | NA | NA | NA |
| HSALNT0289255 | SNHG8 | NCRNA00060,LINC00060 | NA | pathogenic process | gastric cancer;malignant pleural mesothelioma | Neoplasms;Digestive System Diseases |
| HSALNT0289486 | Lnc-EPCAM-1:2 | BC200,BC200a,NCRNA00004,LINC00004 | splicing regulation;translational control | pathogenic process | aging;lung cancer;glioma;ovarian cancer;esophageal squamous cell cancer;non-small cell lung cancer;esophageal cancer;Alzheimer's disease;tongue cancer;parotid cancer;breast cancer;cervical cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Stomatognathic Diseases;Mental Disorders;Female Urogenital Diseases and Pregnancy Complications;Physiological Phenomena;Endocrine System Diseases;Nervous System Diseases |
| HSALNT0144426 | ZFAT-AS1 | ZFATAS,ZFAT-AS,SAS-ZFAT,NCRNA00070 | NA | pathogenic process | autoimmune disease | Immune System Diseases |
| HSALNT0289285 | ZEB1-AS1 | NA | NA | pathogenic process | esophageal squamous cell cancer;autoimmune thyroid disease;hepatocelluar cancer | Immune System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289185 | MIRLET7BHG | linc-Ppara | NA | developmental process | NA | NA |
| HSALNT0289374 | NBR2 | NCRNA00192 | transcriptional regulation | pathogenic process | gastric cancer;breast cancer;cancer | Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289417 | NONHSAT084827 | FLJ20618,NCRNA00080,LINC00080 | transcriptional regulation;ceRNA | pathogenic process | osteosarcoma;prostate cancer;glioma;ovarian cancer;glioblastoma;non-small cell lung cancer;B-cell neoplasms;chronic kidney disease;melanoma;bladder cancer;urothelial cancer of the bladder;esophageal squamous cell cancer;multiple sclerosis;breast cancer;hepatoblastoma;colorectal cancer;multiple myeloma;gastric cancer;Huntington disease;hepatocellular cancer;oesophageal squamous cell cancer;renal cell cancer | Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases |
| HSALNT0288973 | FAS-AS1 | FASA, FAS-A,SAF | transcriptional regulation | pathogenic process | ataxia telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Immune System Diseases;Nutritional and Metabolic Diseases;Cardiovascular Diseases;Nervous System Diseases |
| HSALNT0288996 | HAS2-AS1 | HAS2A, HAS2-A,HASNT,NCRNA00077 | transcriptional regulation | NA | NA | NA |
| HSALNT0289390 | PSORS1C3 | NCRNA00196 | NA | pathogenic process | rheumatoid arthritis;psoriasis | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases |
| HSALNT0289868 | HLA-AS1 | NA | NA | pathogenic process | psoriasis;liver injury;multiple sclerosis;AIDS | Skin and Connective Tissue Diseases;Immune System Diseases;Virus Diseases;Digestive System Diseases;Nervous System Diseases |
| HSALNT0290154 | NONHSAT011777 | NCRNA00074 | transcriptional regulation | pathogenic process | psoriasis;prostate cancer | Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms |
| HSALNT0262809 | PEG3-AS1 | PEG3AS,PEG3-AS,APEG3,NCRNA00155 | NA | NA | NA | NA |
| HSALNT0289533 | Lnc-LRR1-1:1 | 7S RNA,SRP RNA,4.5S SRP RNA,4.5S RNA,RN7SL1 RNA,ENSG00000258486,lnc-LRR1-1:1 | protein localization | pathogenic process | AIDS;Leishmaniasis;dermatomyositis;polymyositis | Skin and Connective Tissue Diseases;Immune System Diseases;Virus Diseases;Musculoskeletal Diseases;Parasitic Diseases;Nervous System Diseases |
| HSALNT0290081 | Lnc-C11orf16-1:1 | 29A,lnc-C11orf16-1:1 | NA | pathogenic process | neuroblastoma | Neoplasms |
| HSALNT0289382 | NONHSAT134764 | NCRNA00194 | NA | pathogenic process | AIDS;Down syndrome;HIV | Immune System Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases;Virus Diseases |
| HSALNT0289253 | Lnc-TCF24-2:3 | U87HG,HBII-276HG,NCRNA00058 | translational control;ceRNA | pathogenic process | hepatocellular cancer;hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289653 | NONHSAT017676 | AY195961.1,NONHSAT017674,AY034469.1,NONHSAT017675,AY034470.1 | NA | NA | NA | NA |
| HSALNT0290398 | ENST00000554403.1 | Zfh-5AS,ENSG00000157306,ENST00000554403.1 | NA | NA | NA | NA |
| HSALNT0011306 | MIR137HG | NA | NA | pathogenic process | schizophrenia;lung cancer;malignant lymphoma | Respiratory Tract Diseases;Mental Disorders;Neoplasms |
| HSALNT0289449 | Lnc-EVX1-9:1 | HOXA6as | NA | pathogenic process | glioma | Neoplasms |
| HSALNT0289451 | CCDC26 | MGC27434,RAM | transcriptional regulation | pathogenic process | hematological malignancies;glioma;acute myeloid leukemia;leukemia;pancreatic cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms;Hemic and Lymphatic Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0289893 | LINC00271 | C6orf217,NCRNA00271 | NA | pathogenic process | type 2 diabetes;schizophrenia | Nutritional and Metabolic Diseases;Mental Disorders;Endocrine System Diseases |
| HSALNT0288892 | BCAR4 | NA | transcriptional regulation | pathogenic process | osteosarcoma;breast cancer;colorectal cancer | Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289890 | LINC00032 | C9orf14,NCRNA00032 | NA | pathogenic process | narcolepsy;melanoma | Mental Disorders;Neoplasms;Nervous System Diseases |
| HSALNT0274572 | PICSAR | C21orf113,LINC00162,NCRNA00162,NLC1-C,NLC1C,PRED74 | transcriptional regulation | pathogenic process | testicular embryonal cancer;narcolepsy;cutaneous squamous cell cancer | Male Urogenital Diseases;Mental Disorders;Neoplasms;Nervous System Diseases |
| HSALNT0256354 | Lnc-OR10H5-1:1 | CUDR,LINC00178,NCRNA00178,UCAT1,onco-lncRNA-36 | transcriptional regulation;ceRNA | developmental process;pathogenic process | oral squamous cell cancer;osteosarcoma;prostate cancer;ovarian cancer;non-small cell lung cancer;acute myocardial infarction;pancreaticobiliary maljunction;pancreatic cancer;melanoma;tongue squamous cell cancer;hepatocelluar cancer;bladder cancer;acute myeloid leukemia;esophageal squamous cell cancer;esophageal cancer;liver cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;urinary bladder;gastric cancer;endometrial cancer;breast cancer;hepatocellular cancer;squamous cell cancer;lung cancer;renal cell cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0289475 | Lnc-BIRC7-2:1 | HAR1F,NCRNA00064,LINC00064 | transcriptional regulation | pathogenic process | Huntington disease;Alzheimer's disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Mental Disorders;Nervous System Diseases |
| HSALNT0288995 | ENST00000447910.2 | HAR1R,NCRNA00065,LINC00065 | transcriptional regulation | pathogenic process | Huntington disease;hereditary haemorrhagic telangiectasia;Alzheimer's disease | Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Nervous System Diseases |
| HSALNT0288958 | EPB41L4A-AS1 | C5orf26,NCRNA00219,TIGA1 | NA | pathogenic process | lung cancer;cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289170 | Lnc-CRYBA4-2:1 | C22orf35,FLJ25967,Rncr2,gomafu,NCRNA00066,LINC00066,lncRNA-MIAT | splicing regulation;ceRNA | pathogenic process | prostate cancer;chronic lymphocytic leukemia;cancer;drug abuse;diabetes-induced microvascular dysfunction;schizophrenia;acute myocardial infarction;dilated cardiomyopathy;lung adenocarcinoma;diabetic retinopathy;myocardial infarction;Alzheimer's disease | Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Chemically-Induced Disorders;Hemic and Lymphatic Diseases;Cardiovascular Diseases;Mental Disorders;Endocrine System Diseases;Nervous System Diseases |
| HSALNT0289007 | NONHSAT107640 | NCRNA00078,LINC00078,HCCAT1 | transcriptional regulation;ceRNA | pathogenic process | prostate cancer;glioma;hepatocelluar cancer;osteosarcoma;atherosclerosis;gastric cancer;hepatocellular cancer;esophageal cancer;liver cirrhosis;diffuse large B-cell lymphoma;pancreatic cancer;papillary thyroid cancer;liver cancer;cervical cancer;colorectal cancer | Neoplasms;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0288940 | NONHSAT087635 | EGO,NCRNA00190 | NA | pathogenic process;developmental process | prostate cancer;breast cancer | Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms |
| HSALNT0289387 | PINK1-AS | PINK1-AS1,FLJ00387,PINK1A, naPINK1 | transcriptional regulation | pathogenic process | glucose metabolism disorder;Parkinson's disease;diabetes | Nutritional and Metabolic Diseases;Endocrine System Diseases;Nervous System Diseases |
| HSALNT0289225 | ENST00000513868.2 | NCRNA00079,LINC00079,onco-lncRNA-100,MIR1204HG,PVT | transcriptional regulation;translational control | pathogenic process | murine plasmacytomas;prostate cancer;cancer;ovarian cancer;renal cancer;B-cell lymphoma;non-small cell lung cancer;pancreatic cancer;Hodgkin's lymphoma;asthma;hepatocelluar cancer;bladder cancer;plasmacytoma;cleft lip;acute promyelocytic leukemia;diabetic nephropathy;esophageal cancer;kidney cancer;type 1 diabetes;breast cancer;cervical cancer;diabetic kidney disease;hematological malignancies;colorectal cancer;neuroblastoma;cardiac hypertrophy;multiple myeloma;gastric cancer;lymphoma;type 2 diabetes;thyroid cancer;pleural mesothelioma;lung squamous cell cancer;Burkitt lymphoma;hepatocellular cancer;renal cell cancer | Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Immune System Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0289189 | ENST00000604258.1 | NA | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0246525 | NARF-AS1 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0147433 | NONHSAT130421 | CDKN2BA,ANRIL,RP11-145E5.4,NCRNA00089,p15A, CDKN2B-A, PCAT12 | siRNA;transcriptional regulation;ceRNA | pathogenic process | glaucoma;prostate cancer;glioma;cancer;osteosarcoma;neurofibromatosis;ischemic heart failure;stroke;non-small cell lung cancer;hypertension;intracranial aneurysm;aortic aneurysm;periodontitis;acute lymphoblastic leukemia;Alzheimer's disease;coronary artery disease;melanoma;bladder cancer;abdominal aortic aneurysm;ovarian cancer;esophageal cancer;basal cell cancer;breast cancer;cervical cancer;coronary heart disease;gallbladder cancer;acute myocardial infarction;colorectal cancer;neuroblastoma;peripheral artery disease;esophageal squamous cell cancer;atherosclerosis;leukemia;hereditary cutaneous malignant melanoma;gastric cancer;cardiovascular disease;coronary disease;frailty;diabetes;type 2 diabetes;thyroid cancer;primary open-angle glaucoma;ischemic stroke;plexiform neurofibroma;laryngeal squamous cell cancer;hepatocellular cancer;nasopharyngeal cancer;myocardial infarction;lung cancer;endometriosis;primary myelofibrosis | Eye Diseases;Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Male Urogenital Diseases;Stomatognathic Diseases;Immune System Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Mental Disorders;Nervous System Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0050854 | NONHSAT087920 | NCRNA00068,GHRL-AS1 | transcriptional regulation | NA | NA | NA |
| HSALNT0288959 | ENST00000583516.1 | HESRG | NA | pathogenic process | embryonal cancer | Neoplasms |
| HSALNT0287173 | FMR1-AS1 | FMR1A, FMR1-A,ASFMR1,FMR4 | transcriptional regulation | pathogenic process | fragile X syndrome;neurological disorder | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0289499 | HCG4 | HCGIV-10,HCGIV.9 | NA | pathogenic process | NA | NA |
| HSALNT0288994 | HAND2-AS1 | DEIN,NBLA00301,FLJ11539 | NA | pathogenic process | neuroblastoma | Neoplasms |
| HSALNT0289286 | NONHSAT074775 | ZEB2A, ZEB2-A,ZEB2NAT | splicing regulation | pathogenic process | bladder cancer;hepatocellular cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
| HSALNT0017702 | NONHSAT007663 | SNHG2,NCRNA00030 | transcriptional regulation;ceRNA | pathogenic process | varicose great saphenous veins;prostate cancer;glioma;cancer;ovarian cancer;non-small cell lung cancer;hypertension;pancreatic cancer;B-cell neoplasms;melanoma;head and neck cancer;hepatocelluar cancer;bladder cancer;autoimmune disease;liver fibrosis;kidney cancer;breast cancer;cervical cancer;colorectal cancer;multiple myeloma;gastric cancer;osteoarthritis;endometrial cancer;lymphoma;type 2 diabetes;pleural mesothelioma;hepatocellular cancer;lung adenocarcinoma;lung cancer;renal cell cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Nutritional and Metabolic Diseases;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0288891 | NONHSAT024403 | BACE1A,FJ573250,NCRNA00177,BACE1-AS1 | translational control;transcriptional regulation | pathogenic process | ovarian cancer;colorectal cancer;Alzheimer's disease | Neoplasms;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Nervous System Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0289414 | TRPM2-AS | TRPM2-AS1 | NA | pathogenic process | melanoma;prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0288935 | DNM3OS | DNM3-AS1,MIR199A2HG | NA | pathogenic process | epithelial ovarian cancer | Neoplasms |
| HSALNT0288930 | DGCR5 | NCRNA00037,LINC00037 | transcriptional regulation | pathogenic process | Huntington disease;DiGeorge syndrome;velocardiofacial syndrome;clear cell renal cell cancer | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Endocrine System Diseases;Nervous System Diseases |
| HSALNT0288893 | ENST00000499008.3 | BDNFO,BT2A,BT2B,BT2C,BT2D,NCRNA00049,BDNF-AS1,BDNFAS | siRNA;transcriptional regulation | developmental process;pathogenic process | Huntington disease;schizophrenia;psychiatric disease;obesity | Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nutritional and Metabolic Diseases;Mental Disorders;Physiological Phenomena;Nervous System Diseases |
| HSALNT0120317 | Lnc-EVX1-12:1 | HOXA-AS1,NCRNA00179,HOXA1-AS1 | transcriptional regulation | pathogenic process;developmental process | colorectal cancer;Pancreatic ductal adenocarcinoma;promyelocytic leukemia;acute myeloid leukemia;infiltrating ductal cancers ;acute promyelocytic leukemia;leukemia;glioma | Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases |
| HSALNT0290158 | NONHSAT129210 | PTCSC,AK023948,NCRNA00197 | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0289004 | NONHSAT028508 | HOXC-AS4,HOXC11-AS1,NCRNA00072 | siRNA;transcriptional regulation;ceRNA | pathogenic process | oral squamous cell cancer;prostate cancer;glioma;cancer;breast cancer;osteosarcoma;renal cancer;glioblastoma;non-small cell lung cancer;sarcoma;pancreatic cancer;large B-Cell lymphoma;bladder transitional cell cancer;B-cell neoplasms;melanoma;asthenozoospermia;hepatocelluar cancer;bladder cancer;acute myeloid leukemia;aortic valve calcification;infiltrating ductal cancers ;ovarian cancer;diffuse large B-cell lymphoma;gastrointestinal stromal tumor;atypical teratoid rhabdoid tumor;urothelial cancer;triple-negative breast cancer;gastric cardia adenocarcinoma;cervical cancer;temporomandibular joint osteoarthritis;gallbladder cancer;esophageal squamous cell cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;rheumatoid arthritis;gastric cancer ;pre-eclampsia;acute leukemia;small cell lung cancer;multiple myeloma;gastric cancer;osteoarthritis;LPS-induced sepsis;endometrial cancer;head and neck squamous cell cancer;gastric adenocarcinoma;lung cancer;liver cancer;ischemic stroke;ischemic heart failure;laryngeal squamous cell cancer;pituitary adenoma;hepatocellular cancer;nasopharyngeal cancer;lung adenocarcinoma;papillary thyroid cancer;Parkinson's disease;renal cell cancer;gastrointestinal cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Musculoskeletal Diseases;Female Urogenital Diseases and Pregnancy Complications;Cardiovascular Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Nervous System Diseases |
| HSALNT0289192 | ENST00000501122.2 | NCRNA00084,TncRNA,MENepsilon/beta,LINC00084,VINC | transcriptional regulation;ceRNA | pathogenic process | oral squamous cell cancer;glioma;ovarian cancer;amyotrophic lateral sclerosis;paraspeckle disintegration;nasopharyngeal cancer;AIDS;frontotemporal lobar degeneration;prostate cancer;systemic lupus erythematosus;renal syndrome;TDP-43-associated pathological states;HIV;Huntington disease;chronic lymphocytic leukemia;acute promyelocytic leukemia;esophageal squamous cell cancer;multiple sclerosis;breast cancer;intrauterine growth restriction;colorectal cancer;leukemia;gastric cancer;malignant pleural mesothelioma;endometrial cancer;gastric adenocarcinoma;papillary thyroid cancer;infertility;bladder cancer;hepatocellular cancer;non-small cell lung cancer;obesity;lung cancer;Parkinson's disease;laryngeal squamous cell cancer | Skin and Connective Tissue Diseases;Pathological Conditions, Signs and Symptoms;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Nutritional and Metabolic Diseases;Stomatognathic Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Mental Disorders;Physiological Phenomena;Nervous System Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0095094 | NONHSAT104072 | U19H,NCRNA00059 | NA | pathogenic process | myelodysplastic syndrome | Hemic and Lymphatic Diseases |
| HSALNT0245443 | NONHSAT056039 | ncRAN,Nbla12061,Nbla10727 | NA | pathogenic process | bladder cancer;bladder cancer;colorectal cancer;neuroblastoma | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
| HSALNT0288897 | BOK-AS1 | BOKA,NCRNA00151,NAToB | NA | pathogenic process | esophageal squamous cell cancer;testicular cancer;cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289532 | NONHSAT113149 | 7-3 RNA,K-RNA,7SK-RNA,7SK snRNA,RN7SK,ENSG00000202198,NONHSAT113149 | transcriptional regulation | developmental process;pathogenic process | cancer;cardiac hypertrophy;gastric cancer;AIDS;multiple sclerosis;colorectal adenocarcinoma | Neoplasms;Immune System Diseases;Virus Diseases;Cardiovascular Diseases;Digestive System Diseases;Nervous System Diseases |
| HSALNT0289182 | MIR4435-2HG | MIR4435-1HG,LINC00978,AGD2,AK001796,lncRNA-AWPPH,MORRBID | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289200 | PARTICL | PARTICLE | transcriptional regulation | pathogenic process | low-dose irradiation | Disorders of Environmental Origin |
| HSALNT0289172 | ENST00000517411.1 | LINC01604,TCONS_00015189 | transcriptional regulation;ceRNA | pathogenic process | gallbladder cancer;Burkitt lymphoma | Neoplasms;Immune System Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Digestive System Diseases |
| HSALNT0001792 | NPPA-AS1 | NPPAA, NPPA-AS | splicing regulation | pathogenic process | cardiovascular disease | Cardiovascular Diseases |
| HSALNT0290230 | RRP1B | NA | transcriptional regulation | pathogenic process | spinocerebellar ataxia;laryngeal squamous cell cancer;cancer | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Nervous System Diseases |
| HSALNT0289467 | CLLU1 | NA | NA | NA | NA | NA |
| HSALNT0289173 | ENST00000531381.1 | AGD1,lncRNA-N2,linc-NeD125 | NA | developmental process;pathogenic process | myeloid leukemia;myopia;cervical cancer;neuroblastoma | Eye Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0059175 | NONHSAT091315 | LINC00902,LSAMP-AS1,LSAMP-AS3,LSAMPAS3,NCRNA00295 | transcriptional regulation;ceRNA | pathogenic process | glioma;Pancreatic ductal adenocarcinoma;osteosarcoma;esophageal squamous cell cancer;ischemic heart failure;gastric cancer;hepatocellular cancer;non-small cell lung cancer;acute myeloid leukemia;colorectal cancer | Respiratory Tract Diseases;Cardiovascular Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289647 | BC040587 | NA | NA | pathogenic process | osteosarcoma;breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0059186 | LINC00901 | LSAMP-AS4,TCONS_00005428,BC040587 | NA | pathogenic process | osteosarcoma;gastric cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0233366 | HCCAT5 | HTA,FJ222407 | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290040 | LSINCT5 | NA | NA | pathogenic process | chronic heart failure;colorectal cancer;ovarian cancer;gastric cancer;lung cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0179611 | DISC1FP1 | Boymaw | transcriptional regulation | pathogenic process | schizophrenia | Mental Disorders |
| HSALNT0217643 | SNHG14 | 115HG,IC-SNURF-SNRPN,LNCAT,NCRNA00214,U-UBE3A-AT, UBE3A-A, UBE3A-AS1,UBE3AATS | ceRNA | pathogenic process | Angelman syndrome;cerebral infarction;Prader-Willi syndrome | Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Nervous System Diseases |
| HSALNT0289273 | TP73-AS1 | KIAA0495,PDAM | NA | pathogenic process | esophageal squamous cell cancer;oligodendroglial tumors;non-small cell lung cancer;glioblastoma;multiple myeloma | Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Hemic and Lymphatic Diseases;Cardiovascular Diseases |
| HSALNT0290311 | TP53COR1 | Trp53cor1 | transcriptional regulation | pathogenic process | prostate cancer;colorectal cancer;hepatocelluar cancer;atherosclerosis;Burkitt lymphoma;chronic lymphocytic leukemia;B cell lymphoma;lung cancer;cervical cancer | Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Virus Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
| HSALNT0289221 | NONHSAT129019 | CARLo-3,PCAT8 | transcriptional regulation | pathogenic process | gastric cancer;prostate cancer;glioma;colorectal cancer | Male Urogenital Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0020131 | PCAT6 | KDM5B-AS1,ncRNA-a2,PCAN-R1,KDM5BAS1,onco-lncRNA-96 | transcriptional regulation | pathogenic process | prostate cancer;triple-negative breast cancer;lung cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms |
| HSALNT0289277 | TRERNA1 | LINC00651,ncRNA-a7,treRNA | transcriptional regulation | NA | NA | NA |
| HSALNT0014972 | ENST00000416894.1 | LINC00568,ncRNA-a1,FAL1 | transcriptional regulation | pathogenic process | ovarian cancer;thyroid cancer | Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Neoplasms |
| HSALNT0290008 | Lnc-SNAI1-1:1 | Noncoding RNA activating7: ncRNA-a7,ENST00000431460.1,ENSG00000231265,TRERNA1 | transcriptional regulation | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290248 | Lnc-BSPH1-1:1 | EU035784.1,lnc-BSPH1-1:1 | transcriptional regulation | NA | NA | NA |
| HSALNT0289342 | Lnc-ZCCHC13-1:1 | NCRNA00183,ENOX,LINC00183,DCBALD06 | transcriptional regulation | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289280 | VLDLR-AS1 | lincRNA-VLDLR | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0288982 | ENST00000602812.1 | NCRNA00182,MIR374AHG,LINC00182,FLJ33139 | transcriptional regulation | pathogenic process | hepatocellular cancer;breast cancer;colorectal cancer;hepatocelluar cancer | Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0091079 | MEF2C-AS1 | NA | NA | pathogenic process | gastric cancer;Prader-Willi syndrome and Angelman syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases;Nervous System Diseases |
| HSALNT0189341 | PCBP2-OT1 | TUC338 | NA | pathogenic process | hepatocellular cancer;tongue squamous cell cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290373 | WRAP53 | NA | NA | pathogenic process | hepatocellular cancer;cancer;dyskeratosis congenita | Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases |
| HSALNT0289265 | NONHSAT112472 | LINC00532,lincRNA-NRNA024015 | NA | pathogenic process | esophageal squamous cell cancer;gastric cancer;testicular cancer;aplastic anemia | Male Urogenital Diseases;Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases |
| HSALNT0289175 | NONHSAT081499 | MIRHG2,BIC,NCRNA00172 | NA | pathogenic process | B-cell chronic lymphocytic leukemia;chronic lymphocytic leukemia;breast cancer;glioma | Immune System Diseases;Skin and Connective Tissue Diseases;Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0289051 | LINC00620 | NA | NA | pathogenic process | cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0120390 | NONHSAT119717 | NCRNA00213,HOXA-AS6,RP1-170O19.3,HOXA13-AS1 | transcriptional regulation | pathogenic process | hirschsprung disease;colorectal cancer;prostate cancer;tongue squamous cell cancer;Pancreatic ductal adenocarcinoma;osteosarcoma;hepatocelluar cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;pancreatic cancer;lung cancer;glioma | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0289287 | NONHSAT080206 | C20orf199,NCRNA00275,ZNFX1-AS1,HSUP1,HSUP2 | transcriptional regulation;ceRNA | pathogenic process | gastric cancer;hepatocellular cancer;ductal cancer;colorectal cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289259 | Lnc-NDFIP1-3:1 | SPRIGHTLY | transcriptional regulation | pathogenic process | prostate cancer;melanoma;glioma;esophageal squamous cell cancer;pre-eclampsia;bladder cancer;renal clear cell cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;lung cancer;breast cancer;cervical cancer;colorectal cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
| HSALNT0105595 | Lnc-CDKN1A-1:1 | PANDA | transcriptional regulation | pathogenic process | colorectal cancer;cancer;bladder cancer;gastric cancer;hepatocellular cancer;non-small cell lung cancer;p53-associated pathological states;breast cancer;renal cell cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
| HSALNT0068185 | HTT-AS | HTT-AS1,HTTAS | NA | pathogenic process | Huntington disease | Mental Disorders;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0099036 | HEIH | LINC-HEIH,lncRNA-HEIH,LINC00848,HCCAT2 | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0222533 | NPTN-IT1 | lncRNA-LET | NA | pathogenic process | gallbladder cancer;colorectal cancer;hepatocelluar cancer;esophageal squamous cell cancer;lung squamous cell cancer;nasopharyngeal cancer;gastric cancer;hypoxia;squamous cell lung cancer;cervical cancer | Pathological Conditions, Signs and Symptoms;Neoplasms;Respiratory Tract Diseases;Stomatognathic Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Digestive System Diseases |
| HSALNT0289747 | DQ786243 | NA | transcriptional regulation | pathogenic process | crohn's disease;colorectal cancer;hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289204 | ENST00000561978.1 | PCAT-1,PCA1 | transcriptional regulation;ceRNA | pathogenic process | prostate cancer;colorectal cancer;esophageal squamous cell cancer;bladder cancer;hepatocellular cancer;lung cancer | Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
| HSALNT0275894 | PCAT14 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0211999 | HIF1A-AS2 | 3'aHIF-1A,aHIF | translational control | pathogenic process | bladder cancer;osteosarcoma;renal cancer;glioblastoma;gastric cancer;acute myocardial infarction;kidney cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
| HSALNT0288999 | HIF1A-AS1 | 5'aHIF-1A,5'aHIF1alpha | NA | pathogenic process | acute myocardial infarction;non-small cell lung cancer;cardiovascular disease;aortic aneurysm;thoracoabdominal aorta aneurysm;kidney cancer | Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Cardiovascular Diseases;Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0289258 | SOX2-OT | SOX2OT,DKFZp761J1324,NCRNA00043 | transcriptional regulation | pathogenic process | colorectal cancer;esophageal squamous cell cancer;lung squamous cell cancer;retinal neurodegeneration;neurodevelopmental syndromes associated with the SOX2 locus;hepatocellular cancer;lung cancer;breast cancer;Alzheimer's disease | Eye Diseases;Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Mental Disorders;Digestive System Diseases;Nervous System Diseases |
| HSALNT0289700 | CDR1-AS | CDR1NAT,ciRS-7,CDR1as | ceRNA | NA | NA | NA |
| HSALNT0289149 | LINCMD1 | MIR133BHG,LINC-MD1 | ceRNA | developmental process;pathogenic process | Duchenne muscular dystrophy | Musculoskeletal Diseases |
| HSALNT0288894 | BGLT3 | LINC01083,BGL3,lncRNA-BGL3 | ceRNA | pathogenic process | chronic myeloid leukemia | Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0289042 | LINC00473 | C6orf176,bA142J11.1 | transcriptional regulation | pathogenic process | non-small cell lung cancer;renal cell cancer | Respiratory Tract Diseases;Male Urogenital Diseases;Neoplasms |
| HSALNT0101681 | LINC01108 | LncRNA-ES1 | NA | developmental process | NA | NA |
| HSALNT0289418 | TUNAR | LINC00617,TUNA,HI-LNC78 | transcriptional regulation | developmental process;pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289197 | ENST00000500949.2 | cyrano,linc-OIP5 | NA | developmental process | NA | NA |
| HSALNT0289046 | Lnc-PRL-6:2 | NA | NA | pathogenic process | West Syndrome;West syndrome | Nervous System Diseases |
| HSALNT0289656 | BX118339 | NA | NA | pathogenic process | West syndrome | Nervous System Diseases |
| HSALNT0021726 | LINC00538 | Yiya,PROX1UT | NA | pathogenic process | colorectal cancer;cancer | Neoplasms;Digestive System Diseases |
| HSALNT0273249 | CBR3-AS1 | PlncRNA-1,PlncRNA1 | ceRNA | pathogenic process | esophageal squamous cell cancer;hepatocellular cancer;prostate cancer | Male Urogenital Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289179 | NONHSAT130385 | LOC554202,hsa-lnc-31,LncHIFCAR | ceRNA | pathogenic process | bladder cancer;gastric cancer;breast cancer;colorectal cancer;Pancreatic ductal adenocarcinoma | Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
| HSALNT0288925 | NONHSAT096369 | KIAA0114,SNHG13,ANCR,AGU2,lncRNA-ANCR | transcriptional regulation | developmental process;pathogenic process | prostate cancer;colorectal cancer;osteosarcoma;bone diseases;postmenopausal osteoporosis;hepatocellular cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Musculoskeletal Diseases;Digestive System Diseases |
| HSALNT0290329 | Uc.388 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289842 | FR0348383 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289279 | TTTY15 | DKFZP434I143,NCRNA00138 | NA | pathogenic process | NA | NA |
| HSALNT0289718 | Lnc-IRX3-4:2 | LOC643911,LINC00180,CRNDEP | transcriptional regulation;ceRNA | pathogenic process | gallbladder cancer;colorectal cancer;ovarian cancer;medulloblastoma;chronic lymphocytic leukemia;renal cell cancer;glioma | Neoplasms;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0289685 | CCND1 | NA | NA | pathogenic process | tumor;cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289935 | LincRNA-p21 | NA | transcriptional regulation | pathogenic process | lung cancer;cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290134 | PCNCR1 | NA | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289492 | NONHSAT099821 | DBE-T,DUX4L30 | transcriptional regulation | developmental process;pathogenic process | facioscapulohumeral muscular dystrophy | Musculoskeletal Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0289455 | BANCR | LINC00586 | transcriptional regulation | pathogenic process | osteosarcoma ;lung cancer;melanoma;colorectal cancer;osteosarcoma;esophageal squamous cell cancer;bladder cancer;eosinophilic esophagitis;gastric cancer;hepatocellular cancer;non-small cell lung cancer;retinoblastoma;papillary thyroid cancer | Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Male Urogenital Diseases;Hemic and Lymphatic Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0209589 | ENST00000556013.2 | NA | ceRNA | pathogenic process | papillary thyroid cancer;thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0289103 | LINC01268 | LOC285758 | NA | pathogenic process | NA | NA |
| HSALNT0289070 | LINC00887 | linc-ATP13A4-8,HEIRCC | transcriptional regulation | pathogenic process | hypoxic and inflammatory renal epithelial injury;renal clear cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0288931 | NONHSAT035954 | C14orf167,PRO1488,AS1DHRS4 | transcriptional regulation | NA | NA | NA |
| HSALNT0288974 | FENDRR | FOXF1-AS1,TCONS_00024240,lincFOXF1,onco-lncRNA-21 | transcriptional regulation | developmental process;pathogenic process | osteosarcoma;gastric cancer;non-small cell lung cancer;lung cancer | Respiratory Tract Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0106473 | LINC01512 | LOC100132354,TCONS_00011120,HI-LNC77 | NA | pathogenic process | lung adenocarcinoma;type 2 diabetes | Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Endocrine System Diseases;Neoplasms |
| HSALNT0289059 | LINC00673 | HI-LNC75,HILNC75,LUCAIR1,SLNCR,SLNCR1 | transcriptional regulation | pathogenic process | pancreatic cancer;type 2 diabetes;non-small cell lung cancer;melanoma;Pancreatic ductal adenocarcinoma | Neoplasms;Respiratory Tract Diseases;Nutritional and Metabolic Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0289107 | LINC01433 | LOC728228 | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0143571 | NONHSAT129017 | CARLo-5,onco-lncRNA-40 | ceRNA | pathogenic process | gallbladder cancer;glioma;hepatocelluar cancer;ovarian cancer;acute myeloid leukemia;gastric cancer;hepatocellular cancer;non-small cell lung cancer;lung adenocarcinoma;endometrial cancer;lung cancer;breast cancer;colorectal cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0289408 | ENST00000448587.1 | ENST00000448587.1,FLJ90734,NCRNA00036,LINC00036,onco-lncRNA-16 | translational control | pathogenic process;developmental process | bladder cancer;colorectal cancer;esophageal squamous cell cancer;gastric cancer;skin desease;squamous cell cancer | Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
| HSALNT0289152 | LNCPRESS1 | lncPRESS1 | translational control | NA | NA | NA |
| HSALNT0289145 | LINC02561 | RP11-445P17.8 | NA | pathogenic process | cystic fibrosis | Respiratory Tract Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases |
| HSALNT0289065 | LINC00850 | KUCG1 | NA | pathogenic process | Duchenne muscular dystrophy | Musculoskeletal Diseases |
| HSALNT0289431 | AFAP1-AS1 | AFAP1A, AFAP1-A,MGC10981 | NA | pathogenic process | non-small cell lung cancer;colorectal cancer;Pancreatic ductal adenocarcinoma;esophageal squamous cell cancer;hepatocellular cancer;nasopharyngeal cancer;lung adenocarcinoma;pancreatic cancer;Barrett's Esophagus;lung cancer | Neoplasms;Respiratory Tract Diseases;Stomatognathic Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0289519 | XACT | NA | NA | NA | NA | NA |
| HSALNT0248684 | GATA6-AS1 | locus5689,BM742401 | NA | pathogenic process | gastric cancer;chronic lymphocytic leukemia | Immune System Diseases;Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases |
| HSALNT0289222 | ENST00000430058.1 | NA | transcriptional regulation | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0289655 | BTG3-AS1 | ASBEL | translational control | pathogenic process | ovarian cancer;colorectal cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
| HSALNT0289224 | NONHSAT130775 | NONHSAT130775,PTENpg1,PTEN2,ENSG00000237984 | transcriptional regulation;ceRNA | pathogenic process | gastric cancer;prostate cancer;renal cell cancer;cancer;hepatocelluar cancer | Male Urogenital Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0290129 | PAN | NA | transcriptional regulation | pathogenic process | Kaposi's sarcoma | Neoplasms;Virus Diseases |
| HSALNT0289939 | LINC-ROR | lincRNA-RoR,lincRNA-ST8SIA3,ROR | transcriptional regulation;ceRNA | pathogenic process | gallbladder cancer;liver cancer;glioma;malignant melanoma;unveal melanoma;breast cancer;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;pancreatic cancer;endometrial cancer;triple-negative breast cancer;colorectal cancer | Skin and Connective Tissue Diseases;Neoplasms;Stomatognathic Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0290322 | UBE3A-ATS | NA | NA | pathogenic process | Angelman syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0091004 | LINC00461 | EyeLinc1,Visc-1a,Visc-1b,Visc-2,LOC645323 | NA | pathogenic process;developmental process | retinal and visual function | Eye Diseases |
| HSALNT0289491 | CTBP1-AS | PCAT10 | transcriptional regulation | pathogenic process | chronic hepatitis C;prostate cancer;polycystic ovary syndrome | Neoplasms;Male Urogenital Diseases;Virus Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
| HSALNT0037401 | ENST00000441383.1 | LINC00876,AC096655.1-002 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0120344 | NONHSAT119676 | HOXA3as | transcriptional regulation | pathogenic process | promyelocytic leukemia;gastric cancer | Neoplasms;Hemic and Lymphatic Diseases;Digestive System Diseases |
| HSALNT0091313 | ENST00000511918.1 | SCAL1 | transcriptional regulation | pathogenic process | non-small cell lung cancer;lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289425 | BLACAT1 | linc-UBC1,LINC00912,onco-lncRNA-30 | transcriptional regulation | pathogenic process | bladder cancer;gastric cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
| HSALNT0149012 | GLIDR | LINC01172,MGC21881,TCONS_00015562 | NA | pathogenic process | glioblastoma | Neoplasms |
| HSALNT0217561 | PWAR5 | PAR5,PAR-5 | NA | pathogenic process | glioblastoma;Prader-Willi syndrome and Angelman syndrome;Prader-Willi syndrome | Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Nervous System Diseases |
| HSALNT0289272 | TP53TG1 | TP53AP1,H_RG012D21.9,LINC00096 | NA | pathogenic process | non-small cell lung cancer;ataxia telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Respiratory Tract Diseases;Immune System Diseases;Nutritional and Metabolic Diseases;Cardiovascular Diseases;Nervous System Diseases |
| HSALNT0289598 | AK126698 | NA | NA | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0217598 | NONHSAT041063 | NCRNA00002 | transcriptional regulation | pathogenic process | Prader-Willi syndrome | Nutritional and Metabolic Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0143633 | CCAT2 | NCCP1,LINC00873 | transcriptional regulation | pathogenic process | non-small cell lung cancer;oral squamous cell cancer;colorectal cancer;ovarian cancer;esophageal squamous cell cancer;bladder cancer;small cell lung cancer;gastric cancer;hepatocellular cancer;prostate cancer;cervical squamous cell cancer;lung cancer;breast cancer;cervical cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0289026 | LINC00261 | C20orf56,NCRNA00261,bA216C10.1,HCCDR1,TCONS_00027846,ALIEN,DEANR1,onco-lncRNA-17 | NA | pathogenic process | pancreatic cancer;non-small cell lung cancer;gastric cancer | Respiratory Tract Diseases;Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289078 | LINC00982 | FLJ42875 | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290082 | NEAT1_2 | NEAT1_2 | protein localization | pathogenic process | amyotrophic lateral sclerosis | Nutritional and Metabolic Diseases;Nervous System Diseases |
| HSALNT0288989 | GATA3-AS1 | NA | transcriptional regulation | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289427 | GNG12-AS1 | NA | transcriptional regulation | NA | NA | NA |
| HSALNT0290395 | YAM1 | Yam-1 | transcriptional regulation | pathogenic process;developmental process | skeletal myogenesis | Musculoskeletal Diseases |
| HSALNT0289202 | PAX8-AS1 | NA | NA | pathogenic process | malignant pleural mesothelioma;cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0054469 | RASSF1-AS1 | ANRASSF1 | transcriptional regulation | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0290261 | SUMO1P3 | SUMO1P3 | NA | pathogenic process | bladder cancer;gastric cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
| HSALNT0289002 | HNF1A-AS1 | C12orf27,NCRNA00262,FLJ38690,HAS1 | ceRNA | pathogenic process | esophageal adenocarcinoma;osteosarcoma;esophageal squamous cell cancer;gastric cancer;hepatocellular cancer;nasopharyngeal cancer;adenocarcinoma;lung adenocarcinoma;pancreatic cancer | Neoplasms;Respiratory Tract Diseases;Otorhinolaryngologic Diseases;Endocrine System Diseases;Digestive System Diseases;Stomatognathic Diseases |
| HSALNT0289377 | NIPBL-AS1 | NIPBL-DT,NIPBL-AS | NA | pathogenic process | autism spectrum disorder | Mental Disorders |
| HSALNT0289249 | SNHG15 | C7orf40,FLJ38860,MYO1GUT,Linc-Myo1g | NA | pathogenic process | gastric cancer;hepatocellular cancer;hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0235898 | ENST00000574306.1 | C17orf91,MGC14376,DKFZp686O06159 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0235898 | ENST00000574306.1 | C17orf91,MGC14376,DKFZp686O06159 | NA | NA | NA | NA |
| HSALNT0288984 | ENST00000579368.1 | MTCL1-AS1,HMlincRNA717 | NA | pathogenic process | pancreatic cancer;non-small cell lung cancer;gastric cancer | Respiratory Tract Diseases;Endocrine System Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289369 | MIF-AS1 | LOC284889,MIF-AS | transcriptional regulation | pathogenic process | malaria;nephrolithiasis | Skin and Connective Tissue Diseases;Male Urogenital Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Parasitic Diseases |
| HSALNT0129086 | NONHSAT123382 | MKLN1-AS1,FLJ43663,PINT,LincRNA-Pint | transcriptional regulation | pathogenic process | colorectal cancer;heart failure | Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289240 | NONHSAT075852 | LINC00913,SChLAP1,PCAT11 | transcriptional regulation | pathogenic process | bladder cancer;prostate cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0193241 | SOCS2-AS1 | NA | transcriptional regulation | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0138824 | CASC9 | ESCCAL-1,ESSCAL1,LINC00981 | NA | pathogenic process | esophageal squamous cell cancer;esophageal cancer | Neoplasms |
| HSALNT0267627 | HNF4A-AS1 | uc002xlx | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289194 | NKILA | NA | NA | pathogenic process | nasopharyngeal cancer;breast cancer;tongue squamous cell cancer | Skin and Connective Tissue Diseases;Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0289304 | LINC00942 | NA | NA | pathogenic process | ovarian cancer;autism spectrum disorder | Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Mental Disorders;Neoplasms |
| HSALNT0289187 | MNX1-AS1 | CCAT5,LOC645249 | NA | pathogenic process | ovarian cancer;colorectal cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
| HSALNT0289518 | VPS9D1-AS1 | MYU | NA | pathogenic process | ovarian cancer;colorectal cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
| HSALNT0290266 | TC0101441 | NA | NA | pathogenic process | epithelial ovarian cancer | Neoplasms |
| HSALNT0289426 | ERLNC1 | TC0101441,ElncRNA1 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290050 | ENST00000416928.2 | NA | NA | NA | NA | NA |
| HSALNT0043560 | ENST00000416928.2 | HOXD-AS1,Mdgt | NA | pathogenic process | bladder cancer;neuroblastoma | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289092 | LINC01158 | PANTR1,linc-Brn1a,linc-POU3F3 | transcriptional regulation | pathogenic process;developmental process | esophageal squamous cell cancer;gastric cancer;glioma | Neoplasms;Digestive System Diseases |
| HSALNT0289448 | GHET1 | lncRNA-GHET1 | NA | pathogenic process | bladder cancer;gastric cancer;colorectal cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
| HSALNT0289514 | PEG13 | NA | transcriptional regulation | pathogenic process | intellectual disabilities | Behavior and Behavior Mechanisms;Pathological Conditions, Signs and Symptoms;Mental Disorders;Nervous System Diseases |
| HSALNT0289183 | ENST00000414769.1 | MGC16121,H19X | NA | pathogenic process | choriocarcinoma | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289201 | NONHSAT018635 | NA | transcriptional regulation | pathogenic process;developmental process | uveal melanoma | Neoplasms |
| HSALNT0288956 | LINC01234 | LCAL84,onco-lncRNA-32 | ceRNA | pathogenic process | oesophageal squamous cell cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289021 | CYTOR | C2orf59,NCRNA00152,MGC4677 | transcriptional regulation;ceRNA | pathogenic process | colorectal cancer;gastric cancer;hepatocellular cancer;pancreatic cancer;breast cancer;renal cell cancer | Skin and Connective Tissue Diseases;Neoplasms;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0289706 | CHRF | NA | ceRNA | pathogenic process | cardiac hypertrophy;silicosis | Respiratory Tract Diseases;Occupational Diseases;Cardiovascular Diseases |
| HSALNT0143635 | ENST00000502056.1 | LINC00860,CARLo-1 | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0143672 | CASC11 | TCONS_00014535,LINC00990,CARLo-7,ENST00000518376 | transcriptional regulation | pathogenic process | hepatocellular cancer;colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289032 | LINC00323 | PRED42,FLJ37173 | NA | pathogenic process | breast cancer;hereditary haemorrhagic telangiectasia | Skin and Connective Tissue Diseases;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms |
| HSALNT0024655 | LINC01139 | LINK-A,TCONS_00000027 | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0289018 | LEF1-AS1 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia;colorectal cancer | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0247326 | LINC00667 | NA | NA | pathogenic process | hereditary haemorrhagic telangiectasia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Cardiovascular Diseases |
| HSALNT0290145 | POU3F3 | NA | transcriptional regulation | pathogenic process | esophageal squamous cell cancer;glioma | Neoplasms |
| HSALNT0199349 | LINC00426 | NA | NA | pathogenic process | primary Sjögren's syndrome | Immune System Diseases |
| HSALNT0155974 | LINC00963 | MetaLnc9 | NA | pathogenic process | prostate cancer;renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289211 | PCF11-AS1 | NA | NA | pathogenic process | hepatocellular cancer;adolescent idiopathic scoliosis | Musculoskeletal Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289534 | 91H | NA | transcriptional regulation | pathogenic process | osteosarcoma;esophageal squamous cell cancer;breast cancer;colorectal cancer | Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289446 | ELFN1-AS1 | MYCLo-2 | transcriptional regulation | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0288883 | ACTA2-AS1 | uc001kfo.1,ZXF1 | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289443 | NONHSAT121673 | RSBN1L-AS1 | transcriptional regulation | pathogenic process | liver fibrosis;glioblastoma | Neoplasms;Digestive System Diseases |
| HSALNT0289986 | LncRNA-MVIH | NA | NA | pathogenic process | hepatocellular cancer;non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289977 | LncRNA-ATB | NA | ceRNA | pathogenic process | colorectal cancer;hepatocelluar cancer;gastric cancer;pancreatic cancer;renal cell cancer;pneumoconiosis | Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Occupational Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0289622 | ATB | NA | ceRNA | pathogenic process | prostate cancer;glioma;keloid;gastric cancer;hepatocellular cancer;pancreatic cancer;breast cancer;colorectal cancer | Pathological Conditions, Signs and Symptoms;Skin and Connective Tissue Diseases;Neoplasms;Tissues;Male Urogenital Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0289586 | AK057054 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0278370 | LINC01315 | lnc-C22orf32-1,C22orf32-1 | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0055601 | ADAMTS9-AS2 | NA | NA | pathogenic process | non-small cell lung cancer;glioma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289383 | ENST00000608917.1 | PACER,PTGS2-AS1 | transcriptional regulation | pathogenic process | osteosarcoma;osteoarthritis;inflammation and cancer | Musculoskeletal Diseases;Neoplasms |
| HSALNT0289268 | TGFB2-OT1 | FLJ11812 | ceRNA | NA | NA | NA |
| HSALNT0288938 | DUBR | LINC00883 | ceRNA | pathogenic process | asthma and chronic obstructive pulmonary disease | Respiratory Tract Diseases |
| HSALNT0289440 | Lnc-FOXC1-1:1 | LINC01379,TCONS_00011636 | transcriptional regulation | pathogenic process | esophageal squamous cell cancer;basal-like breast cancer;oral squamous cell cancer | Neoplasms |
| HSALNT0288924 | CYP51A1-AS1 | ENST00000453068,LRRD1-AS1 | NA | pathogenic process | renal cell cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289395 | RPL34-AS1 | FLJ37673,RP11-462C24.1 | NA | pathogenic process | gastric cancer;colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289435 | C5orf66-AS1 | CTC-276P9.1,Epist | NA | pathogenic process | esophageal squamous cell cancer;bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289052 | LINC00623 | NA | NA | pathogenic process | nasopharyngeal cancer | Otorhinolaryngologic Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0289831 | FER1L4 | FER1L4 | ceRNA | pathogenic process | gastric cancer;endometrial cancer;colorectal cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
| HSALNT0288985 | ENST00000426539.1 | LINC01458,lncRNA-AC130710 | NA | pathogenic process | ovarian cancer;gastric cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
| HSALNT0288881 | ABHD11-AS1 | WBSCR26,LINC00035,NCRNA00035 | NA | pathogenic process | gastric cancer;mutant huntingtin | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Neoplasms;Digestive System Diseases |
| HSALNT0282263 | ZNF674-AS1 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289207 | PCAT29 | NA | NA | pathogenic process | prostate cancer;glioma;bladder cancer;renal clear cell cancer;skin melanoma;hepatocellular cancer;lung adenocarcinoma;stomach adenocarcinoma | Neoplasms;Respiratory Tract Diseases;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Digestive System Diseases |
| HSALNT0289672 | CADM1 | NA | NA | NA | NA | NA |
| HSALNT0289297 | LINC01527 | lnc-SPRR2D-1,RP1-13P20.6 | NA | pathogenic process | squamous cell cancer | Neoplasms |
| HSALNT0289158 | LUNAR1 | NA | transcriptional regulation | pathogenic process | diffuse large B-cell lymphoma;T cell acute lymphoblastic leukemia | Hemic and Lymphatic Diseases |
| HSALNT0289830 | FAR2P-1 | NA | NA | pathogenic process | lung adenocarcinoma;non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289263 | ENST00000607033.1 | EYA4-AS1 | transcriptional regulation | pathogenic process | kidney clear cell sarcoma | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0145373 | MAFA-AS1 | RP11-909N17.3,TCONS_00014882 | NA | pathogenic process | lung adenocarcinoma;non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290229 | RPLP0P2 | RPLP0P2 | NA | pathogenic process | lung adenocarcinoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289291 | ZNF295-AS1 | C21orf121,NCRNA00318,PRED87 | NA | pathogenic process | lung adenocarcinoma;epithelial ovarian cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0084473 | LINC01513 | RP11-1C1.7,TCONS_00009352 | NA | pathogenic process | NA | NA |
| HSALNT0289471 | IRAIN | IGF1R-AS | transcriptional regulation | pathogenic process | pancreatic cancer;acute myeloid leukemia;non-small cell lung cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms;Respiratory Tract Diseases;Endocrine System Diseases;Digestive System Diseases |
| HSALNT0290402 | ZNRD1-AS1 | NA | NA | pathogenic process | hepatocellular cancer;lung cancer;cervical cancer | Respiratory Tract Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
| HSALNT0289504 | LCAL1 | onco-lncRNA-27 | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289169 | MHRT | Myheart | transcriptional regulation | pathogenic process | heart hypertrophy;acute myocardial infarction | Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases |
| HSALNT0289859 | HA117 | NA | NA | pathogenic process | hirschsprung disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Digestive System Diseases |
| HSALNT0026673 | ENST00000414795.1 | lncRNA-CMPK2 | transcriptional regulation | pathogenic process | chronic hepatitis C;HCV | Digestive System Diseases;Virus Diseases |
| HSALNT0289887 | LET | NA | NA | pathogenic process | gallbladder cancer;esophageal squamous cell cancer;gastric cancer;nasopharyngeal cancer;renal cell cancer;cervical cancer | Neoplasms;Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Otorhinolaryngologic Diseases;Digestive System Diseases;Stomatognathic Diseases |
| HSALNT0007921 | NFIA-AS1 | RP5-833A20.1 | transcriptional regulation | pathogenic process | atherosclerosis;glioma | Cardiovascular Diseases;Neoplasms |
| HSALNT0247156 | GAPLINC | LINC01540,TCONS_00026238,lncRNA-uc002kmd.1 | siRNA | pathogenic process | gastric cancer;colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0288917 | CERNA2 | HOST2,lncRNA-HOST2 | ceRNA | pathogenic process | hepatocellular cancer;epithelial ovarian cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289113 | LINC01564 | TCONS_00011314 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0289088 | LINC01105 | FLJ30594,LOC150622 | NA | pathogenic process | gastric cancer;leukemia and neuroblastoma | Neoplasms;Digestive System Diseases |
| HSALNT0289464 | AGAP2-AS1 | LOC100130776,PUNISHER | transcriptional regulation | pathogenic process | non-small cell lung cancer;glioma;leukemia and neuroblastoma | Respiratory Tract Diseases;Neoplasms |
| HSALNT0288960 | EWSAT1 | TMEM84,NCRNA00277,LINC00277,FLJ33768 | transcriptional regulation | pathogenic process | Ewing sarcoma | Neoplasms |
| HSALNT0289242 | SLC25A25-AS1 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289317 | KCNK15-AS1 | RP11-445H22.4 | NA | pathogenic process | osteoarthritis;breast cancer | Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289864 | HIF2PUT | NA | NA | pathogenic process | osteosarcoma;colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289267 | TEX41 | DKFZp686O1327,LINC00953 | transcriptional regulation | NA | NA | NA |
| HSALNT0290361 | UFC1 | NA | transcriptional regulation;ceRNA | pathogenic process | osteoarthritis;hepatocellular cancer | Musculoskeletal Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289886 | LEIGC | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289367 | MDC1-AS1 | MDC1-AS | NA | pathogenic process | bladder cancer;glioma | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289190 | NBAT1 | CASC14,NBAT-1 | transcriptional regulation | pathogenic process | breast cancer;renal clear cell cancer;neuroblastoma | Skin and Connective Tissue Diseases;Male Urogenital Diseases;Neoplasms |
| HSALNT0234826 | LINC00917 | NA | NA | pathogenic process | intervertebral disc degeneration;breast cancer | Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289419 | LINC00173 | NCRNA00173,FLJ42957 | NA | pathogenic process | HIV-1-infected;hepatocelluar cancer | Virus Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0290138 | PEG10 | NA | NA | pathogenic process | diffuse large B-cell lymphoma;esophageal cancer | Neoplasms;Hemic and Lymphatic Diseases |
| HSALNT0289136 | LINC02224 | BRCAT107,ENST00000505706 | NA | pathogenic process | active tuberculosis | Bacterial Infections and Mycoses |
| HSALNT0289866 | HIT | NA | transcriptional regulation | pathogenic process | non-small cell lung cancer;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0003927 | SNHG12 | ASLNC04080,C1orf79,LINC00100,NCRNA00100,PNAS-123 | NA | pathogenic process | osteosarcoma;endometrial cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289099 | LINC01225 | NA | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0290047 | MALAT2 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0176345 | NONHSAT021826 | LINC00057,NCRNA00057,U22HG,UHG,lncRNA16 | NA | pathogenic process | astrocytoma;hepatocellular cancer;non-small cell lung cancer;Parkinson's disease;neuroblastoma | Respiratory Tract Diseases;Neoplasms;Digestive System Diseases;Nervous System Diseases |
| HSALNT0094592 | WSPAR | TCONS_00009511-XLOC_004555,lncTCF7 | transcriptional regulation | pathogenic process | hepatocellular cancer;liver cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289308 | LINC00511 | onco-lncRNA-12 | NA | pathogenic process | lung adenocarcinoma;breast cancer | Respiratory Tract Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0289452 | FAM83H-AS1 | onco-lncRNA-3 | NA | pathogenic process | NA | NA |
| HSALNT0289041 | LINC00472 | C6orf155,dJ288M22.3,FLJ13189 | NA | pathogenic process | ovarian cancer;breast cancer | Skin and Connective Tissue Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Endocrine System Diseases |
| HSALNT0289925 | Linc-ITGB1 | NA | NA | pathogenic process | gallbladder cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0016239 | LINC01133 | lncRNA-PAGBC | transcriptional regulation | pathogenic process | non-small cell lung cancer;colorectal cancer;lung squamous cell cancer | Respiratory Tract Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289489 | CCEPR | CCHE1,lncRNA-CCHE1 | transcriptional regulation | pathogenic process | hepatocellular cancer;cervical cancer | Female Urogenital Diseases and Pregnancy Complications;Neoplasms;Digestive System Diseases |
| HSALNT0289402 | SOX21-AS1 | NA | NA | pathogenic process | lung adenocarcinoma;oral squamous cell cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0288905 | CASC15 | LINC00340,lnc-SOX4-1 | NA | pathogenic process | basal cell cancer;melanoma;neuroblastoma | Neoplasms |
| HSALNT0289555 | AC104699.1 | NA | NA | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0096322 | CLMAT3 | SPARC-AS1 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289233 | RGMB-AS1 | NA | NA | pathogenic process | lung adenocarcinoma;non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0289908 | LINC01419 | LVCAT7,TCONS_00014497 | NA | pathogenic process | hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289541 | AB209630 | NA | NA | pathogenic process | hypopharyngeal squamous cell cancer | Neoplasms |
| HSALNT0289608 | AOC4P | AOC4P | NA | pathogenic process | colorectal cancer;hepatocelluar cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289082 | LINC01021 | LINC01021,LOC643401,RP11-46C20.1 | NA | pathogenic process | NA | NA |
| HSALNT0196121 | LINC01089 | LIMT | NA | pathogenic process | breast cancer;astrocytoma | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0123080 | EGFR-AS1 | NA | NA | pathogenic process | hepatocellular cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289539 | AB073614 | NA | NA | pathogenic process | ovarian cancer;glioma | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0242418 | CACNA1G-AS1 | NA | NA | pathogenic process | keloid | Pathological Conditions, Signs and Symptoms;Skin and Connective Tissue Diseases;Tissues |
| HSALNT0170814 | MIR210HG | NA | transcriptional regulation | pathogenic process | hypoxic and inflammatory stress | NA |
| HSALNT0288979 | FOXC2-AS1 | ODRUL | NA | pathogenic process | osteosarcoma | Neoplasms |
| HSALNT0289022 | LINC00160 | C21orf52,NCRNA00160 | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0105274 | LINC01016 | NA | NA | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0288904 | CARMN | MIR143HG,CARMEN | transcriptional regulation | pathogenic process | cardiac differentiation | Cardiovascular Diseases |
| HSALNT0289123 | LINC01630 | LOC100287225 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0288971 | FAM30A | C14orf110,KIAA0125,HSPC053 | NA | pathogenic process | gallbladder cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289506 | LINC00346 | C13orf29,NCRNA00346 | NA | pathogenic process | hepatocellular cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289643 | BC032469 | NA | ceRNA | pathogenic process | esophageal squamous cell cancer;gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289580 | AK024171 | NA | NA | pathogenic process | intervertebral disc degeneration;gastric cancer | Musculoskeletal Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0290187 | RP11-284N8.3.1 | NA | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289839 | FMR6 | NA | NA | pathogenic process | fragile X syndrome;fragile X-associated premature ovarian insufficiency | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Female Urogenital Diseases and Pregnancy Complications;Nervous System Diseases |
| HSALNT0290152 | PRAL | lncRNA-PRAL | NA | pathogenic process | hepatocellular cancer;lung cancer | Respiratory Tract Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289380 | NORAD | LINC00657 | transcriptional regulation;translational control | pathogenic process | breast cancer | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0086803 | LIFR-AS1 | NA | NA | pathogenic process | preterm | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0076183 | PANCR | NA | NA | pathogenic process | atrial fibrillation | Pathological Conditions, Signs and Symptoms;Cardiovascular Diseases |
| HSALNT0288975 | FEZF1-AS1 | NA | transcriptional regulation | pathogenic process | gastric cancer;colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0238475 | CCDC144NL-AS1 | NA | ceRNA | pathogenic process | ovarian cancer;cardiac hypertrophy | Female Urogenital Diseases and Pregnancy Complications;Endocrine System Diseases;Cardiovascular Diseases;Neoplasms |
| HSALNT0290102 | NR_026689 | NA | NA | pathogenic process | ovarian cancer;lung cancer | Respiratory Tract Diseases;Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289522 | ADARB2-AS1 | C10orf109,NCRNA00168,bA466B20.1 | NA | pathogenic process | breast cancer;pancreatic ductal adenocarcinoma | Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0288936 | DPP10-AS1 | BC032913 | NA | pathogenic process | breast cancer;colorectal cancer | Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0289474 | GAS8-AS1 | C16orf3 | NA | pathogenic process | papillary thyroid cancer;breast cancer | Skin and Connective Tissue Diseases;Endocrine System Diseases;Neoplasms |
| HSALNT0289063 | LINC00704 | LINC00704 | NA | pathogenic process | NA | NA |
| HSALNT0289238 | SAMMSON | LINC01212 | NA | pathogenic process | melanoma | Neoplasms |
| HSALNT0289027 | LINC00302 | C1orf46,NCRNA00302,XP33 | NA | developmental process | NA | NA |
| HSALNT0245543 | SNHG20 | C17orf86,NCRNA00338,LINC00338,PRO0872,FLJ25582,DKFZp686L05235,SCARNA16HG | transcriptional regulation | pathogenic process | hepatocellular cancer;colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0015631 | DCST1-AS1 | RP11-307C12.11 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0149810 | PGM5-AS1 | FAM233A,LOC572558 | NA | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0290236 | SBF2-AS1 | NA | transcriptional regulation | pathogenic process | non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0290325 | Uc.338 | NA | transcriptional regulation | pathogenic process | hepatocellular cancer;lung cancer | Respiratory Tract Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0290002 | LOC100130476 | NA | NA | pathogenic process | esophageal squamous cell cancer;gastric cardia adenocarcinoma | Neoplasms |
| HSALNT0289049 | Lnc-TNKS-1:1 | Rncr3 | NA | pathogenic process | diabetes | Endocrine System Diseases |
| HSALNT0020406 | LINC00628 | NA | transcriptional regulation | pathogenic process | gastric cancer | Neoplasms;Digestive System Diseases |
| HSALNT0289478 | DSCR4 | DCRB | NA | pathogenic process | Down syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0017675 | GAS5-AS1 | NA | NA | pathogenic process | oral submucous fibrosis;non-small cell lung cancer | Respiratory Tract Diseases;Neoplasms;Stomatognathic Diseases |
| HSALNT0289523 | HCG11 | bK14H9.3,FLJ14049,FLJ30357 | NA | pathogenic process | prostate cancer | Male Urogenital Diseases;Neoplasms |
| HSALNT0134828 | LINC02099 | AC145110.1 | NA | pathogenic process | rheumatoid arthritis;breast cancer | Immune System Diseases;Musculoskeletal Diseases;Skin and Connective Tissue Diseases;Neoplasms |
| HSALNT0209098 | G2E3-AS1 | CAT1647 | NA | pathogenic process | bladder cancer | Male Urogenital Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0289139 | LINC02245 | lnc-SERTAD2-3,AC007386.2 | NA | pathogenic process | ovarian cancer | Endocrine System Diseases;Female Urogenital Diseases and Pregnancy Complications;Neoplasms |
| HSALNT0008167 | FOXD3-AS1 | pasFOXD3 | transcriptional regulation | pathogenic process | glioma | Neoplasms |
| HSALNT0289335 | LINC00998 | NA | NA | pathogenic process | major depression disorder | Behavior and Behavior Mechanisms |
| HSALNT0289379 | NNT-AS1 | NA | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0055497 | PSMD6-AS1 | ENST00000462717,lnc00462717 | NA | pathogenic process | papillary thyroid cancer;glioma | Endocrine System Diseases;Neoplasms |
| HSALNT0289130 | LINC02081 | CTD-2357A8.3,XLOC_012582 | NA | pathogenic process | esophageal cancer | Neoplasms |
| HSALNT0289306 | LINC00052 | TMEM83,NCRNA00052,FLJ31461 | ceRNA | pathogenic process | hepatocellular cancer;breast cancer | Skin and Connective Tissue Diseases;Neoplasms;Digestive System Diseases |
| HSALNT0199070 | PLUT | PDX1-AS1,PLUTO,HI-LNC71 | transcriptional regulation | pathogenic process | type 2 diabetes | Nutritional and Metabolic Diseases;Endocrine System Diseases |
| HSALNT0289341 | LINC01505 | RP11-308N19.1 | NA | pathogenic process | NA | NA |
| HSALNT0289315 | LINC01116 | TALNEC2 | transcriptional regulation | pathogenic process | prostate cancer;glioblastoma | Male Urogenital Diseases;Neoplasms |
| HSALNT0006439 | FOXD2-AS1 | MGC12982 | NA | pathogenic process | lung cancer | Respiratory Tract Diseases;Neoplasms |
| HSALNT0252387 | LINC00305 | C18orf20,NCRNA00305,MGC39571,HsT1235 | NA | NA | NA | NA |
| HSALNT0289473 | FBXL19-AS1 | NCRNA00095,MGC125469,MGC125470,MGC125472 | NA | pathogenic process | colorectal cancer | Neoplasms;Digestive System Diseases |
| HSALNT0187807 | LINC02555 | AC079630.2 | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0251493 | LINC01929 | CTD-2171N6.1 | NA | pathogenic process | papillary thyroid cancer | Endocrine System Diseases;Neoplasms |
| HSALNT0244776 | LINC01152 | TCONS_00025128,CMPD | NA | pathogenic process | NA | NA |
| HSALNT0284591 | DIAPH2-AS1 | NA | NA | pathogenic process | Hodgkin's disease | Neoplasms |
| HSALNT0289226 | PWAR1 | PAR1,PAR-1 | NA | pathogenic process | Prader-Willi syndrome and Angelman syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Nervous System Diseases |
| HSALNT0289339 | LINC00950 | FP588 | NA | NA | NA | NA |
| HSALNT0289740 | DGCR12 | DGS-E | NA | pathogenic process;developmental process | DiGeorge syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Cardiovascular Diseases;Endocrine System Diseases |
| HSALNT0275220 | DGCR9 | DGS-A,POM121L5P | NA | pathogenic process | DiGeorge syndrome | Congenital, Hereditary, and Neonatal Diseases and Abnormalities;Hemic and Lymphatic Diseases;Musculoskeletal Diseases;Cardiovascular Diseases;Endocrine System Diseases |
| HSALNT0288929 | DGCR10 | DGS-B | NA | pathogenic process | NA | NA |
| HSALNT0289494 | DGCR11 | DGS-D | NA | pathogenic process | NA | NA |
| HSALNT0267755 | LINC02597 | NA | Transcriptional regulation | Pathogenic process | Postmenopausal osteoporosis (PMOP) | Musculoskeletal Diseases |
| HSALNT0178412 | UVRAG-DT | NA | Transcriptional regulation | Pathogenic process | Postmenopausal osteoporosis (PMOP) | Musculoskeletal Diseases |
| HSALNT0185540 | LINC02598 | NA | _ | Pathogenic process | Lung squamous cell carcinoma (LUSC) | Neoplasms; Respiratory Tract Diseases |
| HSALNT0278274 | SREBF2-AS1 | NA | _ | Pathogenic process | Lung squamous cell carcinoma (LUSC) | Neoplasms; Respiratory Tract Diseases |
| HSALNT0021177 | LINC02602 | NA | _ | Pathogenic process | Non-small cell lung cancer (NSCLC) | Neoplasms; Respiratory Tract Diseases |
| HSALNT0021052 | MIR205HG | NA | CeRNA | Pathogenic process | Head & neck squamous cell carcinoma (HNSCC) | Neoplasms |
| HSALNT0107588 | ZNF451-AS1 | NA | Transcriptional regulation | Pathogenic process | Pancreatic ductal adenocarcinoma (PDAC) | Neoplasms |
| HSALNT0189537 | SCAT2 | NA | _ | Pathogenic process | Kidney clear cell carcinoma (KIRC) | Neoplasm |
| HSALNT0107867 | SCAT8 | NA | _ | Pathogenic process | Kidney clear cell carcinoma (KIRC) | Neoplasm |
| HSALNT0158500 | LINC00707 | NA | Transcriptional regulation | Pathogenic process | Lung cancer (LC) | Neoplasms; Respiratory Tract Diseases |
| HSALNT0185476 | LINC02470 | NA | _ | Pathogenic process | Non-small cell lung cancer (NSCLC) and overian cancer | Neoplasm |
| HSALNT0068302 | LINC02600 | NA | _ | Pathogenic process | Non-small cell lung cancer (NSCLC) and overian cancer | Neoplasm |
| HSALNT0123915 | LINC02604 | NA | CeRNA | Pathogenic process | Glioblastoma | Neoplasms |
| HSALNT0160932 | MACORIS | NA | Transcriptional regulation | _ | Cardiometabolic Diseases | Cardiovascular Diseases |
| HSALNT0171022 | KRTAP5-AS1 | NA | CeRNA | Pathogenic process | Gastric Cancer | Neoplasms; Digestive System Diseases |
| HSALNT0215076 | GSC-DT | NA | _ | Developmental process | _ | _ |
| HSALNT0072605 | CHAER1 | NA | Translational control | Pathogenic process | Cardiac hypertrophy | Cardiovascular Diseases |
| HSALNT0027291 | ODC1-DT | NA | CeRNA | Pathogenic process | Head and neck carcinoma | Neoplasm |
| HSALNT0039409 | MAP3K2-DT | NA | _ | Pathogenic process | Polycystic ovary syndrome (PCOS) | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0208284 | ZFHX2-AS1 | NA | Transcriptional regulation | Developmental process | _ | _ |
| HSALNT0152349 | LINC02603 | NA | _ | _ | _ | _ |
| HSALNT0081596 | TENM3-AS1 | NA | _ | _ | _ | _ |
| HSALNT0165522 | LINC00858 | NA | _ | _ | non-small cell lung cancer | Respiratory Tract Diseases |
| HSALNT0281930 | SCAT1 | NA | _ | _ | esophagal cancer | Digestive system Diseases |
| HSALNT0191750 | LNCOG | NA | _ | _ | osteogenic differenciation | Musculoskeletal Diseases |
| HSALNT0246388 | DCXR-DT | NA | _ | _ | prostate cancer | Male Urogenital Diseases |
| HSALNT0209659 | NKX2-1-AS1 | NA | _ | _ | lung cancer | Respiratory Tract Diseases |
| HSALNT0038250 | ACTR3-AS1 | NA | _ | _ | glioblastoma | Nervous system diseases |
| HSALNT0043145 | ITGA6-AS1 | NA | _ | _ | glioblastoma | Nervous system diseases |
| HSALNT0281822 | LINC02601 | NA | _ | _ | glioblastoma | Nervous system diseases |
| NA | ZKSCAN7-AS1 | NA | _ | _ | glioblastoma | Nervous system diseases |
| HSALNT0120721 | GARS-DT | NA | _ | _ | heroine addiction | Nervous system diseases |
| NA | GPRACR | NA | _ | _ | liver cancer | Digestive system Diseases |
| HSALNT0082561 | LINC01060 | NA | _ | _ | pancreatic cancer | Digestive system Diseases |
| HSALNT0058704 | TBILA | NA | _ | _ | non-small cell lung cancer | Respiratory Tract Diseases |
| NA | UGDH-AS1 | NA | _ | _ | invertebral disc degeneration | Musculoskeletal Diseases |
| HSALNT0245777 | TNRC6C-AS1 | NA | _ | _ | Thyroid cancer | Endocrine system Disease |
| HSALNT0225753 | LINC02244 | NA | _ | _ | obesity | Digestive system Diseases |
| NA | NKAIN3-IT1 | NA | _ | _ | glioblastoma | Nervous system diseases |
| HSALNT0013113 | NGF-AS1 | NA | _ | _ | dysmenorhea | Female Urogenital Diseases |
| HSALNT0031057 | LINC01121 | NA | _ | _ | pancreatic cancer | Digestive system Diseases |
| HSALNT0234176 | ARLNC1 | NA | _ | _ | prostate cancer | Male Urogenital Diseases |
| NA | MPPED2-AS1 | NA | _ | _ | thyroid neoplasias | Endocrine system Disease |
| NA | LINC01703 | NA | _ | _ | Hepatocellular carcinoma | Digestive system Diseases |
| HSALNT0144162 | HPYR1 | NA | _ | pathogenic process | H. pylori infection | _ |
| HSALNT0172266 | LINC00958 | NA | protein localization,transcriptional regulation | pathogenic process | bladder cancer, glioma | _ |
| HSALNT0167574 | SH3PXD2A-AS1 | NA | transcriptional regulation | pathogenic process | colorectal cancer | _ |
| NA | SSTR5-AS1 | NA | transcriptional regulation | pathogenic process | neuroendocrine prostate cancer | _ |
| NA | TSPOAP1-AS1 | NA | _ | pathogenic process | breast cancer | _ |
| NA | LINC00174 | NA | ceRNA | pathogenic process | colorectal carcinoma | _ |
| HSALNT0169064 | LINC01561 | NA | ceRNA | pathogenic process | breast cancer | _ |
| NA | LINC00514 | NA | transcriptional regulation | pathogenic process | neuroendocrine prostate cancer | _ |
| HSALNT0282164 | LINC02595 | NA | _ | pathogenic process | colorectal cancer | _ |
| HSALNT0197396 | FZD10-AS1 | NA | _ | _ | _ | _ |
| NA | LINC01567 | NA | transcriptional regulation | pathogenic process | colon cancer | _ |
| NA | ADPGK-AS1 | NA | transcriptional regulation | pathogenic process | pancreatic cancer | _ |
| HSALNT0255381 | RAB11B-AS1 | NA | transcriptional regulation | pathogenic process | osteosarcoma | _ |
| HSALNT0237805 | SNHG29 | NA | transcriptional regulation | pathogenic process | acute myeloid leukemia, rheumatoid arthritis | _ |
| NA | SNHG17 | NA | transcriptional regulation | pathogenic process | colorectal cancer | _ |
| HSALNT0215138 | DICER1-AS1 | NA | transcriptional regulation | pathogenic process | osteosarcoma | _ |
| HSALNT0043929 | TTN-AS1 | NA | transcriptional regulation | pathogenic process | esophageal squamous cell carcinoma | _ |
| HSALNT0152594 | LINC00092 | NA | transcriptional regulation | pathogenic process | ovarian cancer | _ |
| HSALNT0050704 | THUMPD3-AS1 | NA | transcriptional regulation | pathogenic process | Neuron death in stroke | _ |
| HSALNT0205980 | LINC00554 | NA | transcriptional regulation | pathogenic process | liver cancer | _ |
| HSALNT0141703 | ZFPM2-AS1 | NA | transcriptional regulation | pathogenic process | multiple cancers, gastric carcinogenesis | _ |
| NA | HOXB-AS1 | NA | transcriptional regulation | pathogenic process | autosomal dominant polycistic kidney disease | _ |
| HSALNT0167650 | CFAP58-DT | NA | transcriptional regulation | pathogenic process | innate immune response to viral infection | _ |
| NA | FAM230A | NA | _ | _ | _ | _ |
| NA | CPNE8-AS1 | NA | transcriptional regulation | pathogenic process | cervical cancer | _ |
| NA | THORLNC | NA | transcriptional regulation | pathogenic process | melanoma, skin squamous cell carcinoma,osteosarcoma, renal cell carcinoma | _ |
| NA | IATPR | NA | transcriptional regulation | pathogenic process | breast cancer, gallbladder cancer | _ |
| HSALNT0242280 | PICART1 | NA | transcriptional regulation | pathogenic process | breast cancer, colorectal cancer, lung cancer | _ |
| NA | LINC02599 | NA | transcriptional regulation | pathogenic process | breast cancer | _ |
| HSALNT0183231 | ETS1-AS1 | NA | transcriptional regulation | pathogenic process | gastric cancer, neuroblastoma | _ |
| NA | MAPK6-DT | NA | transcriptional regulation | pathogenic process | liver cancer | _ |
| HSALNT0036655 | IL1R1-AS1 | NA | transcriptional regulation | pathogenic process | Oral squamous cell carcinoma, breast cancer | _ |
| HSALNT0001134 | LINC01672 | NA | transcriptional regulation | pathogenic process | Esophageal squamous cell carcinoma | _ |
| HSALNT0135857 | SIRLNT | NA | ceRNA | pathogenic process | Breast cancer | _ |
| HSALNT0135484 | LINC01605 | NA | transcriptional regulation | pathogenic process | Colon Cancer, Bladder cancer | _ |
| HSALNT0184552 | GAU1 | NA | transcriptional regulation | pathogenic process | Neuroblastoma and retinoblastoma | _ |
| HSALNT0287294 | LINC00894 | NA | transcriptional regulation | pathogenic process | Lung adenocarcinoma | _ |
| HSALNT0000250 | LINC02593 | NA | _ | pathogenic process | breast cancer, hepatocellular carcinoma | _ |
| HSALNT0241060 | LINC02594 | NA | _ | _ | gastric cancer | _ |
| HSALNT0022481 | LINC01705 | NA | transcriptional regulation | pathogenic process | gastric cancer | _ |
| HSALNT0022477 | LINC02474 | NA | transcriptional regulation | pathogenic process | gastric cancer | _ |
| HSALNT0030809 | LINC02590 | NA | transcriptional regulation | pathogenic process | gastric cancer | _ |
| HSALNT0170966 | MUC5B-AS1 | NA | transcriptional regulation | pathogenic process | lung adenocarcinoma | _ |
| HSALNT0275151 | FAM230D | NA | _ | _ | _ | _ |
| HSALNT0275163 | FAM230E | NA | _ | _ | _ | _ |
| HSALNT0275179 | FAM230F | NA | _ | _ | _ | _ |
| NA | FAM230G | NA | _ | _ | _ | _ |
| NA | FAM230H | NA | _ | _ | Papillary thyroid carcinoma | _ |
| NA | FAM230I | NA | _ | _ | _ | _ |
| HSALNT0275150 | FAM230J | NA | _ | _ | _ | _ |
| HSALNT0103387 | HCG14 | NA | transcriptional regulation | pathogenic process | Celiac disease, Nutritional and Metabolic Diseases | _ |
| NA | LINC01510 | NA | transcriptional regulation, ceRNA | pathogenic process | Colorectal cancer, Non-small cell lung cancer | _ |
| NA | LNCOC1 | NA | transcriptional regulation | pathogenic process | Ovarian cancer | _ |
| NA | LGALSL-DT | NA | transcriptional regulation | pathogenic process | Postmenopausal osteoporosis (PMOP) | _ |
| HSALNT0002862 | LINC02596 | NA | transcriptional regulation | pathogenic process | Postmenopausal osteoporosis (PMOP) | _ |
| NA | DEC1 | NA | NA | NA | NA | NA |
| NA | MYOPARR | NA | NA | NA | NA | NA |
| NA | PCED1B-AS1 | NA | NA | NA | NA | NA |
| NA | UMLILO | NA | NA | NA | NA | NA |
| NA | LINC02631 | NA | NA | NA | NA | NA |
| NA | BMNCR | NA | NA | NA | NA | NA |
| NA | ZEBTR | NA | NA | NA | NA | NA |
| NA | SNHG31 | NA | NA | NA | NA | NA |
| NA | LINC00574 | NA | NA | NA | NA | NA |
| NA | RCC2-AS1 | NA | NA | NA | NA | NA |
| NA | PRDM16-DT | NA | NA | NA | NA | NA |
| NA | BCL6-AS1 | NA | NA | NA | NA | NA |
| NA | C1orf220 | NA | NA | NA | NA | NA |
| NA | MIR122HG | NA | NA | NA | NA | NA |
| NA | PANTR1 | NA | NA | NA | NA | NA |
| NA | C11orf72 | NA | NA | NA | NA | NA |
| NA | CT66 | NA | NA | NA | NA | NA |
| NA | CT75 | NA | NA | NA | NA | NA |
| NA | MIR9-3HG | NA | NA | NA | NA | NA |
| NA | RN7SL2 | NA | NA | NA | NA | NA |
| NA | RN7SL3 | NA | NA | NA | NA | NA |
| NA | CT70 | NA | NA | NA | NA | NA |
| NA | CT69 | NA | NA | NA | NA | NA |
| NA | C10orf91 | NA | NA | NA | NA | NA |
| NA | CTBP1-DT | NA | NA | NA | NA | NA |
| NA | FAM201B | NA | NA | NA | NA | NA |
| NA | MAFG-DT | NA | NA | NA | NA | NA |
| NA | RPP38-DT | NA | NA | NA | NA | NA |
| NA | CDRT3 | NA | NA | NA | NA | NA |
| NA | DLEU2L | NA | NA | NA | NA | NA |
